Publications from OUS - Department of Urology

724 publications found

Publications 2025

1. Botti S, Ceccato T, Rizzo M, Liguori G, Zucchi A, Palmieri A, Johansen TEB, Cai T (2025)
   Could Urology's Antimicrobial Stewardship Be Enhanced by the Routine Use of the Meares and Stamey Test?
   Diagnostics (Basel), 15 (8)
   DOI 10.3390/diagnostics15081002, PubMed 40310395
2. Cai T, Brugnolli A, Lanzafame M, Dellai F, Tascini C, Scarparo C, Racanelli V, Massidda O, Bonkat G, Gallelli L, Johansen TEB (2025)
   A Precision Medicine Model for Targeted Antibiotic Therapy in Urinary Tract Infections: A Valuable Tool to Reduce Hospitalization Stay and the Time to Switch to Oral Treatment
   Antibiotics (Basel), 14 (2)
   DOI 10.3390/antibiotics14020211, PubMed 40001454
3. Cai T, Ceccato T, Botti S, Kranz J, Verze P, Bonkat G, Aversa A, Racanelli V, Bjerklund Johansen TE (2025)
   Impact of Lifestyle and the Microbiome on Male Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia
   Eur Urol Focus (in press)
   DOI 10.1016/j.euf.2025.04.013, PubMed 40254491
4. Glott T, Wright DN, Nilsen OJ, Annavini E, Boulland JL (2025)
   Urodynamics with MEMS-Based pressure sensors, a clinical validation
   Biosens Bioelectron, 278, 117320
   DOI 10.1016/j.bios.2025.117320, PubMed 40056567
5. Holm HV, Lumen N, Ludwig TA, Fisch M, Hofer M, Brandes S, Kurtzman J, Simhan J, Venkatesan K, Gómez RG, Nikolavsky D, Tryfonyuk L, Martins FE (2025)
   Urinary Diversion as Last Option After Failed Artificial Urinary Sphincter and Iatrogenic Devastated Bladder Outlet
   Neurourol Urodyn, 44 (4), 914-921
   DOI 10.1002/nau.70013, PubMed 39960064
6. Kjøbli E, Haug ES, Salvesen Ø, Arstad C, Bergesen AK, Brennhovd B, Carlsen B, Gharib-Alhaug B, Gudbrandsdottir G, Juliebø-Jones P, Haugland JN, Karlsvik AK, Larsen M, Lilleaasen GM, Mûller S, Plathan ML, Roaldsen M, Roth I, Schwenke BLL, Wahlqvist R, Wessel N, Wibe A, Beisland C (2025)
   "Modernized" en Bloc Radical Cystectomy Versus Standard Radical Cystectomy: A Nationwide Multi-Institutional Propensity Score Matched Analysis
   Cancers (Basel), 17 (3)
   DOI 10.3390/cancers17030404, PubMed 39941772

Publications 2024

1. Bjerklund Johansen TE, Cai T, Zahl PH (2024)
   Re: Transperineal vs Transrectal Prostate Biopsy-The PREVENT Randomized Clinical Trial
   Eur Urol, 87 (6), 731-732
   DOI 10.1016/j.eururo.2024.11.010, PubMed 39603968
2. Bjerner J, Bratt O, Aas K, Albertsen PC, Carlsson SV, Oldenburg J (2024)
   Reply to Rongkang Li, Lei Peng, Shaohua Zhang, and Song Wu's Letter to the Editor re: Johan Bjerner, Ola Bratt, Kirsti Aas, et al. Baseline Serum Prostate-specific Antigen Value Predicts the Risk of Subsequent Prostate Cancer Death-Results from the Norwegian Prostate Cancer Consortium. Eur Urol 2024;86:20-6
   Eur Urol, 86 (6), e150-e151
   DOI 10.1016/j.eururo.2024.08.034, PubMed 39294047
3. Cai T, Boeri L, Miacola C, Palumbo F, Albo G, Ditonno P, Racanelli V, Palmieri A, Bjerklund Johansen TE, Aversa A (2024)
   Can nutraceuticals counteract the detrimental effects of the environment on male fertility? A parallel systematic review and expert opinion
   Minerva Endocrinol (Torino), 50 (1), 84-96
   DOI 10.23736/S2724-6507.24.04218-0, PubMed 39259514
4. Cai T, Tamanini I, Odorizzi K, Gallelli L, Lanzafame M, Mazzoli S, Lanzafame P, Massidda O, Palmieri A, Wagenlehner FME, Bjerklund Johansen TE, De Nunzio C (2024)
   The diagnostic yield of the Meares & Stamey test can be significantly improved by symptom-based patient selection and the experience of the test performer
   Prostate Cancer Prostatic Dis, 27 (2), 300-304
   DOI 10.1038/s41391-024-00824-0, PubMed 38555411
5. Cai T, Tamanini I, Puglisi M, Bizzotto L, Rizzo M, Liguori G, Gallelli L, Palmieri A, Bjerklund Johansen TE (2024)
   Phytotherapy Might Have a Role in Reducing Unnecessary Prostate Biopsies: Results from an Exploratory, Randomized Controlled Trial of Two Different Phytotherapeutic Agents
   Clin Pract, 14 (1), 188-197
   DOI 10.3390/clinpract14010016, PubMed 38391402
6. Ceccato T, Botti S, Tascini C, Lanzafame M, Brugnolli A, Ruggera L, Massidda O, Racanelli V, Bjerklund Johansen TE, Cai T (2024)
   Emerging strategies in tackling antimicrobial resistance in urology: Narrative review and expert opinion
   Urologia, 92 (2), 185-193
   DOI 10.1177/03915603241310389, PubMed 40172006
7. Ceccato T, Botti S, Tascini C, Lanzafame M, Brugnolli A, Ruggera L, Massidda O, Racanelli V, Johansen TEB, Cai T (2024)
   Emerging strategies in tackling antimicrobial resistance in urology: Narrative review and expert opinion
   Urologia Journal, 0, 1-9
   DOI 10.1177/03915603241310389, PublikaID 513
8. Galtung KF, Lauritzen PM, Sandbæk G, Bay D, Baco E, Rud E (2024)
   Urinary stone assessment in a single-phase may replace the unenhanced and multiphase computed tomography protocol in painless visible haematuria
   Scand J Urol, 59, 147-155
   DOI 10.2340/sju.v59.40679, PubMed 39268780
9. Galtung KF, Lauritzen PM, Sandbæk G, Bay D, Ponzi E, Baco E, Cowan NC, Naas AM, Rud E (2024)
   Computed tomography for visible haematuria - a single nephrographic phase is sufficient for detecting renal cell carcinoma
   Scand J Urol, 59, 10-18
   DOI 10.2340/sju.v59.18467, PubMed 38226799
10. Gerdtsson A, Negaard HFS, Almås B, Bergdahl AG, Cohn-Cedermark G, Glimelius I, Halvorsen D, Haugnes HS, Hedlund A, Hellström M, Holmberg G, Karlsdóttir Á, Kjellman A, Larsen SM, Thor A, Wahlqvist R, Ståhl O, Tandstad T (2024)
    Initial surveillance in men with marker negative clinical stage IIA non-seminomatous germ cell tumours
    BJU Int, 133 (6), 717-724
    DOI 10.1111/bju.16289, PubMed 38293778
11. Jacewicz M, Rud E, Lauritzen P, Baco E (2024)
    Non-infectious adverse events of transperineal prostate biopsies performed under local anaesthesia
    BJU Int, 134 (2), 300-306
    DOI 10.1111/bju.16383, PubMed 38679416
12. Löffeler S, Bertilsson H, Müller C, Aas K, Haugnes HS, Aksnessæther B, Pesonen M, Thon K, Tandstad T, Murtola T, Poulsen MH, Nordstrøm T, Vigmostad MN, Ottosson F, Holmsten K, Christiansen O, Slaaen M, Haug ES, Storås AH, Asphaug L, Rannikko A, Brasso K, Scandinavian Prostate Cancer Group (SPCG) and the Norwegian Get‐Randomized (GRand) Initiative (2024)
    Protocol of a randomised, controlled trial comparing immediate curative therapy with conservative treatment in men aged ≥75 years with non-metastatic high-risk prostate cancer (SPCG 19/GRand-P)
    BJU Int, 133 (6), 680-689
    DOI 10.1111/bju.16314, PubMed 38469686
13. Martins FE, Lumen N, Holm HV (2024)
    Management of the Devastated Bladder Outlet after Prostate CANCER Treatment
    Curr Urol Rep, 25 (7), 149-162
    DOI 10.1007/s11934-024-01206-8, PubMed 38750347
14. Medina-Polo J, Falkensammer E, Köves B, Kranz J, Tandogdu Z, Tapia AM, Cai T, Wagenlehner FME, Schneidewind L, Bjerklund Johansen TE, UTISOLVE Research Group (2024)
    Systematic Review and Meta-Analysis Provide no Guidance on Management of Asymptomatic Bacteriuria within the First Year after Kidney Transplantation
    Antibiotics (Basel), 13 (5)
    DOI 10.3390/antibiotics13050442, PubMed 38786170
15. Qvigstad LF, Eri LM, Lien MD, Fosså SD, Aas K, Berge V (2024)
    Reduction of lower urinary tract symptoms in prostate cancer patients treated with robot assisted laparoscopic prostatectomy
    Scand J Urol, 59, 121-125
    DOI 10.2340/sju.v59.40070, PubMed 38888041
16. Thor A, Negaard HFS, Grenabo Bergdahl A, Almås B, Melsen Larsen S, Lundgren PO, Gerdtsson A, Halvorsen D, Johannsdottir B, Jansson AK, Hellström M, Wahlqvist R, Langberg CW, Hedlund A, Akre O, Glimelius I, Ståhl O, Haugnes HS, Cohn-Cedermark G, Kjellman A, Tandstad T (2024)
    Primary Retroperitoneal Lymph Node Dissection as Treatment for Low-volume Metastatic Seminoma in a Population-based Cohort: The Swedish Norwegian Testicular Cancer Group Experience
    Eur Urol Open Sci, 65, 13-19
    DOI 10.1016/j.euros.2024.05.006, PubMed 38966804
17. Vasantharajan S, Wessel N, Thune I, Habberstad A (2024)
    [Not Available]
    Tidsskr Nor Laegeforen, 144 (12)
    DOI 10.4045/tidsskr.24.0104, PubMed 39404242
18. Vedeld HM, Pharo H, Sørbø AK, Brandt-Winge S, Five MB, Jeanmougin M, Guldberg P, Wahlqvist R, Lind GE (2024)
    Distinct longitudinal patterns of urine tumor DNA in patients undergoing surveillance for bladder cancer
    Mol Oncol, 18 (11), 2684-2695
    DOI 10.1002/1878-0261.13639, PubMed 38720532

Publications 2023

1. Berge V, Beisland C (2023)
   [The PSA test must be used more astutely]
   Tidsskr Nor Laegeforen, 143 (12)
   DOI 10.4045/tidsskr.23.0528, PubMed 37668129
2. Bjerner J, Bratt O, Aas K, Albertsen PC, Fosså SD, Kvåle R, Lilja H, Müller C, Müller S, Stensvold A, Thomas O, Røe OD, Vickers A, Walz J, Carlsson SV, Oldenburg J (2023)
   Baseline Serum Prostate-specific Antigen Value Predicts the Risk of Subsequent Prostate Cancer Death-Results from the Norwegian Prostate Cancer Consortium
   Eur Urol, 86 (1), 20-26
   DOI 10.1016/j.eururo.2023.04.028, PubMed 37169639
3. Boe RT, Nilsen OJ, Holm HV (2023)
   AdVance™ male sling for stress urinary incontinence: Long-term follow-up and patient satisfaction
   BJUI Compass, 5 (1), 42-51
   DOI 10.1002/bco2.287, PubMed 38179034
4. Cai T, Anceschi U, Prata F, Collini L, Brugnolli A, Migno S, Rizzo M, Liguori G, Gallelli L, Wagenlehner FME, Johansen TEB, Montanari L, Palmieri A, Tascini C (2023)
   Artificial Intelligence Can Guide Antibiotic Choice in Recurrent UTIs and Become an Important Aid to Improve Antimicrobial Stewardship
   Antibiotics (Basel), 12 (2)
   DOI 10.3390/antibiotics12020375, PubMed 36830285
5. Cai T, Verze P, Arcaniolo D, Pandolfo SD, Smarrazzo F, Manfredi C, Tascini C, Caciagli P, Lanzafame M, De Sio M, Wagenlehner F, Johansen TEB, Palmieri A (2023)
   Antibiotic Resistance Patterns Among Uropathogens in Female Outpatients Affected by Uncomplicated Cystitis: Focus on Fosfomycin Trometamol
   Int J Antimicrob Agents, 62 (5), 106974
   DOI 10.1016/j.ijantimicag.2023.106974, PubMed 37739241
6. Deivasigamani S, Kotamarti S, Rastinehad AR, Salas RS, de la Rosette JJMCH, Lepor H, Pinto P, Ahmed HU, Gill I, Klotz L, Taneja SS, Emberton M, Lawrentschuk N, Wysock J, Feller JF, Crouzet S, Kumar M P, Seguier D, Adams ES, Michael Z, Abreu A, Jack Tay K, Ward JF, Shinohara K, Katz AE et al. (2023)
   Primary Whole-gland Ablation for the Treatment of Clinically Localized Prostate Cancer: A Focal Therapy Society Best Practice Statement
   Eur Urol, 84 (6), 547-560
   DOI 10.1016/j.eururo.2023.06.013, PubMed 37419773
7. Eubank MN, Švihra J, DiBona KC, Sommers M, Oe T, Strnádel J, Miklušica J, Szépe P, Marcinek J, King BJ, Plante MK, Ľupták J, Poulsen MHA, Kida M, Baco E, Švihra J, Zvara P (2023)
   Tissue distribution of ethanol after intraprostatic injection using a porous needle
   Front Oncol, 12, 1063781
   DOI 10.3389/fonc.2022.1063781, PubMed 36686794
8. Falkensammer E, Erenler E, Johansen TEB, Tzelves L, Schneidewind L, Yuan Y, Cai T, Koves B, Tandogdu Z (2023)
   Antimicrobial Prophylaxis in Robot-Assisted Laparoscopic Radical Prostatectomy: A Systematic Review
   Antibiotics (Basel), 12 (12)
   DOI 10.3390/antibiotics12121744, PubMed 38136777
9. Galtung KF, Lauritzen PM, Sandbæk G, Bay D, Ponzi E, Baco E, Cowan NC, Naas AM, Rud E (2023)
   Is a Single Nephrographic Phase Computed Tomography Sufficient for Detecting Urothelial Carcinoma in Patients with Visible Haematuria? A Prospective Paired Noninferiority Comparison
   Eur Urol Open Sci, 55, 1-10
   DOI 10.1016/j.euros.2023.06.005, PubMed 37693732
10. Gerdtsson A, Torisson G, Thor A, Grenabo Bergdahl A, Almås B, Håkansson U, Törnblom M, Negaard HFS, Glimelius I, Halvorsen D, Karlsdóttir Á, Haugnes HS, Larsen SM, Holmberg G, Wahlqvist R, Tandstad T, Cohn-Cedermark G, Ståhl O, Kjellman A (2023)
    Validation of a prediction model for post-chemotherapy fibrosis in nonseminoma patients
    BJU Int, 132 (3), 329-336
    DOI 10.1111/bju.16040, PubMed 37129962
11. Haug ES, Myklebust TÅ, Juliebø-Jones P, Reisæter LAR, Aas K, Berg AS, Müller C, Hofmann B, Størkersen Ø, Nilsen KL, Johannesen TB, Beisland C (2023)
    Impact of prebiopsy MRI on prostate cancer staging: Results from the Norwegian Prostate Cancer Registry
    BJUI Compass, 4 (3), 331-338
    DOI 10.1002/bco2.214, PubMed 37025477
12. Johansen TEB, Zahl PH (2023)
    [Is it better not to perform a PSA test?]
    Tidsskr Nor Laegeforen, 143 (8)
    DOI 10.4045/tidsskr.23.0248, PubMed 37254991
13. Johansen TEB, Zahl PH (2023)
    [T.E.B. Johansen and P.H. Zahl respond]
    Tidsskr Nor Laegeforen, 143 (12)
    DOI 10.4045/tidsskr.23.0531, PubMed 37668126
14. Johansen TEB, Zahl PH (2023)
    [T.E.B. Johansen and P.H. Zahl respond]
    Tidsskr Nor Laegeforen, 143 (12)
    DOI 10.4045/tidsskr.23.0529, PubMed 37668128
15. Lauritzen PM, Jacewitz M, Baco E, Rud E, NORAPP authors (2023)
    Re: Peter Ka-Fung Chiu, Veeru Kasivisvanathan, Giorgio Gandaglia, European Association of Urology Young Academic Urologists Prostate Cancer Working Party. Moving the Needle: Antibiotic Prophylaxis Is No Longer Required in the Era of Transperineal Prostate Biopsy. Eur Urol. 2023;84:154-55
    Eur Urol, 85 (4), e118-e119
    DOI 10.1016/j.eururo.2023.06.024, PubMed 37482513
16. Martins FE, Bernal J, Tryfonyuk L, Holm HV (2023)
    Artificial urinary sphincter and stricture disease: surgical principles in management
    Transl Androl Urol, 13 (8), 1717-1728
    DOI 10.21037/tau-23-16, PubMed 39280683
17. Moen CA, Falkenthal TE, Thorkelsen TK, Hopland A, Rio OE, Honoré A, Juliebø-Jones P, Dongre HN, Costea DE, Bostad L, Brennan P, Johansson M, Ferreiro-Iglesias A, Brenner N, Waterboer T, Nygård M, Beisland C (2023)
    Penile Cancers Attributed to Human Papillomavirus Are Associated with Improved Survival for Node-positive Patients. Findings from a Norwegian Cohort Study Spanning 50 Years
    Eur Urol Oncol, 7 (4), 778-785
    DOI 10.1016/j.euo.2023.10.013, PubMed 37949729
18. Møller CT, Tafjord G, Blindheim A, Berge V, Fosså S, Andreassen BK (2023)
    Initial management and survival of patients with primary metastatic bladder cancer before the immunotherapy era: a population-based study from Norway
    Scand J Urol, 58, 101-108
    DOI 10.2340/sju.v58.5923, PubMed 37953521
19. Nolsøe AB, Holm HV, Murtola TJ, Østergren PB, Fode M (2023)
    Management of functional outcomes after radical prostatectomy in the Nordic countries: A survey of uro-oncological centers
    Int J Impot Res, 36 (5), 486-492
    DOI 10.1038/s41443-023-00772-8, PubMed 37816870
20. Schneidewind L, Kiss B, Stangl FP, Tandogdu Z, Wagenlehner FME, Johansen TEB, Köves B, Medina-Polo J, Tapia AM, Kranz J (2023)
    Practice Patterns in Fournier's Gangrene in Europe and Implications for a Prospective Registry Study
    Antibiotics (Basel), 12 (2)
    DOI 10.3390/antibiotics12020197, PubMed 36830108
21. Solbakken AM, Sellevold S, Spasojevic M, Julsrud L, Emblemsvåg HL, Reims HM, Sørensen O, Thorgersen EB, Fauske L, Ågren JSM, Brennhovd B, Ryder T, Larsen SG, Flatmark K (2023)
    Navigation-Assisted Surgery for Locally Advanced Primary and Recurrent Rectal Cancer
    Ann Surg Oncol, 30 (12), 7602-7611
    DOI 10.1245/s10434-023-13964-9, PubMed 37481493
22. Stangl FP, Schneidewind L, Kiss B, Kranz J, Wagenlehner FM, Johansen TEB, Köves B, Medina-Polo J, Tapia AM, Tandogdu Z (2023)
    Non-Antibiotic Prophylaxis for Recurrent UTIs in Neurogenic Lower Urinary Tract Dysfunction (NAPRUN): Study Protocol for a Prospective, Longitudinal Multi-Arm Observational Study
    Methods Protoc, 6 (3)
    DOI 10.3390/mps6030052, PubMed 37367996
23. Switlyk MD, Hopland A, Reitan E, Sivanesan S, Brennhovd B, Axcrona U, Hole KH (2023)
    Multiparametric Magnetic Resonance Imaging of Penile Cancer: A Pictorial Review
    Cancers (Basel), 15 (22)
    DOI 10.3390/cancers15225324, PubMed 38001583
24. Switlyk MD, Hopland A, Sivanesan S, Brennhovd B, Ottosson F, Berner K, Axcrona U, Hole KH (2023)
    Multi-parametric MRI without artificial erection for preoperative assessment of primary penile carcinoma: A pilot study on the correlation between imaging and histopathological findings
    Eur J Radiol Open, 10, 100478
    DOI 10.1016/j.ejro.2023.100478, PubMed 36793771

Publications 2022

1. Axcrona K, Aas K, Axcrona U, Skotheim RI (2022)
   Re: Spatially Resolved Clonal Copy Number Alterations in Benign and Malignant Tissue
   Eur Urol, 83 (2), 183
   DOI 10.1016/j.eururo.2022.11.013, PubMed 36464529
2. Baco E (2022)
   Editorial Comment
   J Urol, 207 (1), 33
   DOI 10.1097/JU.0000000000002251.01, PubMed 34879759
3. Baco E (2022)
   Infection Rate after Transperineal Prostate Biopsy with and without Prophylactic Antibiotics: Results from a Systematic Review and Meta-Analysis of Comparative Studies EDITORIAL COMMENTS
   J. Urol., 207 (1), 33
4. Cai T, Privitera S, Trovato F, Capogrosso P, Dehò F, Cimino S, Rizzo M, Liguori G, Salonia A, Palmieri A, Verze P, Johansen TEB (2022)
   A Proposal of a New Nomogram to Predict the Need for Testosterone ReplACEment (TRACE): A Simple Tool for Everyday Clinical Practice
   J Pers Med, 12 (10)
   DOI 10.3390/jpm12101654, PubMed 36294793
5. Cai T, Tamanini I, Collini L, Brugnolli A, Migno S, Mereu L, Tateo S, Pilatz A, Rizzo M, Liguori G, Bonkat G, Wagenlehner FME, Bjerklund Johansen TE (2022)
   Management of Recurrent Cystitis in Women: When Prompt Identification of Risk Factors Might Make a Difference
   Eur Urol Focus, 8 (5), 1476-1482
   DOI 10.1016/j.euf.2022.01.014, PubMed 35135727
6. Christiansen O, Bratt O, Kirkevold Ø, Benth JŠ, Manoharan P, Selnes A, Haug ES, Slaaen M (2022)
   Predictors of upgrading from low-grade cancer at prostatectomy in men with biparametric magnetic resonance imaging
   Cent European J Urol, 75 (1), 35-40
   DOI 10.5173/ceju.2021.0217, PubMed 35591966
7. Dahle DO, Skauby M, Langberg CW, Brabrand K, Wessel N, Midtvedt K (2022)
   Renal Cell Carcinoma and Kidney Transplantation: A Narrative Review
   Transplantation, 106 (1), e52-e63
   DOI 10.1097/TP.0000000000003762, PubMed 33741842
8. Galtung KF, Lauritzen PM, Baco E, Berg RE, Naas AM, Rud E (2022)
   Predictive Performance of Prospectively Applied ISUP and Fuhrman Grade in Nonmetastatic Renal Cell Carcinoma
   Anticancer Res, 42 (6), 2967-2975
   DOI 10.21873/anticanres.15780, PubMed 35641263
9. Guldvik IJ, Braadland PR, Sivanesan S, Ramberg H, Kristensen G, Tennstedt P, Røder A, Schlomm T, Berge V, Eri LM, Lilleby W, Mills IG, Taskén KA (2022)
   Low Blood Levels of LRG1 Before Radical Prostatectomy Identify Patients with High Risk of Progression to Castration-resistant Prostate Cancer
   Eur Urol Open Sci, 45, 68-75
   DOI 10.1016/j.euros.2022.09.002, PubMed 36353660
10. Günzel K, Magheli A, Busch J, Baco E, Cash H, Heinrich S, Edler D, Schostak M, Borgmann H, Schlegel J, Hinz S (2022)
    Evaluation of systematic prostate biopsies when performing transperineal MRI/TRUS fusion biopsy with needle tracking-what is the additional value?
    Int Urol Nephrol, 54 (10), 2477-2483
    DOI 10.1007/s11255-022-03309-y, PubMed 35877030
11. Jacewicz M, Günzel K, Rud E, Sandbæk G, Magheli A, Busch J, Hinz S, Baco E (2022)
    Antibiotic prophylaxis versus no antibiotic prophylaxis in transperineal prostate biopsies (NORAPP): a randomised, open-label, non-inferiority trial
    Lancet Infect Dis, 22 (10), 1465-1471
    DOI 10.1016/S1473-3099(22)00373-5, PubMed 35839791
12. Luiting HB, Remmers S, Boevé ER, Valdagni R, Chiu PK, Semjonow A, Berge V, Tully KH, Rannikko AS, Staerman F, Roobol MJ (2022)
    A Multivariable Approach Using Magnetic Resonance Imaging to Avoid a Protocol-based Prostate Biopsy in Men on Active Surveillance for Prostate Cancer-Data from the International Multicenter Prospective PRIAS Study
    Eur Urol Oncol, 5 (6), 651-658
    DOI 10.1016/j.euo.2022.03.007, PubMed 35437217
13. Møller CT, Fosså SD, Tafjord G, Babigumira R, Berge V, Andreassen BK (2022)
    Primary versus secondary muscle-invasive bladder cancer: survival after curative treatment
    Scand J Urol, 56 (3), 214-220
    DOI 10.1080/21681805.2022.2056633, PubMed 35506475
14. Møller CT, Støer NC, Blindheim A, Berge V, Tafjord G, Fosså SD, Andreassen BK (2022)
    Downstaging and survival after Neoadjuvant chemotherapy for bladder cancer in Norway; a population-based study
    BMC Cancer, 22 (1), 1301
    DOI 10.1186/s12885-022-10394-w, PubMed 36510166
15. Nilsen OJ, Holm HV, Ekerhult TO, Lindqvist K, Grabowska B, Persson B, Sairanen J (2022)
    To Transect or Not Transect: Results from the Scandinavian Urethroplasty Study, A Multicentre Randomised Study of Bulbar Urethroplasty Comparing Excision and Primary Anastomosis Versus Buccal Mucosal Grafting
    Eur Urol, 81 (4), 375-382
    DOI 10.1016/j.eururo.2021.12.017, PubMed 35012771
16. Ouellet V, Erickson A, GAP1 UTMAs Contributing Investigators, Wiley K, Morrissey C, Berge V, Moreno CS, Tasken KA, Trudel D, True LD, Lewis MS, Svindland A, Ertunc O, Vidal ID, Osunkoya AO, Jones T, Bova GS, Lamminen T, Achtman AH, Buzza M, Kouspou MM, Bigler SA, Zhou X, Freedland SJ, Mes-Masson AM et al. (2022)
    The Movember Global Action Plan 1 (GAP1): Unique Prostate Cancer Tissue Microarray Resource
    Cancer Epidemiol Biomarkers Prev, 31 (4), 715-727
    DOI 10.1158/1055-9965.EPI-21-0600, PubMed 35131885
17. Pharo HD, Jeanmougin M, Ager-Wick E, Vedeld HM, Sørbø AK, Dahl C, Larsen LK, Honne H, Brandt-Winge S, Five MB, Monteiro-Reis S, Henrique R, Jeronimo C, Steven K, Wahlqvist R, Guldberg P, Lind GE (2022)
    BladMetrix: a novel urine DNA methylation test with high accuracy for detection of bladder cancer in hematuria patients
    Clin Epigenetics, 14 (1), 115
    DOI 10.1186/s13148-022-01335-2, PubMed 36115961
18. Rud E, Lauritzen P, Jacewicz M, Baco E, authors of the NORAPP study (2022)
    Antibiotic prophylaxis for transperineal prostate biopsy? An unanswered question - Authors' reply
    Lancet Infect Dis, 22 (12), 1663
    DOI 10.1016/S1473-3099(22)00736-8, PubMed 36356607
19. Rud E, Noor D, Galtung KF, Ottosson F, Jacewicz M, Baco E, Lauritzen PM (2022)
    Validating the screening criteria for bone metastases in treatment-naïve unfavorable intermediate and high-risk prostate cancer - the prevalence and location of bone- and lymph node metastases
    Eur Radiol, 32 (12), 8266-8275
    DOI 10.1007/s00330-022-08945-7, PubMed 35939081
20. Sivanesan S, Taskén KA, Grytli HH (2022)
    Association of β-Blocker Use at Time of Radical Prostatectomy With Rate of Treatment for Prostate Cancer Recurrence
    JAMA Netw Open, 5 (1), e2145230
    DOI 10.1001/jamanetworkopen.2021.45230, PubMed 35080602
21. Tutone M, Bjerklund Johansen TE, Cai T, Mushtaq S, Livermore DM (2022)
    SUsceptibility and Resistance to Fosfomycin and other antimicrobial agents among pathogens causing lower urinary tract infections: findings of the SURF study
    Int J Antimicrob Agents, 59 (5), 106574
    DOI 10.1016/j.ijantimicag.2022.106574, PubMed 35307561

Publications 2021

1. Alidjanov JF, Cai T, Bartoletti R, Bonkat G, Bruyère F, Köves B, Kulchavenya E, Medina-Polo J, Naber K, Perepanova T, Pilatz A, Tandogdu Z, Bjerklund Johansen TE, Wagenlehner FM (2021)
   The negative aftermath of prostate biopsy: prophylaxis, complications and antimicrobial stewardship: results of the global prevalence study of infections in urology 2010-2019
   World J Urol, 39 (9), 3423-3432
   DOI 10.1007/s00345-021-03614-8, PubMed 33615393
2. Alidjanov JF, Khudaybergenov UA, Ayubov BA, Pilatz A, Mohr S, Münst JC, Ziviello Yuen ON, Pilatz S, Christmann C, Dittmar F, Mirsaidov NM, Buch-Heberling M, Naber KG, Bjerklund Johansen TE, Wagenlehner FME (2021)
   Linguistic and clinical validation of the acute cystitis symptom score in German-speaking Swiss women with acute cystitis
   Int Urogynecol J, 32 (12), 3275-3286
   DOI 10.1007/s00192-021-04864-1, PubMed 34170341
3. Beiske MJ, Veiby Holm H, Nilsen OJ (2021)
   A comparison of urethral catheterization duration - three weeks versus two weeks after bulbar urethroplasty
   Scand J Urol, 55 (4), 313-316
   DOI 10.1080/21681805.2021.1945141, PubMed 34223800
4. Bjerklund Johansen TE, Kulchavenya E, Lentz GM, Livermore DM, Nickel JC, Zhanel G, Bonkat G (2021)
   Fosfomycin Trometamol for the Prevention of Infectious Complications After Prostate Biopsy: A Consensus Statement by an International Multidisciplinary Group
   Eur Urol Focus, 8 (5), 1483-1492
   DOI 10.1016/j.euf.2021.11.007, PubMed 34920977
5. Cai T, Anceschi U, Tamanini I, Migno S, Rizzo M, Liguori G, Garcia-Larrosa A, Palmieri A, Verze P, Mirone V, Bjerklund Johansen TE (2021)
   Xyloglucan, Hibiscus and Propolis in the Management of Uncomplicated Lower Urinary Tract Infections: A Systematic Review and Meta-Analysis
   Antibiotics (Basel), 11 (1)
   DOI 10.3390/antibiotics11010014, PubMed 35052890
6. Cai T, Caffo O, Malossini G, Bjerklund Johansen TE (2021)
   Delaying Cancer Cases in Urology during COVID-19: Review of the Literature. Letter.J Urol 2020; <b>204:</b> 926
   J Urol, 205 (5), 1534-1535
   DOI 10.1097/JU.0000000000001643, PubMed 33605793
7. Cai T, Cocci A, Di Maida F, Chiodini S, Ciarleglio F, Luciani LG, Pedrotti G, Palmieri A, Malossini G, Rizzo M, Liguori G, Bjerklund Johansen TE (2021)
   Visceral adiposity is associated with worse urinary and sexual function recovery after radical prostatectomy: Results from a longitudinal cohort study
   Arch Ital Urol Androl, 93 (3), 285-290
   DOI 10.4081/aiua.2021.3.285, PubMed 34839633
8. Cai T, Gallelli L, Cione E, Perletti G, Ciarleglio F, Malossini G, De Pretis G, Palmieri A, Mirone V, Bartoletti R, Johansen TEB (2021)
   The use of Lactobacillus casei DG® prevents symptomatic episodes and reduces the antibiotic use in patients affected by chronic bacterial prostatitis: results from a phase IV study
   World J Urol, 39 (9), 3433-3440
   DOI 10.1007/s00345-020-03580-7, PubMed 33442769
9. Cai T, Gallelli L, Cione E, Verze P, Palmieri A, Mirone V, Bonkat G, Wagenlehner FM, Bjerklund Johansen TE (2021)
   The efficacy and tolerability of pollen extract in combination with hyaluronic acid and vitamins in the management of patients affected by chronic prostatitis/chronic pelvic pain syndrome: a 26 weeks, randomized, controlled, single-blinded, phase III study
   Minerva Urol Nephrol, 74 (6), 780-788
   DOI 10.23736/S2724-6051.21.04141-2, PubMed 33781014
10. Cakir OO, Castiglione F, Tandogdu Z, Collins J, Alnajjar HM, Akers C, Albersen M, Alifrangis C, Ayres B, Brouwer O, Cullen I, Hawkey P, Jakobsen JK, Johansen TEB, Kalejaiye O, Kaul A, Köves B, Kumar V, Mancini M, Mitra AV, Parnham A, Pozzi E, Protzel C, Sangar VK, Wagenlehner F et al. (2021)
    Management of penile cancer patients during the COVID-19 pandemic: An eUROGEN accelerated Delphi consensus study
    Urol Oncol, 39 (3), 197.e9-197.e17
    DOI 10.1016/j.urolonc.2020.12.005, PubMed 33397593
11. Ciarleglio FA, Rigoni M, Mereu L, Tommaso C, Carrara A, Malossini G, Tateo S, Tirone G, Bjerklund Johansen TE, Benetollo PP, Ferro A, Guarrera GM, Grattarola M, Nollo G, Brolese A (2021)
    The negative effects of COVID-19 and national lockdown on emergency surgery morbidity due to delayed access
    World J Emerg Surg, 16 (1), 37
    DOI 10.1186/s13017-021-00382-z, PubMed 34256781
12. Cyll K, Kleppe A, Kalsnes J, Vlatkovic L, Pradhan M, Kildal W, Tobin KAR, Reine TM, Wæhre H, Brennhovd B, Askautrud HA, Skaaheim Haug E, Hveem TS, Danielsen HE (2021)
    PTEN and DNA Ploidy Status by Machine Learning in Prostate Cancer
    Cancers (Basel), 13 (17)
    DOI 10.3390/cancers13174291, PubMed 34503100
13. Gerdtsson A, Thor A, Grenabo Bergdahl A, Almås B, Håkansson U, Törnblom M, Negaard HFS, Glimelius I, Halvorsen D, Karlsdóttir Á, Sagstuen Haugnes H, Engen Andreassen K, Melsen Larsen S, Holmberg G, Wahlqvist R, Tandstad T, Cohn-Cedermark G, Ståhl O, Kjellman A (2021)
    Unilateral or Bilateral Retroperitoneal Lymph Node Dissection in Nonseminoma Patients with Postchemotherapy Residual Tumour? Results from RETROP, a Population-based Mapping Study by the Swedish Norwegian Testicular Cancer Group
    Eur Urol Oncol, 5 (2), 235-243
    DOI 10.1016/j.euo.2021.02.002, PubMed 33750683
14. Gjersvik P, Heikkila R, Johansen TEB (2021)
    Rescue treatment for cancer
    Tidsskr. Nor. Laegeforen., 141 (5), 487
15. Günzel K, Magheli A, Baco E, Cash H, Heinrich S, Neubert H, Schlegel J, Schostak M, Henkel T, Asbach P, Hinz S (2021)
    Infection rate and complications after 621 transperineal MRI-TRUS fusion biopsies in local anesthesia without standard antibiotic prophylaxis
    World J Urol, 39 (10), 3861-3866
    DOI 10.1007/s00345-021-03699-1, PubMed 33866401
16. Hopland OA, Fosså SD, Ottosson F, Brennhovd B, Svindland A, Hole KH, Hernes E, Eri LM, Diep LM, Berge V (2021)
    Robotic salvage pelvic lymph node dissection for locoregional recurrence after radical prostatectomy: a single institution experience
    Scand J Urol, 55 (4), 287-292
    DOI 10.1080/21681805.2021.1946135, PubMed 34196594
17. Jacewicz M, Rud E, Galtung KF, Noor D, Baco E (2021)
    Cancer Detection Rates in Targeted Transperineal MRI-TRUS Elastic Fusion-guided Prostate Biopsies Performed Under Local Anesthesia
    Anticancer Res, 41 (9), 4395-4400
    DOI 10.21873/anticanres.15244, PubMed 34475059
18. Johansen TEB, Cai T, Naber K, Nicolle LE, Tandogdu Z, Tønjum T, Wagenlehner F, Zahl PH, Koves B (2021)
    [Pregnant women should be screened for asymptomatic bacteriuria]
    Tidsskr Nor Laegeforen, 141 (11)
    DOI 10.4045/tidsskr.21.0379, PubMed 34423934
19. Martins FE, Holm HV, Lumen N (2021)
    Devastated Bladder Outlet in Pelvic Cancer Survivors: Issues on Surgical Reconstruction and Quality of Life
    J Clin Med, 10 (21)
    DOI 10.3390/jcm10214920, PubMed 34768438
20. Moghaddam S, Jalali A, O'Neill A, Murphy L, Gorman L, Reilly AM, Heffernan Á, Lynch T, Power R, O'Malley KJ, Taskèn KA, Berge V, Solhaug VA, Klocker H, Murphy TB, Watson RW (2021)
    Integrating Serum Biomarkers into Prediction Models for Biochemical Recurrence Following Radical Prostatectomy
    Cancers (Basel), 13 (16)
    DOI 10.3390/cancers13164162, PubMed 34439316
21. Myklebust MP, Thor A, Rosenlund B, Gjengstø P, Karlsdottir Á, Brydøy M, Bercea BS, Olsen C, Johnson I, Berg MI, Langberg CW, Andreassen KE, Kjellman A, Haugnes HS, Dahl O (2021)
    Serum miR371 in testicular germ cell cancer before and after orchiectomy, assessed by digital-droplet PCR in a prospective study
    Sci Rep, 11 (1), 15582
    DOI 10.1038/s41598-021-94812-2, PubMed 34341387
22. Ramberg H, Richardsen E, de Souza GA, Rakaee M, Stensland ME, Braadland PR, Nygård S, Ögren O, Guldvik IJ, Berge V, Svindland A, Taskén KA, Andersen S (2021)
    Proteomic analyses identify major vault protein as a prognostic biomarker for fatal prostate cancer
    Carcinogenesis, 42 (5), 685-693
    DOI 10.1093/carcin/bgab015, PubMed 33609362
23. Ramirez-Garrastacho M, Berge V, Linē A, Llorente A (2021)
    Potential of miRNAs in urinary extracellular vesicles for management of active surveillance in prostate cancer patients
    Br J Cancer, 126 (3), 492-501
    DOI 10.1038/s41416-021-01598-1, PubMed 34811506
24. Svarc P, Hagen T, Waltenburg H, Andersson C, Bläckberg M, Baco E, Taudorf M, Røder MA, Lindgren H, Kløw NE, Lönn LB (2021)
    Center experience and other determinants of patient radiation exposure during prostatic artery embolization: a retrospective study in three Scandinavian centers
    Eur Radiol, 32 (4), 2404-2413
    DOI 10.1007/s00330-021-08351-5, PubMed 34786614
25. Aas K, Berge V, Myklebust TÅ, Fosså SD (2021)
    Comparative Survival Outcomes of High-risk Prostate Cancer Treated with Radical Prostatectomy or Definitive Radiotherapy Regimens
    Eur Urol Open Sci, 26, 55-63
    DOI 10.1016/j.euros.2021.01.011, PubMed 34337508

Publications 2020

1. Berge V (2020)
   PENIS. A MANUAL
   Tidsskr. Nor. Laegeforen., 140 (7), 710
2. Cai T, Tamanini I, Mattevi D, Verze P, Palmieri A, Malossini G, Mirone V, Novelli A, Tascini C, Johansen TEB (2020)
   Fosfomycin trometamol and N-acetyl-L-cysteine as combined oral therapy of difficult-to-treat chronic bacterial prostatitis: Results of a pilot study
   Int J Antimicrob Agents, 56 (1), 105935
   DOI 10.1016/j.ijantimicag.2020.105935, PubMed 32156620
3. Cai T, Tandogdu Z, Wagenlehner FME, Bjerklund Johansen TE (2020)
   Re: COVID-19 Coagulopathy: Considerations for UrologistsJ. S. Jue and M. Alameddine J Urol 2020; <b>204:</b> Epub ahead of print. doi: 10.1097/JU.0000000000001144
   J Urol, 204 (4), 848-849
   DOI 10.1097/JU.0000000000001228, PubMed 32609571
4. Cai T, Tiscione D, Favilla V, Puglisi M, Palumbo F, Zucchi A, Malossini G, Palmieri A, Bjerklund Johansen TE (2020)
   Oral Administration and Intralesional Injection of Hyaluronic Acid Versus Intralesional Injection Alone in Peyronie's Disease: Results from a Phase III Study
   World J Mens Health, 39 (3), 526-532
   DOI 10.5534/wjmh.200048, PubMed 33151042
5. Cai T, Verze P, Luciani L, Malossini G, Bjerklund Johansen TE, Benetollo PP, Guarrera GM (2020)
   What do patients say about telephone-based urological consultations at the time of the COVID-19 pandemic?
   Minerva Urol Nefrol, 72 (4), 515-516
   DOI 10.23736/S0393-2249.20.03940-5, PubMed 32432439
6. Dahl AA, Brennhovd B, Fosså SD, Axcrona K (2020)
   A cross-sectional study of current work ability after radical prostatectomy
   BMC Urol, 20 (1), 9
   DOI 10.1186/s12894-020-0579-9, PubMed 32005115
7. Dahl AA, Fosså SD, Brennhovd B, Axcrona K (2020)
   The EPIC-26 domain scores after radical prostatectomy are associated with the personality trait of neuroticism
   Int Urol Nephrol, 53 (4), 691-698
   DOI 10.1007/s11255-020-02688-4, PubMed 33118115
8. Ersvaer E, Hveem TS, Vlatkovic L, Brennhovd B, Kleppe A, Tobin KAR, Pradhan M, Cyll K, Waehre H, Kerr DJ, Danielsen HE (2020)
   Prognostic value of DNA ploidy and automated assessment of stroma fraction in prostate cancer
   Int J Cancer, 147 (4), 1228-1234
   DOI 10.1002/ijc.32832, PubMed 31846064
9. Fosså SD, Aas K, Müller C, Jerm MB, Tandstad T, Lilleby W, Kvåle R, Gulbrandsen J, Haug E, Myklebust TA (2020)
   Definitive radiotherapy for prostate cancer in Norway 2006-2015: Temporal trends, performance and survival
   Radiother Oncol, 155, 33-41
   DOI 10.1016/j.radonc.2020.10.022, PubMed 33096165
10. Grummet J, Gorin MA, Popert R, O'Brien T, Lamb AD, Hadaschik B, Radtke JP, Wagenlehner F, Baco E, Moore CM, Emberton M, George AK, Davis JW, Szabo RJ, Buckley R, Loblaw A, Allaway M, Kastner C, Briers E, Royce PL, Frydenberg M, Murphy DG, Woo HH (2020)
    "TREXIT 2020": why the time to abandon transrectal prostate biopsy starts now
    Prostate Cancer Prostatic Dis, 23 (1), 62-65
    DOI 10.1038/s41391-020-0204-8, PubMed 31932659
11. Guldvik IJ, Zuber V, Braadland PR, Grytli HH, Ramberg H, Lilleby W, Thiede B, Zucknick M, Saatcioglu F, Gislefoss R, Kvåle R, George A, Grönberg H, Wiklund F, Neal DE, Gnanapragasam VJ, Taskén KA, Mills IG (2020)
    Identification and Validation of Leucine-rich α-2-glycoprotein 1 as a Noninvasive Biomarker for Improved Precision in Prostate Cancer Risk Stratification
    Eur Urol Open Sci, 21, 51-60
    DOI 10.1016/j.euros.2020.08.007, PubMed 34337468
12. Jacewicz M, Günzel K, Rud E, Lauritzen PM, Galtung KF, Hinz S, Magheli A, Baco E (2020)
    Multicenter transperineal MRI-TRUS fusion guided outpatient clinic prostate biopsies under local anesthesia
    Urol Oncol, 39 (7), 432.e1-432.e7
    DOI 10.1016/j.urolonc.2020.11.009, PubMed 33257219
13. Ottosson F, Baco E, Lauritzen PM, Rud E (2020)
    The prevalence and locations of bone metastases using whole-body MRI in treatment-naïve intermediate- and high-risk prostate cancer
    Eur Radiol, 31 (5), 2747-2753
    DOI 10.1007/s00330-020-07363-x, PubMed 33141299
14. Verze P, Cai T, Malossini G, Bjerklund Johansen TE, Baio R, Palmieri A (2020)
    When technological innovations do not reach consensus: the case of tele-consultation of andrological patients
    Int J Impot Res, 33 (6), 660-662
    DOI 10.1038/s41443-020-00348-w, PubMed 32843710
15. Wagenlehner FME, Bjerklund Johansen TE, Cai T, Koves B, Kranz J, Pilatz A, Tandogdu Z (2020)
    Epidemiology, definition and treatment of complicated urinary tract infections
    Nat Rev Urol, 17 (10), 586-600
    DOI 10.1038/s41585-020-0362-4, PubMed 32843751
16. Zhou W, Ma L, Yang J, Qiao H, Li L, Guo Q, Ma J, Zhao L, Wang J, Jiang G, Wan X, Goscinski MA, Ding L, Zheng Y, Li W, Liu H, Suo Z, Zhao W (2020)
    Correction: Potent and specific MTH1 inhibitors targeting gastric cancer
    Cell Death Dis, 11 (10), 868
    DOI 10.1038/s41419-020-03010-x, PubMed 33067425

Publications 2019

1. Cai T, Cocci A, Coccarelli F, Ruggera L, Lanzafame P, Caciagli P, Malossini G, Crisci A, Trinchieri A, Perletti G, Carini M, Bonkat G, Bartoletti R, Bjerklund Johansen TE (2019)
   Infectious Complications After Laser Vaporization of Urinary Stones During Retrograde Intrarenal Surgery Are Not Associated with Spreading of Bacteria into Irrigation Fluid but with Previous Use of Fluoroquinolones
   Eur Urol Focus, 7 (1), 190-197
   DOI 10.1016/j.euf.2019.02.018, PubMed 30853604
2. Cai T, Santi R, Tamanini I, Galli IC, Perletti G, Bjerklund Johansen TE, Nesi G (2019)
   Current Knowledge of the Potential Links between Inflammation and Prostate Cancer
   Int J Mol Sci, 20 (15)
   DOI 10.3390/ijms20153833, PubMed 31390729
3. Cai T, Tamanini I, Cocci A, Di Maida F, Caciagli P, Migno S, Mereu L, Tateo S, Malossini G, Palmieri A, Verze P, Mirone V, Bjerklund Johansen TE (2019)
   Xyloglucan, hibiscus and propolis to reduce symptoms and antibiotics use in recurrent UTIs: a prospective study
   Future Microbiol, 14, 1013-1021
   DOI 10.2217/fmb-2019-0145, PubMed 31469009
4. Cai T, Tamanini I, Tascini C, Köves B, Bonkat G, Gacci M, Novelli A, Horcajada JP, Bjerklund Johansen TE, Zanel G (2019)
   Fosfomycin Trometamol versus Comparator Antibiotics for the Treatment of Acute Uncomplicated Urinary Tract Infections in Women: A Systematic Review and Meta-Analysis
   J Urol, 203 (3), 570-578
   DOI 10.1097/JU.0000000000000620, PubMed 31651226
5. Cai T, Tamanini I, Tascini C, Köves B, Bonkat G, Gacci M, Novelli A, Horcajada JP, Bjerklund Johansen TE, Zanel G (2019)
   Reply by Authors
   J Urol, 203 (3), 578
   DOI 10.1097/JU.0000000000000620.03, PubMed 31854257
6. Dixon M, Stefil M, McDonald M, Bjerklund-Johansen TE, Naber K, Wagenlehner F, Mouraviev V (2019)
   Metagenomics in diagnosis and improved targeted treatment of UTI
   World J Urol, 38 (1), 35-43
   DOI 10.1007/s00345-019-02731-9, PubMed 30944967
7. Gerdtsson A, Håkansson U, Törnblom M, Jancke G, Negaard HFS, Glimelius I, Halvorsen D, Karlsdóttir Á, Haugnes HS, Andreassen KE, Larsen SM, Holmberg G, Wahlqvist R, Tandstad T, Cohn-Cedermark G, Ståhl O, Kjellman A (2019)
   Surgical Complications in Postchemotherapy Retroperitoneal Lymph Node Dissection for Nonseminoma Germ Cell Tumour: A Population-based Study from the Swedish Norwegian Testicular Cancer Group
   Eur Urol Oncol, 3 (3), 382-389
   DOI 10.1016/j.euo.2019.08.002, PubMed 31506250
8. Johansen TEB, Zahl PH, Baco E, Bartoletti R, Bonkat G, Bruyere F, Cai T, Cek M, Kulchavenya E, Köves B, Mouraviev V, Pilatz A, Tandogdu Z, Tenke P, Wagenlehner FME (2019)
   Antibiotic resistance, hospitalizations, and mortality related to prostate biopsy: first report from the Norwegian Patient Registry
   World J Urol, 38 (1), 17-26
   DOI 10.1007/s00345-019-02837-0, PubMed 31183524
9. Rud E, Galtung KF, Lauritzen PM, Baco E, Flatabø T, Sandbæk G (2019)
   Examining the upper urinary tract in patients with hematuria-time to revise the CT urography protocol?
   Eur Radiol, 30 (3), 1664-1670
   DOI 10.1007/s00330-019-06521-0, PubMed 31748856
10. Rud E, Langberg CW, Baco E, Lauritzen P, Sandbæk G (2019)
    MRI in the Follow-up of Testicular Cancer: Less is More
    Anticancer Res, 39 (6), 2963-2968
    DOI 10.21873/anticanres.13427, PubMed 31177136
11. Tandogdu Z, Kakariadis ETA, Naber K, Wagenlehner F, Bjerklund Johansen TE (2019)
    Appropriate empiric antibiotic choices in health care associated urinary tract infections in urology departments in Europe from 2006 to 2015: A Bayesian analytical approach applied in a surveillance study
    PLoS One, 14 (4), e0214710
    DOI 10.1371/journal.pone.0214710, PubMed 31022187
12. Tandogdu Z, Koves B, Cai T, Cek M, Tenke P, Naber K, Wagenlehner F, Johansen TEB (2019)
    Condition-specific surveillance in health care-associated urinary tract infections as a strategy to improve empirical antibiotic treatment: an epidemiological modelling study
    World J Urol, 38 (1), 27-34
    DOI 10.1007/s00345-019-02963-9, PubMed 31555835
13. Zhou W, Ma L, Yang J, Qiao H, Li L, Guo Q, Ma J, Zhao L, Wang J, Jiang G, Wan X, Adam Goscinski M, Ding L, Zheng Y, Li W, Liu H, Suo Z, Zhao W (2019)
    Potent and specific MTH1 inhibitors targeting gastric cancer
    Cell Death Dis, 10 (6), 434
    DOI 10.1038/s41419-019-1665-3, PubMed 31164636

Publications 2018

1. Bartoletti R, Wagenlehner FME, Bjerklund Johansen TE, Köves B, Cai T, Tandogdu Z, Bonkat G (2018)
   Management of Urethritis: Is It Still the Time for Empirical Antibiotic Treatments?
   Eur Urol Focus, 5 (1), 29-35
   DOI 10.1016/j.euf.2018.10.006, PubMed 30318465
2. Bjerklund Johansen TE, Cai T (2018)
   Re: Determinants of Variable Resource Use for Multidisciplinary Team Meetings in Cancer Care
   Eur Urol, 75 (1), 195
   DOI 10.1016/j.eururo.2018.10.037, PubMed 30391077
3. Braadland PR, Giskeødegård G, Sandsmark E, Bertilsson H, Euceda LR, Hansen AF, Guldvik IJ, Selnæs KM, Grytli HH, Katz B, Svindland A, Bathen TF, Eri LM, Nygård S, Berge V, Taskén KA, Tessem MB (2018)
   Ex vivo metabolic fingerprinting identifies biomarkers predictive of prostate cancer recurrence following radical prostatectomy
   Br J Cancer, 118 (6), e11
   DOI 10.1038/bjc.2017.470, PubMed 29462127
4. Cai T, Cocci A, Tiscione D, Puglisi M, Di Maida F, Malossini G, Verze P, Palmieri A, Mirone V, Bjerklund Johansen TE (2018)
   L-Methionine associated with Hibiscus sabdariffa and Boswellia serrata extracts are not inferior to antibiotic treatment for symptoms relief in patients affected by recurrent uncomplicated urinary tract infections: Focus on antibiotic-sparing approach
   Arch Ital Urol Androl, 90 (2), 97-100
   DOI 10.4081/aiua.2018.2.97, PubMed 29974725
5. Cai T, Cocci A, Verze P, Rizzo M, Palmieri A, Liguori G, Trombetta C, Adembri C, Carini M, Bartoletti R, Wagenlehner FM, Bonkat G, Mirone V, Bjerklund Johansen TE, Novelli A (2018)
   The use of oral fosfomycin-trometamol in patients with catheter-associated urinary tract infections (CAUTI): new indications for an old antibiotic?
   J Chemother, 30 (5), 290-295
   DOI 10.1080/1120009X.2018.1500110, PubMed 30843774
6. Cai T, Lanzafame P, Caciagli P, Migno S, Mereu L, Mattevi D, Luciani LG, Tateo S, Malossini G, Bjerklund Johansen TE (2018)
   Role of increasing leukocyturia for detecting the transition from asymptomatic bacteriuria to symptomatic infection in women with recurrent urinary tract infections: A new tool for improving antibiotic stewardship
   Int J Urol, 25 (9), 800-806
   DOI 10.1111/iju.13723, PubMed 30008180
7. Cai T, Tessarolo F, Caola I, Piccoli F, Nollo G, Caciagli P, Mazzoli S, Palmieri A, Verze P, Malossini G, Mirone V, Bjerklund Johansen TE (2018)
   Prostate calcifications: A case series supporting the microbial biofilm theory
   Investig Clin Urol, 59 (3), 187-193
   DOI 10.4111/icu.2018.59.3.187, PubMed 29744476
8. Fan Z, Li L, Li X, Zhang M, Zhong Y, Li Y, Yu D, Cao J, Zhao J, Xiaoming Deng, Zhang M, Jian-Guo Wen, Liu Z, Goscinski MA, Berge V, Nesland JM, Suo Z (2018)
   Generation of an oxoglutarate dehydrogenase knockout rat model and the effect of a high-fat diet
   RSC Adv, 8 (30), 16636-16644
   DOI 10.1039/c8ra00253c, PubMed 35540547
9. Hompland T, Hole KH, Ragnum HB, Aarnes EK, Vlatkovic L, Lie AK, Patzke S, Brennhovd B, Seierstad T, Lyng H (2018)
   Combined MR Imaging of Oxygen Consumption and Supply Reveals Tumor Hypoxia and Aggressiveness in Prostate Cancer Patients
   Cancer Res, 78 (16), 4774-4785
   DOI 10.1158/0008-5472.CAN-17-3806, PubMed 29945958
10. Jain S, Lyons CA, Walker SM, McQuaid S, Hynes SO, Mitchell DM, Pang B, Logan GE, McCavigan AM, O'Rourke D, McArt DG, McDade SS, Mills IG, Prise KM, Knight LA, Steele CJ, Medlow PW, Berge V, Katz B, Loblaw DA, Harkin DP, James JA, O'Sullivan JM, Kennedy RD, Waugh DJ (2018)
    Validation of a Metastatic Assay using biopsies to improve risk stratification in patients with prostate cancer treated with radical radiation therapy
    Ann Oncol, 29 (1), 215-222
    DOI 10.1093/annonc/mdx637, PubMed 29045551
11. Johnson I, Ottosson F, Diep LM, Berg RE, Hoff JR, Wessel N, Eri LM, Berge V (2018)
    Switching from laparoscopic radical prostatectomy to robot assisted laparoscopic prostatectomy: comparing oncological outcomes and complications
    Scand J Urol, 52 (2), 116-121
    DOI 10.1080/21681805.2017.1420099, PubMed 29334304
12. Kløw NE, Grøtta OJ, Bay D, Sandbæk G, Johansen TEB, Hagen T, Baco E (2018)
    Outcome after prostatic artery embolization in patients with symptomatic benign prostatic hyperplasia
    Acta Radiol, 60 (9), 1175-1180
    DOI 10.1177/0284185118813709, PubMed 30450921
13. Mariathasan AB, Boye K, Giercksky KE, Brennhovd B, Gullestad HP, Emblemsvåg HL, Grøholt KK, Dueland S, Flatmark K, Larsen SG (2018)
    Beyond total mesorectal excision in locally advanced rectal cancer with organ or pelvic side-wall involvement
    Eur J Surg Oncol, 44 (8), 1226-1232
    DOI 10.1016/j.ejso.2018.03.029, PubMed 29691115
14. Medlow PW, Steele CJ, McCavigan AM, Reardon W, Brown CM, Lambe SM, Ishiy FAA, Walker SM, Logan GE, Raji OY, Berge V, Katz B, Kay EW, Sheehan K, Watson RW, Harkin DP, Kennedy RD, Knight LA (2018)
    Analytical validation of a prognostic prostate cancer gene expression assay using formalin fixed paraffin embedded tissue
    BMC Med Genomics, 11 (1), 125
    DOI 10.1186/s12920-018-0442-y, PubMed 30591067
15. Oderda M, Marra G, Albisinni S, Altobelli E, Baco E, Beatrici V, Cantiani A, Carbone A, Ciccariello M, Descotes JL, Dubreuil-Chambardel M, Eldred-Evans D, Fasolis G, Ferriero M, Fiard G, Forte V, Giacobbe A, Kumar P, Lacetera V, Mozer P, Muto G, Papalia R, Pastore A, Peltier A, Piechaud T et al. (2018)
    Accuracy of elastic fusion biopsy in daily practice: Results of a multicenter study of 2115 patients
    Int J Urol, 25 (12), 990-997
    DOI 10.1111/iju.13796, PubMed 30187529
16. Prencipe M, Fabre A, Murphy TB, Vargyas E, O'Neill A, Bjartell A, Tasken KA, Grytli HH, Svindland A, Berge V, Eri LM, Gallagher W, Watson RW (2018)
    Role of serum response factor expression in prostate cancer biochemical recurrence
    Prostate, 78 (10), 724-730
    DOI 10.1002/pros.23516, PubMed 29608018
17. Rud E, Diep L, Baco E (2018)
    A prospective study evaluating indirect MRI-signs for the prediction of extraprostatic disease in patients with prostate cancer: tumor volume, tumor contact length and tumor apparent diffusion coefficient
    World J Urol, 36 (4), 629-637
    DOI 10.1007/s00345-018-2171-4, PubMed 29349572
18. Rud E, Lauritzen P, Baco E (2018)
    Re: Henrik Grönberg, Martin Eklund, Wolfgang Picker, et al. Prostate Cancer Diagnostics Using a Combination of the Stockholm3 Blood Test and Multiparametric Magnetic Resonance Imaging. Eur Urol 2018;74:722-8
    Eur Urol, 75 (4), e103
    DOI 10.1016/j.eururo.2018.11.047, PubMed 30528223
19. Stranne J, Brasso K, Brennhovd B, Johansson E, Jäderling F, Kouri M, Lilleby W, Meidahl Petersen P, Mirtti T, Pettersson A, Rannikko A, Thellenberg C, Akre O (2018)
    SPCG-15: a prospective randomized study comparing primary radical prostatectomy and primary radiotherapy plus androgen deprivation therapy for locally advanced prostate cancer
    Scand J Urol, 52 (5-6), 313-320
    DOI 10.1080/21681805.2018.1520295, PubMed 30585526
20. Tulipan AJ, Vlatkovic L, Malinen E, Brennhovd B, Hole KH, Lie AK, Ragnum HB, Revheim ME, Seierstad T (2018)
    Comparison of time curves from dynamic ¹⁸F-fluciclovine positron emission tomography and dynamic contrast-enhanced magnetic resonance imaging for primary prostate carcinomas
    Phys Imaging Radiat Oncol, 7, 51-57
    DOI 10.1016/j.phro.2018.09.003, PubMed 33458405
21. Zuber V, Jönsson EG, Frei O, Witoelar A, Thompson WK, Schork AJ, Bettella F, Wang Y, Djurovic S, Smeland OB, Dieset I, Fanous AH, Desikan RS, Küry S, Bézieau S, Dale AM, Mills IG, Andreassen OA (2018)
    Identification of shared genetic variants between schizophrenia and lung cancer
    Sci Rep, 8 (1), 674
    DOI 10.1038/s41598-017-16481-4, PubMed 29330379
22. Aas K, Fosså SD, Kvåle R, Møller B, Myklebust TÅ, Vlatkovic L, Müller S, Berge V (2018)
    Is time from diagnosis to radical prostatectomy associated with oncological outcomes?
    World J Urol, 37 (8), 1571-1580
    DOI 10.1007/s00345-018-2570-6, PubMed 30483947

Publications 2017

1. Ahmed HU, Berge V, Bottomley D, Cross W, Heer R, Kaplan R, Leslie T, Parker C, Relton C, Stephens R, Sydes MR, Turnbull L, van der Meulen J, Vickers A, Wilt T, Emberton M, and the Prostate Cancer RCT Consensus Group (2017)
   Corrigendum: Can we deliver randomized trials of focal therapy in prostate cancer?
   Nat Rev Clin Oncol (in press)
   DOI 10.1038/nrclinonc.2017.86, PubMed 28895571
2. Axcrona K, Nilsson R, Brennhovd B, Sørebø Ø, Fosså SD, Dahl AA (2017)
   Psychometric properties of the expanded prostate cancer index composite - 26 instrument in a cohort of radical prostatectomy patients: theoretical and practical examinations
   BMC Urol, 17 (1), 111
   DOI 10.1186/s12894-017-0302-7, PubMed 29197360
3. Bilir B, Sharma NV, Lee J, Hammarstrom B, Svindland A, Kucuk O, Moreno CS (2017)
   Effects of genistein supplementation on genome‑wide DNA methylation and gene expression in patients with localized prostate cancer
   Int J Oncol, 51 (1), 223-234
   DOI 10.3892/ijo.2017.4017, PubMed 28560383
4. Bjerklund Johansen TE, Cai T (2017)
   Re: Women with Symptoms of a Urinary Tract Infection but a Negative Urine Culture: PCR-based Quantification of Escherichia coli Suggests Infection in Most Cases
   Eur Urol, 72 (4), 651-652
   DOI 10.1016/j.eururo.2017.05.043, PubMed 28602203
5. Bonkat G, Braissant O, Cai T, Köves B, Bjerklund Johansen TE, Pickard R, Veeratterapillay R (2017)
   Non-molecular Methods to Detect Bacteriuria Prior to Urological Interventions: A Diagnostic Accuracy Systematic Review
   Eur Urol Focus, 3 (6), 535-537
   DOI 10.1016/j.euf.2018.03.004, PubMed 29627196
6. Braadland PR, Giskeødegård G, Sandsmark E, Bertilsson H, Euceda LR, Hansen AF, Guldvik IJ, Selnæs KM, Grytli HH, Katz B, Svindland A, Bathen TF, Eri LM, Nygård S, Berge V, Taskén KA, Tessem MB (2017)
   Ex vivo metabolic fingerprinting identifies biomarkers predictive of prostate cancer recurrence following radical prostatectomy
   Br J Cancer, 117 (11), 1656-1664
   DOI 10.1038/bjc.2017.346, PubMed 28972967
7. Cai T, Bjerklund Johansen TE (2017)
   Reply by the Authors
   Urology, 104, 246
   DOI 10.1016/j.urology.2017.03.025, PubMed 28366699
8. Cai T, Koves B, Johansen TE (2017)
   Asymptomatic bacteriuria, to screen or not to screen - and when to treat?
   Curr Opin Urol, 27 (2), 107-111
   DOI 10.1097/MOU.0000000000000368, PubMed 27906777
9. Cai T, Tamanini I, Kulchavenya E, Perepanova T, Köves B, Wagenlehner FM, Tandogdu Z, Bonkat G, Bartoletti R, Bjerklund Johansen TE (2017)
   The role of nutraceuticals and phytotherapy in the management of urinary tract infections: What we need to know?
   Arch Ital Urol Androl, 89 (1), 1-6
   DOI 10.4081/aiua.2017.1.1, PubMed 28403585
10. Idland AV, Wyller TB, Støen R, Eri LM, Frihagen F, Ræder J, Chaudhry FA, Hansson O, Zetterberg H, Blennow K, Bogdanovic N, Brækhus A, Watne LO (2017)
    Preclinical Amyloid-β and Axonal Degeneration Pathology in Delirium
    J Alzheimers Dis, 55 (1), 371-379
    DOI 10.3233/JAD-160461, PubMed 27662296
11. Li X, Grigalavicius M, Li Y, Li X, Zhong Y, Huang R, Yu D, Berge V, Goscinski MA, Kvalheim G, Nesland JM, Suo Z (2017)
    MtDNA depletion influences the transition of CD44 subtypes in human prostate cancer DU145 cells
    Tumour Biol, 39 (8), 1010428317713671
    DOI 10.1177/1010428317713671, PubMed 28789597
12. Li X, Han G, Li X, Kan Q, Fan Z, Li Y, Ji Y, Zhao J, Zhang M, Grigalavicius M, Berge V, Goscinski MA, Nesland JM, Suo Z (2017)
    Mitochondrial pyruvate carrier function determines cell stemness and metabolic reprogramming in cancer cells
    Oncotarget, 8 (28), 46363-46380
    DOI 10.18632/oncotarget.18199, PubMed 28624784
13. Li X, Lu J, Kan Q, Li X, Fan Q, Li Y, Huang R, Slipicevic A, Dong HP, Eide L, Wang J, Zhang H, Berge V, Goscinski MA, Kvalheim G, Nesland JM, Suo Z (2017)
    Metabolic reprogramming is associated with flavopiridol resistance in prostate cancer DU145 cells
    Sci Rep, 7 (1), 5081
    DOI 10.1038/s41598-017-05086-6, PubMed 28698547
14. McDonald M, Kameh D, Johnson ME, Johansen TEB, Albala D, Mouraviev V (2017)
    A Head-to-Head Comparative Phase II Study of Standard Urine Culture and Sensitivity Versus DNA Next-generation Sequencing Testing for Urinary Tract Infections
    Rev Urol, 19 (4), 213-220
    DOI 10.3909/riu0780, PubMed 29472825
15. Wagenlehner FM, Tandogdu Z, Bjerklund Johansen TE (2017)
    An update on classification and management of urosepsis
    Curr Opin Urol, 27 (2), 133-137
    DOI 10.1097/MOU.0000000000000364, PubMed 27846034
16. Walker SM, Knight LA, McCavigan AM, Logan GE, Berge V, Sherif A, Pandha H, Warren AY, Davidson C, Uprichard A, Blayney JK, Price B, Jellema GL, Steele CJ, Svindland A, McDade SS, Eden CG, Foster C, Mills IG, Neal DE, Mason MD, Kay EW, Waugh DJ, Harkin DP, Watson RW et al. (2017)
    Molecular Subgroup of Primary Prostate Cancer Presenting with Metastatic Biology
    Eur Urol, 72 (4), 509-518
    DOI 10.1016/j.eururo.2017.03.027, PubMed 28408174
17. Aas K, Axcrona K, Kvåle R, Møller B, Myklebust TÅ, Axcrona U, Berge V, Fosså SD (2017)
    Ten-year Mortality in Men With Nonmetastatic Prostate Cancer in Norway
    Urology, 110, 140-147
    DOI 10.1016/j.urology.2017.07.048, PubMed 28823634

Publications 2016

1. Andreassen BK, Aagnes B, Gislefoss R, Andreassen M, Wahlqvist R (2016)
   Incidence and Survival of urothelial carcinoma of the urinary bladder in Norway 1981-2014
   BMC Cancer, 16 (1), 799
   DOI 10.1186/s12885-016-2832-x, PubMed 27737647
2. Baco E, Rud E, Vlatkovic L (2016)
   Reply to Yi Zhou, Weigang Yan, and Hanzhong Li's Letter to the Editor re: Eduard Baco, Erik Rud, Lars Magne Eri, et al. A Randomized Controlled Trial to Assess and Compare the Outcomes of Two-core Prostate Biopsy Guided by Fused Magnetic Resonance and Transrectal Ultrasound Images and Traditional 12-core Systematic Biopsy. Eur Urol 2016;69:149-56
   Eur Urol, 70 (2), e55
   DOI 10.1016/j.eururo.2016.01.031, PubMed 26852076
3. Bigot P, Bernhard JC, Flamand V, Gill I, Verhoest G, Beauval JB, Nouhaud FX, Suer E, Ploussard G, Hetet JF, Rigaud J, Baco E, Larré S, Sebe P, Koutlidis N, Descazeaud A, Eto M, Doerfler A, Roupret M, Vuong NS, Reix B, Matsugasumi T, Bakri AE, Albiges L, Soulié M et al. (2016)
   Localized chromophobe carcinomas treated by nephron-sparing surgery have excellent oncologic outcomes
   Urol Oncol, 35 (1), 35.e15-35.e19
   DOI 10.1016/j.urolonc.2016.08.012, PubMed 27692834
4. Bjerklund Johansen TE, Bonkat G, Cai T, Tandogdu Z, Wagenlehner F, Grabe M (2016)
   Grey Zones in the Field of Urinary Tract Infections
   Eur Urol Focus, 2 (4), 460-462
   DOI 10.1016/j.euf.2016.03.012, PubMed 28723480
5. Bokhorst LP, Lepistö I, Kakehi Y, Bangma CH, Pickles T, Valdagni R, Alberts AR, Semjonow A, Strölin P, Montesino MF, Berge V, Roobol MJ, Rannikko A (2016)
   Complications after prostate biopsies in men on active surveillance and its effects on receiving further biopsies in the Prostate cancer Research International: Active Surveillance (PRIAS) study
   BJU Int, 118 (3), 366-71
   DOI 10.1111/bju.13410, PubMed 26765682
6. Braadland PR, Grytli HH, Ramberg H, Katz B, Kellman R, Gauthier-Landry L, Fazli L, Krobert KA, Wang W, Levy FO, Bjartell A, Berge V, Rennie PS, Mellgren G, Mælandsmo GM, Svindland A, Barbier O, Taskén KA (2016)
   Low β₂-adrenergic receptor level may promote development of castration resistant prostate cancer and altered steroid metabolism
   Oncotarget, 7 (2), 1878-94
   DOI 10.18632/oncotarget.6479, PubMed 26646591
7. Cai T, Bonkat G, Tandogdu Z, Bartoletti R, Wagenlehner FME, Grabe M, Johansen TEB (2016)
   How to Use Antimicrobial Prophylaxis in Urological Procedures
   Eur Urol Focus, 2 (4), 348-350
   DOI 10.1016/j.euf.2016.02.010, PubMed 28723464
8. Cai T, Gallelli L, Cocci A, Tiscione D, Verze P, Lanciotti M, Vanacore D, Rizzo M, Gacci M, Saleh O, Malossini G, Liguori G, Trombetta C, Rocco D, Palmieri A, Bartoletti R, Carini M, Wagenlehner FM, Naber K, Mirone V, Bjerklund Johansen TE (2016)
   Antimicrobial prophylaxis for transrectal ultrasound-guided prostate biopsy: fosfomycin trometamol, an attractive alternative
   World J Urol, 35 (2), 221-228
   DOI 10.1007/s00345-016-1867-6, PubMed 27246847
9. Cai T, Mazzoli S, Lanzafame P, Caciagli P, Malossini G, Nesi G, Wagenlehner FM, Köves B, Pickard R, Grabe M, Bjerklund Johansen TE, Bartoletti R (2016)
   Asymptomatic Bacteriuria in Clinical Urological Practice: Preoperative Control of Bacteriuria and Management of Recurrent UTI
   Pathogens, 5 (1)
   DOI 10.3390/pathogens5010004, PubMed 26742080
10. Cai T, Verze P, Palmieri A, Gacci M, Lanzafame P, Malossini G, Nesi G, Bonkat G, Wagenlehner FM, Mirone V, Bartoletti R, Johansen TE (2016)
    Is Preoperative Assessment and Treatment of Asymptomatic Bacteriuria Necessary for Reducing the Risk of Postoperative Symptomatic Urinary Tract Infections After Urologic Surgical Procedures?
    Urology, 99, 100-105
    DOI 10.1016/j.urology.2016.10.016, PubMed 27773650
11. Drejer D, Béji S, Oezeke R, Nielsen AM, Høyer S, Bjerklund Johansen TE, Lam GW, Jensen JB (2016)
    Comparison of White Light, Photodynamic Diagnosis, and Narrow-band Imaging in Detection of Carcinoma In Situ or Flat Dysplasia at Transurethral Resection of the Bladder: the DaBlaCa-8 Study
    Urology, 102, 138-142
    DOI 10.1016/j.urology.2016.11.032, PubMed 27894979
12. Fosså SD, Storås AH, Steinsvik EA, Myklebust TA, Eri LM, Loge JH, Dahl AA (2016)
    Psychometric testing of the Norwegian version of the Expanded Prostate Cancer Index Composite 26-item version (EPIC-26)
    Scand J Urol, 50 (4), 280-5
    DOI 10.3109/21681805.2016.1163617, PubMed 27049891
13. Johansen TEB, Naber KG (2016)
    Working on a Dream
    Eur. Urol. Suppl., 15 (4), 69-70
    DOI 10.1016/j.eursup.2016.04.006
14. Kulchavenya E, Naber K, Johansen TEB (2016)
    Urogenital Tuberculosis: Classification, Diagnosis, and Treatment
    Eur. Urol. Suppl., 15 (4), 112-121
    DOI 10.1016/j.eursup.2016.04.001
15. Moen LV, Ramberg H, Zhao S, Grytli HH, Sveen A, Berge V, Skotheim RI, Taskén KA, Skålhegg BS (2016)
    Observed correlation between the expression levels of catalytic subunit, Cβ2, of cyclic adenosine monophosphate-dependent protein kinase and prostate cancer aggressiveness
    Urol Oncol, 35 (3), 111.e1-111.e8
    DOI 10.1016/j.urolonc.2016.10.002, PubMed 27838142
16. Novak J, Vik V, Zachoval R, Bjerklund Johansen TE (2016)
    Renal Abscess Caused by Extended-Spectrum Beta-Lactamase-Producing Bacteria and Complicated by the Perforation to a Cyst and to the Renal Pelvis
    J Endourol Case Rep, 2 (1), 123-6
    DOI 10.1089/cren.2016.0022, PubMed 27579439
17. Ramberg H, Grytli HH, Nygård S, Wang W, Ögren O, Zhao S, Løvf M, Katz B, Skotheim RI, Bjartell A, Eri LM, Berge V, Svindland A, Taskén KA (2016)
    PBX3 is a putative biomarker of aggressive prostate cancer
    Int J Cancer, 139 (8), 1810-20
    DOI 10.1002/ijc.30220, PubMed 27273830
18. Ross-Adams H, Ball S, Lawrenson K, Halim S, Russell R, Wells C, Strand SH, Ørntoft TF, Larson M, Armasu S, Massie CE, Asim M, Mortensen MM, Borre M, Woodfine K, Warren AY, Lamb AD, Kay J, Whitaker H, Ramos-Montoya A, Murrell A, Sørensen KD, Fridley BL, Goode EL, Gayther SA et al. (2016)
    HNF1B variants associate with promoter methylation and regulate gene networks activated in prostate and ovarian cancer
    Oncotarget, 7 (46), 74734-74746
    DOI 10.18632/oncotarget.12543, PubMed 27732966
19. Rud E, Baco E (2016)
    Re: Jeffrey C. Weinreb, Jelle O. Barentsz, Peter L. Choyke, et al. PI-RADS Prostate Imaging - Reporting and Data System: 2015, Version 2. Eur Urol 2016;69:16-40: Is Contrast-enhanced Magnetic Resonance Imaging Really Necessary When Searching for Prostate Cancer?
    Eur Urol, 70 (5), e136
    DOI 10.1016/j.eururo.2016.04.017, PubMed 27126376
20. Skotland T, Ekroos K, Kauhanen D, Simolin H, Seierstad T, Berge V, Sandvig K, Llorente A (2016)
    Molecular lipid species in urinary exosomes as potential prostate cancer biomarkers
    Eur J Cancer, 70, 122-132
    DOI 10.1016/j.ejca.2016.10.011, PubMed 27914242
21. Smelov V, Naber K, Bjerklund Johansen TE (2016)
    Letter to the Editor: Diagnostic Criteria in Urological Diseases do not Always Match with Findings by Extended Culture Techniques and Metagenomic Sequencing of 16S rDNA
    Open Microbiol J, 10, 23-6
    DOI 10.2174/1874285801610010023, PubMed 27006726
22. Smelov V, Naber K, Johansen TEB (2016)
    Improved Classification of Urinary Tract Infection: Future Considerations
    Eur. Urol. Suppl., 15 (4), 71-80
    DOI 10.1016/j.eursup.2016.04.002
23. Tandstad T, Ståhl O, Dahl O, Haugnes HS, Håkansson U, Karlsdottir Å, Kjellman A, Langberg CW, Laurell A, Oldenburg J, Solberg A, Söderström K, Stierner U, Cavallin-Ståhl E, Wahlqvist R, Wall N, Cohn-Cedermark G, SWENOTECA (2016)
    Treatment of stage I seminoma, with one course of adjuvant carboplatin or surveillance, risk-adapted recommendations implementing patient autonomy: a report from the Swedish and Norwegian Testicular Cancer Group (SWENOTECA)
    Ann Oncol, 27 (7), 1299-304
    DOI 10.1093/annonc/mdw164, PubMed 27052649
24. Vahlensieck W, Perepanova T, Johansen TEB, Tenke P, Naber KG, Wagenlehner FME (2016)
    Management of Uncomplicated Recurrent Urinary Tract Infections
    Eur. Urol. Suppl., 15 (4), 95-101
    DOI 10.1016/j.eursup.2016.04.007
25. Wang L, Skotland T, Berge V, Sandvig K, Llorente A (2016)
    Exosomal proteins as prostate cancer biomarkers in urine: From mass spectrometry discovery to immunoassay-based validation
    Eur J Pharm Sci, 98, 80-85
    DOI 10.1016/j.ejps.2016.09.023, PubMed 27664330
26. Østby-Deglum M, Axcrona K, Brennhovd B, Dahl AA (2016)
    Ability to Reach Orgasm in Patients With Prostate Cancer Treated With Robot-assisted Laparoscopic Prostatectomy
    Urology, 92, 38-43
    DOI 10.1016/j.urology.2015.11.066, PubMed 26972145

Publications 2015

1. Andreassen OA, Desikan RS, Wang Y, Thompson WK, Schork AJ, Zuber V, Doncheva NT, Ellinghaus E, Albrecht M, Mattingsdal M, Franke A, Lie BA, Mills IG, Aukrust P, McEvoy LK, Djurovic S, Karlsen TH, Dale AM (2015)
   Abundant genetic overlap between blood lipids and immune-mediated diseases indicates shared molecular genetic mechanisms
   PLoS One, 10 (4), e0123057
   DOI 10.1371/journal.pone.0123057, PubMed 25853426
2. Asim M, Massie CE, Orafidiya F, Pértega-Gomes N, Warren AY, Esmaeili M, Selth LA, Zecchini HI, Luko K, Qureshi A, Baridi A, Menon S, Madhu B, Escriu C, Lyons S, Vowler SL, Zecchini VR, Shaw G, Hessenkemper W, Russell R, Mohammed H, Stefanos N, Lynch AG, Grigorenko E, D'Santos C et al. (2015)
   Choline Kinase Alpha as an Androgen Receptor Chaperone and Prostate Cancer Therapeutic Target
   J Natl Cancer Inst, 108 (5)
   DOI 10.1093/jnci/djv371, PubMed 26657335
3. Baco E, Rud E, Eri L, Oen G, Latkovic L, Svindland A, Eggesbø H, Ukimura O (2015)
   [Not Available]
   Prog Urol, 25 (13), 832-3
   DOI 10.1016/j.purol.2015.08.231, PubMed 26544425
4. Baco E, Rud E, Eri LM, Moen G, Vlatkovic L, Svindland A, Eggesbø HB, Ukimura O (2015)
   A Randomized Controlled Trial To Assess and Compare the Outcomes of Two-core Prostate Biopsy Guided by Fused Magnetic Resonance and Transrectal Ultrasound Images and Traditional 12-core Systematic Biopsy
   Eur Urol, 69 (1), 149-56
   DOI 10.1016/j.eururo.2015.03.041, PubMed 25862143
5. Barfeld SJ, Fazli L, Persson M, Marjavaara L, Urbanucci A, Kaukoniemi KM, Rennie PS, Ceder Y, Chabes A, Visakorpi T, Mills IG (2015)
   Myc-dependent purine biosynthesis affects nucleolar stress and therapy response in prostate cancer
   Oncotarget, 6 (14), 12587-602
   DOI 10.18632/oncotarget.3494, PubMed 25869206
6. Bartoletti R, Cai T, Perletti G, M E Wagenlehner F, Bjerklund Johansen TE (2015)
   Finafloxacin for the treatment of urinary tract infections
   Expert Opin Investig Drugs, 24 (7), 957-63
   DOI 10.1517/13543784.2015.1052401, PubMed 26068714
7. Bigot P, Bernhard JC, Gill IS, Vuong NS, Verhoest G, Flamand V, Reix B, Suer E, Gökce I, Beauval JB, Nouhaud FX, Eto M, Baco E, Matsugasumi T, Chowaniec Y, Rigaud J, Lenormand C, Pfister C, Hetet JF, Ploussard G, Roupret M, Léon P, Bakri AE, Larré S, Tillou X et al. (2015)
   The subclassification of papillary renal cell carcinoma does not affect oncological outcomes after nephron sparing surgery
   World J Urol, 34 (3), 347-52
   DOI 10.1007/s00345-015-1634-0, PubMed 26149352
8. Bjerklund Johansen TE (2015)
   The problematical prostate cancer
   Tidsskr Nor Laegeforen, 135 (6), 508
   DOI 10.4045/tidsskr.15.0057, PubMed 25806735
9. Bollineni RC, Guldvik IJ, Grönberg H, Wiklund F, Mills IG, Thiede B (2015)
   A differential protein solubility approach for the depletion of highly abundant proteins in plasma using ammonium sulfate
   Analyst, 140 (24), 8109-17
   DOI 10.1039/c5an01560j, PubMed 26541119
10. Cai T, Verze P, Brugnolli A, Tiscione D, Luciani LG, Eccher C, Lanzafame P, Malossini G, Wagenlehner FM, Mirone V, Bjerklund Johansen TE, Pickard R, Bartoletti R (2015)
    Adherence to European Association of Urology Guidelines on Prophylactic Antibiotics: An Important Step in Antimicrobial Stewardship
    Eur Urol, 69 (2), 276-83
    DOI 10.1016/j.eururo.2015.05.010, PubMed 26001610
11. Eri LM (2015)
    [Re: Implementation of guidelines for PSA testing in general practice]
    Tidsskr Nor Laegeforen, 135 (1), 15
    DOI 10.4045/tidsskr.14.1494, PubMed 25589118
12. Johansen TE (2015)
    [Different guidelines for treatment of prostate cancer]
    Tidsskr Nor Laegeforen, 135 (10), 924-5
    DOI 10.4045/tidsskr.15.0317, PubMed 26037750
13. Johansen TE (2015)
    [Re: Different guidelines for treatment of prostate cancer]
    Tidsskr Nor Laegeforen, 135 (17), 1535-6
    DOI 10.4045/tidsskr.15.0928, PubMed 26394579
14. Johansen TE (2015)
    [Re: The problematical prostate cancer]
    Tidsskr Nor Laegeforen, 135 (17), 1536
    DOI 10.4045/tidsskr.15.0915, PubMed 26394580
15. Lund K, Dembinski JL, Solberg N, Urbanucci A, Mills IG, Krauss S (2015)
    Slug-dependent upregulation of L1CAM is responsible for the increased invasion potential of pancreatic cancer cells following long-term 5-FU treatment
    PLoS One, 10 (4), e0123684
    DOI 10.1371/journal.pone.0123684, PubMed 25860483
16. Mouraviev V, Lee B, Patel V, Albala D, Johansen TE, Partin A, Ross A, Perera RJ (2015)
    Clinical prospects of long noncoding RNAs as novel biomarkers and therapeutic targets in prostate cancer
    Prostate Cancer Prostatic Dis, 19 (1), 14-20
    DOI 10.1038/pcan.2015.48, PubMed 26503110
17. Rud E, Baco E, Klotz D, Rennesund K, Svindland A, Berge V, Lundeby E, Wessel N, Hoff JR, Berg RE, Diep L, Eggesbø HB, Eri LM (2015)
    Does preoperative magnetic resonance imaging reduce the rate of positive surgical margins at radical prostatectomy in a randomised clinical trial?
    Eur Urol, 68 (3), 487-96
    DOI 10.1016/j.eururo.2015.02.039, PubMed 25813692
18. Seglen PO, Luhr M, Mills IG, Sætre F, Szalai P, Engedal N (2015)
    Macroautophagic cargo sequestration assays
    Methods, 75, 25-36
    DOI 10.1016/j.ymeth.2014.12.021, PubMed 25576638
19. Sevilla LM, Latorre V, Carceller E, Boix J, Vodák D, Mills IG, Pérez P (2015)
    Glucocorticoid receptor and Klf4 co-regulate anti-inflammatory genes in keratinocytes
    Mol Cell Endocrinol, 412, 281-9
    DOI 10.1016/j.mce.2015.05.015, PubMed 26001834
20. Shaw GL, Whitaker H, Corcoran M, Dunning MJ, Luxton H, Kay J, Massie CE, Miller JL, Lamb AD, Ross-Adams H, Russell R, Nelson AW, Eldridge MD, Lynch AG, Ramos-Montoya A, Mills IG, Taylor AE, Arlt W, Shah N, Warren AY, Neal DE (2015)
    The Early Effects of Rapid Androgen Deprivation on Human Prostate Cancer
    Eur Urol, 70 (2), 214-8
    DOI 10.1016/j.eururo.2015.10.042, PubMed 26572708
21. Sheng X, Arnoldussen YJ, Storm M, Tesikova M, Nenseth HZ, Zhao S, Fazli L, Rennie P, Risberg B, Wæhre H, Danielsen H, Mills IG, Jin Y, Hotamisligil G, Saatcioglu F (2015)
    Divergent androgen regulation of unfolded protein response pathways drives prostate cancer
    EMBO Mol Med, 7 (6), 788-801
    DOI 10.15252/emmm.201404509, PubMed 25864123
22. Solberg A, Angelsen A, Berge V, Lilleby W, Iversen J, Klepp O, Brennhovd B, Johannessen D, Nygård Y, Larsen K, Stensvold A (2015)
    [Re: Different guidelines for treatment of prostate cancer]
    Tidsskr Nor Laegeforen, 135 (12-13), 1105
    DOI 10.4045/tidsskr.15.0652, PubMed 26130530
23. Szalai P, Hagen LK, Sætre F, Luhr M, Sponheim M, Øverbye A, Mills IG, Seglen PO, Engedal N (2015)
    Autophagic bulk sequestration of cytosolic cargo is independent of LC3, but requires GABARAPs
    Exp Cell Res, 333 (1), 21-38
    DOI 10.1016/j.yexcr.2015.02.003, PubMed 25684710
24. Tandstad T, Ståhl O, Håkansson U, Wahlqvist R, Klepp O, Cavallin-Ståhl E, Cohn-Cedermark G, SWENOTECA (2015)
    The SWENOTECA group: A good example of continuous binational and multidisciplinary collaboration for patients with testicular cancer in Sweden and Norway
    Scand J Urol, 50 (1), 9-13
    DOI 10.3109/21681805.2015.1059360, PubMed 26116316
25. Østby-Deglum M, Brennhovd B, Axcrona K, Fosså SD, Dahl AA (2015)
    A comparative study of erectile function and use of erectile aids in high-risk prostate cancer patients after robot-assisted laparoscopic prostatectomy
    Scand J Urol, 49 (6), 433-439
    DOI 10.3109/21681805.2015.1042038, PubMed 26116048
26. Øverbye A, Skotland T, Koehler CJ, Thiede B, Seierstad T, Berge V, Sandvig K, Llorente A (2015)
    Identification of prostate cancer biomarkers in urinary exosomes
    Oncotarget, 6 (30), 30357-76
    DOI 10.18632/oncotarget.4851, PubMed 26196085

Publications 2014

1. Ahmed HU, Berge V, Bottomley D, Cross W, Heer R, Kaplan R, Leslie T, Parker C, Relton C, Stephens R, Sydes MR, Turnbull L, van der Meulen J, Vickers A, Wilt T, Emberton M, Prostate Cancer RCT Consensus Group (2014)
   Can we deliver randomized trials of focal therapy in prostate cancer?
   Nat Rev Clin Oncol, 11 (8), 482-91
   DOI 10.1038/nrclinonc.2014.44, PubMed 24751803
2. Andreassen OA, Zuber V, Thompson WK, Schork AJ, Bettella F, PRACTICAL Consortium, CRUK GWAS, Djurovic S, Desikan RS, Mills IG, Dale AM (2014)
   Shared common variants in prostate cancer and blood lipids
   Int J Epidemiol, 43 (4), 1205-14
   DOI 10.1093/ije/dyu090, PubMed 24786909
3. Baco E, Gelet A, Crouzet S, Rud E, Rouvière O, Tonoli-Catez H, Berge V, Chapelon JY, Eggesbø HB (2014)
   Hemi salvage high-intensity focused ultrasound (HIFU) in unilateral radiorecurrent prostate cancer: a prospective two-centre study
   BJU Int, 114 (4), 532-40
   DOI 10.1111/bju.12545, PubMed 24930692
4. Baco E, Ukimura O, Rud E, Vlatkovic L, Svindland A, Aron M, Palmer S, Matsugasumi T, Marien A, Bernhard JC, Rewcastle JC, Eggesbø HB, Gill IS (2014)
   Magnetic resonance imaging-transectal ultrasound image-fusion biopsies accurately characterize the index tumor: correlation with step-sectioned radical prostatectomy specimens in 135 patients
   Eur Urol, 67 (4), 787-94
   DOI 10.1016/j.eururo.2014.08.077, PubMed 25240973
5. Bancroft EK, Page EC, Castro E, Lilja H, Vickers A, Sjoberg D, Assel M, Foster CS, Mitchell G, Drew K, Mæhle L, Axcrona K, Evans DG, Bulman B, Eccles D, McBride D, van Asperen C, Vasen H, Kiemeney LA, Ringelberg J, Cybulski C, Wokolorczyk D, Selkirk C, Hulick PJ, Bojesen A et al. (2014)
   Targeted prostate cancer screening in BRCA1 and BRCA2 mutation carriers: results from the initial screening round of the IMPACT study
   Eur Urol, 66 (3), 489-99
   DOI 10.1016/j.eururo.2014.01.003, PubMed 24484606
6. Barfeld SJ, Itkonen HM, Urbanucci A, Mills IG (2014)
   Androgen-regulated metabolism and biosynthesis in prostate cancer
   Endocr Relat Cancer, 21 (4), T57-66
   DOI 10.1530/ERC-13-0515, PubMed 24497572
7. Bon H, Wadhwa K, Schreiner A, Osborne M, Carroll T, Ramos-Montoya A, Ross-Adams H, Visser M, Hoffmann R, Ahmed AA, Neal DE, Mills IG (2014)
   Salt-inducible kinase 2 regulates mitotic progression and transcription in prostate cancer
   Mol Cancer Res, 13 (4), 620-635
   DOI 10.1158/1541-7786.MCR-13-0182-T, PubMed 25548099
8. Cek M, Tandoğdu Z, Wagenlehner F, Tenke P, Naber K, Bjerklund-Johansen TE (2014)
   Healthcare-associated urinary tract infections in hospitalized urological patients--a global perspective: results from the GPIU studies 2003-2010
   World J Urol, 32 (6), 1587-94
   DOI 10.1007/s00345-013-1218-9, PubMed 24452449
9. Dahl S, Loge JH, Berge V, Dahl AA, Cvancarova M, Fosså SD (2014)
   Influence of radical prostatectomy for prostate cancer on work status and working life 3 years after surgery
   J Cancer Surviv, 9 (2), 172-9
   DOI 10.1007/s11764-014-0399-6, PubMed 25216609
10. Donaldson IA, Alonzi R, Barratt D, Barret E, Berge V, Bott S, Bottomley D, Eggener S, Ehdaie B, Emberton M, Hindley R, Leslie T, Miners A, McCartan N, Moore CM, Pinto P, Polascik TJ, Simmons L, van der Meulen J, Villers A, Willis S, Ahmed HU (2014)
    Focal therapy: patients, interventions, and outcomes--a report from a consensus meeting
    Eur Urol, 67 (4), 771-7
    DOI 10.1016/j.eururo.2014.09.018, PubMed 25281389
11. Engedal N, Mills IG (2014)
    Endosomal signaling and oncogenesis
    Methods Enzymol, 535, 179-200
    DOI 10.1016/B978-0-12-397925-4.00012-2, PubMed 24377925
12. Holm HV, Fosså SD, Hedlund H, Schultz A, Dahl AA (2014)
    How should continence and incontinence after radical prostatectomy be evaluated? A prospective study of patient ratings and changes with time
    J Urol, 192 (4), 1155-61
    DOI 10.1016/j.juro.2014.03.113, PubMed 24727062
13. Holm HV, Fosså SD, Hedlund H, Schultz A, Dahl AA (2014)
    Severe postprostatectomy incontinence: Is there an association between preoperative urodynamic findings and outcome of incontinence surgery?
    Scand J Urol, 49 (3), 250-9
    DOI 10.3109/21681805.2014.980845, PubMed 25428752
14. Itkonen HM, Engedal N, Babaie E, Luhr M, Guldvik IJ, Minner S, Hohloch J, Tsourlakis MC, Schlomm T, Mills IG (2014)
    UAP1 is overexpressed in prostate cancer and is protective against inhibitors of N-linked glycosylation
    Oncogene, 34 (28), 3744-50
    DOI 10.1038/onc.2014.307, PubMed 25241896
15. Johansen TE, Naber KG (2014)
    Urinary Tract Infections
    Antibiotics (Basel), 3 (3), 375-7
    DOI 10.3390/antibiotics3030375, PubMed 27025751
16. Mills IG (2014)
    HOXB13, RFX6 and prostate cancer risk
    Nat Genet, 46 (2), 94-5
    DOI 10.1038/ng.2881, PubMed 24473320
17. Mills IG (2014)
    Maintaining and reprogramming genomic androgen receptor activity in prostate cancer
    Nat Rev Cancer, 14 (3), 187-98
    DOI 10.1038/nrc3678, PubMed 24561445
18. Nilsson R, Omland H, Dahl AA, Johansen TE (2014)
    Early outcome of orchiopexy and analysis of predictive factors: a retrospective study from 2001 to 2010 in a Norwegian regional hospital
    Scand J Urol, 48 (5), 474-81
    DOI 10.3109/21681805.2014.905631, PubMed 24720831
19. Ragnum HB, Vlatkovic L, Lie AK, Axcrona K, Julin CH, Frikstad KM, Hole KH, Seierstad T, Lyng H (2014)
    The tumour hypoxia marker pimonidazole reflects a transcriptional programme associated with aggressive prostate cancer
    Br J Cancer, 112 (2), 382-90
    DOI 10.1038/bjc.2014.604, PubMed 25461803
20. Ramos-Montoya A, Lamb AD, Russell R, Carroll T, Jurmeister S, Galeano-Dalmau N, Massie CE, Boren J, Bon H, Theodorou V, Vias M, Shaw GL, Sharma NL, Ross-Adams H, Scott HE, Vowler SL, Howat WJ, Warren AY, Wooster RF, Mills IG, Neal DE (2014)
    HES6 drives a critical AR transcriptional programme to induce castration-resistant prostate cancer through activation of an E2F1-mediated cell cycle network
    EMBO Mol Med, 6 (5), 651-61
    DOI 10.1002/emmm.201303581, PubMed 24737870
21. Rud E, Baco E, Lien D, Klotz D, Eggesbø HB (2014)
    Detection of radiorecurrent prostate cancer using diffusion-weighted imaging and targeted biopsies
    AJR Am J Roentgenol, 202 (3), W241-6
    DOI 10.2214/AJR.12.10483, PubMed 24555620
22. Rud E, Klotz D, Rennesund K, Baco E, Berge V, Lien D, Svindland A, Lundeby E, Berg RE, Eri LM, Eggesbø HB (2014)
    Detection of the index tumour and tumour volume in prostate cancer using T2-weighted and diffusion-weighted magnetic resonance imaging (MRI) alone
    BJU Int, 114 (6b), E32-E42
    DOI 10.1111/bju.12637, PubMed 24447606
23. Rud E, Klotz D, Rennesund K, Baco E, Johansen TE, Diep LM, Svindland A, Eri LM, Eggesbø HB (2014)
    Preoperative magnetic resonance imaging for detecting uni- and bilateral extraprostatic disease in patients with prostate cancer
    World J Urol, 33 (7), 1015-21
    DOI 10.1007/s00345-014-1362-x, PubMed 25059766
24. Salji M, Jones R, Paul J, Birrell F, Dixon-Hughes J, Hutchison C, Johansen TE, Greene D, Parr N, Leung HY, Cryotherapy in Prostate Cancer (CROP) study team (2014)
    Feasibility study of a randomised controlled trial to compare (deferred) androgen deprivation therapy and cryotherapy in men with localised radiation-recurrent prostate cancer
    Br J Cancer, 111 (3), 424-9
    DOI 10.1038/bjc.2014.316, PubMed 24946001
25. Schultz A, Boye B, Jonsson O, Thind P, Månsson W (2014)
    Urostomy and health-related quality of life in patients with lower urinary tract dysfunction
    Scand J Urol, 49 (1), 2-7
    DOI 10.3109/21681805.2013.876095, PubMed 25370732
26. Servoll E, Sæter T, Vlatkovic L, Nesland JM, Waaler G, Axcrona K (2014)
    Prostate-specific antigen doubling time subsequent to radical prostatectomy is a predictor of outcome following salvage external beam radiation therapy: a single-centre experience
    Scand J Urol, 49 (3), 218-23
    DOI 10.3109/21681805.2014.982168, PubMed 25428750
27. Servoll E, Vlatkovic L, Sæter T, Nesland JM, Axcrona U, Waaler G, Axcrona K (2014)
    The length of a positive surgical margin is of prognostic significance in patients with clinically localized prostate cancer treated with radical prostatectomy
    Urol Int, 93 (3), 289-95
    DOI 10.1159/000362342, PubMed 25170745
28. Sharma NL, Massie CE, Butter F, Mann M, Bon H, Ramos-Montoya A, Menon S, Stark R, Lamb AD, Scott HE, Warren AY, Neal DE, Mills IG (2014)
    The ETS family member GABPα modulates androgen receptor signalling and mediates an aggressive phenotype in prostate cancer
    Nucleic Acids Res, 42 (10), 6256-69
    DOI 10.1093/nar/gku281, PubMed 24753418
29. Siddiqui H, Lagesen K, Nederbragt AJ, Eri LM, Jeansson SL, Jakobsen KS (2014)
    Pathogens in Urine from a Female Patient with Overactive Bladder Syndrome Detected by Culture-independent High Throughput Sequencing: A Case Report
    Open Microbiol J, 8, 148-53
    DOI 10.2174/1874285801408010148, PubMed 25685246
30. Tandstad T, Ståhl O, Håkansson U, Dahl O, Haugnes HS, Klepp OH, Langberg CW, Laurell A, Oldenburg J, Solberg A, Söderström K, Cavallin-Ståhl E, Stierner U, Wahlquist R, Wall N, Cohn-Cedermark G, SWENOTECA (2014)
    One course of adjuvant BEP in clinical stage I nonseminoma mature and expanded results from the SWENOTECA group
    Ann Oncol, 25 (11), 2167-2172
    DOI 10.1093/annonc/mdu375, PubMed 25114021
31. Tenke P, Köves B, Johansen TE (2014)
    An update on prevention and treatment of catheter-associated urinary tract infections
    Curr Opin Infect Dis, 27 (1), 102-7
    DOI 10.1097/QCO.0000000000000031, PubMed 24345923
32. Wagenlehner FM, Pilatz A, Waliszewski P, Weidner W, Johansen TE (2014)
    Reducing infection rates after prostate biopsy
    Nat Rev Urol, 11 (2), 80-6
    DOI 10.1038/nrurol.2013.322, PubMed 24418806

Publications 2013

1. Baust JG, Gage AA, Bjerklund Johansen TE, Baust JM (2013)
   Mechanisms of cryoablation: clinical consequences on malignant tumors
   Cryobiology, 68 (1), 1-11
   DOI 10.1016/j.cryobiol.2013.11.001, PubMed 24239684
2. Berge V, Berg RE, Hoff JR, Wessel N, Diep LM, Karlsen SJ, Eri LM (2013)
   A prospective study of transition from laparoscopic to robot-assisted radical prostatectomy: quality of life outcomes after 36-month follow-up
   Urology, 81 (4), 781-6
   DOI 10.1016/j.urology.2013.01.017, PubMed 23465150
3. Berge V, Dickinson L, McCartan N, Hindley RG, Diep LM, Emberton M, Ahmed HU (2013)
   Morbidity associated with primary high intensity focused ultrasound and redo high intensity focused ultrasound for localized prostate cancer
   J Urol, 191 (6), 1764-9
   DOI 10.1016/j.juro.2013.12.036, PubMed 24373800
4. Bjerklund Johansen TE (2013)
   Predictors of biochemical failure in patients undergoing prostate whole-gland salvage cryotherapy: a novel risk stratification model
   BJU Int, 112 (4), E262-4
   DOI 10.1111/j.1464-410X.2012.11784.x, PubMed 23879910
5. Engedal N, Torgersen ML, Guldvik IJ, Barfeld SJ, Bakula D, Sætre F, Hagen LK, Patterson JB, Proikas-Cezanne T, Seglen PO, Simonsen A, Mills IG (2013)
   Modulation of intracellular calcium homeostasis blocks autophagosome formation
   Autophagy, 9 (10), 1475-90
   DOI 10.4161/auto.25900, PubMed 23970164
6. Fosså A, Røsok BI, Kazaryan AM, Holte HJ, Brennhovd B, Westerheim O, Marangos IP, Edwin B (2013)
   Laparoscopic versus open surgery in stage I-III adrenocortical carcinoma -- a retrospective comparison of 32 patients
   Acta Oncol, 52 (8), 1771-7
   DOI 10.3109/0284186X.2013.765065, PubMed 23398621
7. Fosså SD, Nilssen Y, Kvåle R, Hernes E, Axcrona K, Møller B (2013)
   Treatment and 5-year survival in patients with nonmetastatic prostate cancer: the Norwegian experience
   Urology, 83 (1), 146-52
   DOI 10.1016/j.urology.2013.08.081, PubMed 24238563
8. Holm HV, Fosså SD, Hedlund H, Dahl AA (2013)
   Study of generic quality of life in patients operated on for post-prostatectomy incontinence
   Int J Urol, 20 (9), 889-95
   DOI 10.1111/iju.12077, PubMed 23418855
9. Itkonen HM, Mills IG (2013)
   N-linked glycosylation supports cross-talk between receptor tyrosine kinases and androgen receptor
   PLoS One, 8 (5), e65016
   DOI 10.1371/journal.pone.0065016, PubMed 23724116
10. Itkonen HM, Minner S, Guldvik IJ, Sandmann MJ, Tsourlakis MC, Berge V, Svindland A, Schlomm T, Mills IG (2013)
    O-GlcNAc transferase integrates metabolic pathways to regulate the stability of c-MYC in human prostate cancer cells
    Cancer Res, 73 (16), 5277-87
    DOI 10.1158/0008-5472.CAN-13-0549, PubMed 23720054
11. Lilleby W, Stensvold A, Mills IG, Nesland JM (2013)
    Disseminated tumor cells and their prognostic significance in nonmetastatic prostate cancer patients
    Int J Cancer, 133 (1), 149-55
    DOI 10.1002/ijc.28002, PubMed 23280694
12. Liu Y, Sæter T, Vlatkovic L, Servoll E, Waaler G, Axcrona U, Giercksky KE, Nesland JM, Suo ZH, Axcrona K (2013)
    Dendritic and lymphocytic cell infiltration in prostate carcinoma
    Histol Histopathol, 28 (12), 1621-8
    DOI 10.14670/HH-28.1621, PubMed 23729368
13. Liu Y, Wu X, Li X, Kvalheim G, Axcrona U, Axcrona K, Suo Z (2013)
    Blocking mtDNA replication upregulates the expression of stemness-related genes in prostate cancer cell lines
    Ultrastruct Pathol, 37 (4), 258-66
    DOI 10.3109/01913123.2013.770112, PubMed 23634795
14. Ma Y, Liang D, Liu J, Wen JG, Servoll E, Waaler G, Sæter T, Axcrona K, Vlatkovic L, Axcrona U, Paus E, Yang Y, Zhang Z, Kvalheim G, Nesland JM, Suo Z (2013)
    SHBG is an important factor in stemness induction of cells by DHT in vitro and associated with poor clinical features of prostate carcinomas
    PLoS One, 8 (7), e70558 (Retracted)
    DOI 10.1371/journal.pone.0070558, PubMed 23936228
15. Schultz A (2013)
    [Ritual circumcision in the global world]
    Tidsskr Nor Laegeforen, 133 (15), 1556
    DOI 10.4045/tidsskr.13.0873, PubMed 23970256
16. Ulvik Ø, Rennesund K, Gjengstø P, Wentzel-Larsen T, Ulvik NM (2013)
    Ureteroscopy with and without safety guide wire: should the safety wire still be mandatory?
    J Endourol, 27 (10), 1197-202
    DOI 10.1089/end.2013.0248, PubMed 23795760
17. Wagenlehner FM, Bartoletti R, Cek M, Grabe M, Kahlmeter G, Pickard R, Bjerklund-Johansen TE (2013)
    Antibiotic stewardship: a call for action by the urologic community
    Eur Urol, 64 (3), 358-60
    DOI 10.1016/j.eururo.2013.05.044, PubMed 23746854

Publications 2012

1. Andersen AV, Granlund P, Schultz A, Talseth T, Hedlund H, Frich L (2012)
   Long-term experience with surgical treatment of selected patients with bladder pain syndrome/interstitial cystitis
   Scand J Urol Nephrol, 46 (4), 284-9
   DOI 10.3109/00365599.2012.669789, PubMed 22452583
2. Axcrona K, Aaltomaa S, da Silva CM, Ozen H, Damber JE, Tankó LB, Colli E, Klarskov P (2012)
   Androgen deprivation therapy for volume reduction, lower urinary tract symptom relief and quality of life improvement in patients with prostate cancer: degarelix vs goserelin plus bicalutamide
   BJU Int, 110 (11), 1721-8
   DOI 10.1111/j.1464-410X.2012.11107.x, PubMed 22500884
3. Çek M, Tandoğdu Z, Naber K, Tenke P, Wagenlehner F, van Oostrum E, Kristensen B, Bjerklund Johansen TE, Global Prevalence Study of Infections in Urology Investigators (2012)
   Antibiotic prophylaxis in urology departments, 2005-2010
   Eur Urol, 63 (2), 386-94
   DOI 10.1016/j.eururo.2012.09.038, PubMed 23031676
4. Grisanzio C, Werner L, Takeda D, Awoyemi BC, Pomerantz MM, Yamada H, Sooriakumaran P, Robinson BD, Leung R, Schinzel AC, Mills I, Ross-Adams H, Neal DE, Kido M, Yamamoto T, Petrozziello G, Stack EC, Lis R, Kantoff PW, Loda M, Sartor O, Egawa S, Tewari AK, Hahn WC, Freedman ML (2012)
   Genetic and functional analyses implicate the NUDT11, HNF1B, and SLC22A3 genes in prostate cancer pathogenesis
   Proc Natl Acad Sci U S A, 109 (28), 11252-7
   DOI 10.1073/pnas.1200853109, PubMed 22730461
5. Hart LS, Cunningham JT, Datta T, Dey S, Tameire F, Lehman SL, Qiu B, Zhang H, Cerniglia G, Bi M, Li Y, Gao Y, Liu H, Li C, Maity A, Thomas-Tikhonenko A, Perl AE, Koong A, Fuchs SY, Diehl JA, Mills IG, Ruggero D, Koumenis C (2012)
   ER stress-mediated autophagy promotes Myc-dependent transformation and tumor growth
   J Clin Invest, 122 (12), 4621-34
   DOI 10.1172/JCI62973, PubMed 23143306
6. Hautmann RE, Abol-Enein H, Davidsson T, Gudjonsson S, Hautmann SH, Holm HV, Lee CT, Liedberg F, Madersbacher S, Manoharan M, Mansson W, Mills RD, Penson DF, Skinner EC, Stein R, Studer UE, Thueroff JW, Turner WH, Volkmer BG, Xu A, International Consultation on Urologic Disease-European Association of Urology Consultation on Bladder Cancer 2012 (2012)
   ICUD-EAU International Consultation on Bladder Cancer 2012: Urinary diversion
   Eur Urol, 63 (1), 67-80
   DOI 10.1016/j.eururo.2012.08.050, PubMed 22995974
7. Heidenreich A, Witjes WP, Bjerklund-Johansen TE, Patel A, EAU Research Foundation (2012)
   Therapies used in prostate cancer patients by European urologists: data on indication with a focus on expectations, perceived barriers and guideline compliance related to the use of bisphosphonates
   Urol Int, 89 (1), 30-8
   DOI 10.1159/000338810, PubMed 22699678
8. Hole KH, Axcrona K, Lie AK, Vlatkovic L, Geier OM, Brennhovd B, Knutstad K, Olsen DR, Seierstad T (2012)
   Routine pelvic MRI using phased-array coil for detection of extraprostatic tumour extension: accuracy and clinical significance
   Eur Radiol, 23 (4), 1158-66
   DOI 10.1007/s00330-012-2669-x, PubMed 23114883
9. Lazarevic B, Hammarström C, Yang J, Ramberg H, Diep LM, Karlsen SJ, Kucuk O, Saatcioglu F, Taskèn KA, Svindland A (2012)
   The effects of short-term genistein intervention on prostate biomarker expression in patients with localised prostate cancer before radical prostatectomy
   Br J Nutr, 108 (12), 2138-47
   DOI 10.1017/S0007114512000384, PubMed 22397815
10. Lindberg J, Mills IG, Klevebring D, Liu W, Neiman M, Xu J, Wikström P, Wiklund P, Wiklund F, Egevad L, Grönberg H (2012)
    The mitochondrial and autosomal mutation landscapes of prostate cancer
    Eur Urol, 63 (4), 702-8
    DOI 10.1016/j.eururo.2012.11.053, PubMed 23265383
11. Liu Y, Vlatkovic L, Sæter T, Servoll E, Waaler G, Nesland JM, Giercksky KE, Axcrona K (2012)
    Is the clinical malignant phenotype of prostate cancer a result of a highly proliferative immune-evasive B7-H3-expressing cell population?
    Int J Urol, 19 (8), 749-56
    DOI 10.1111/j.1442-2042.2012.03017.x, PubMed 22487487
12. Ma Y, Liang D, Liu J, Axcrona K, Kvalheim G, Giercksky KE, Nesland JM, Suo Z (2012)
    Synergistic effect of SCF and G-CSF on stem-like properties in prostate cancer cell lines
    Tumour Biol, 33 (4), 967-78
    DOI 10.1007/s13277-012-0325-3, PubMed 22252524
13. Paulo P, Ribeiro FR, Santos J, Mesquita D, Almeida M, Barros-Silva JD, Itkonen H, Henrique R, Jerónimo C, Sveen A, Mills IG, Skotheim RI, Lothe RA, Teixeira MR (2012)
    Molecular subtyping of primary prostate cancer reveals specific and shared target genes of different ETS rearrangements
    Neoplasia, 14 (7), 600-11
    DOI 10.1593/neo.12600, PubMed 22904677
14. Rud E, Baco E, Eggesbø HB (2012)
    MRI and ultrasound-guided prostate biopsy using soft image fusion
    Anticancer Res, 32 (8), 3383-9
    PubMed 22843919
15. Schröder F, Crawford ED, Axcrona K, Payne H, Keane TE (2012)
    Androgen deprivation therapy: past, present and future
    BJU Int, 109 Suppl 6, 1-12
    DOI 10.1111/j.1464-410X.2012.11215.x, PubMed 22672120
16. Sharma NL, Massie CE, Ramos-Montoya A, Zecchini V, Scott HE, Lamb AD, MacArthur S, Stark R, Warren AY, Mills IG, Neal DE (2012)
    The androgen receptor induces a distinct transcriptional program in castration-resistant prostate cancer in man
    Cancer Cell, 23 (1), 35-47
    DOI 10.1016/j.ccr.2012.11.010, PubMed 23260764
17. Steinsvik EA, Axcrona K, Angelsen A, Beisland C, Dahl A, Eri LM, Haug ES, Svindland A, Fosså S (2012)
    Does a surgeon's annual radical prostatectomy volume predict the risk of positive surgical margins and urinary incontinence at one-year follow-up? Findings from a prospective national study
    Scand J Urol, 47 (2), 92-100
    DOI 10.3109/00365599.2012.707684, PubMed 22860630
18. Stensvold A, Dahl AA, Brennhovd B, Småstuen MC, Fosså SD, Lilleby W, Steinsvik A, Axcrona K, Smeland S (2012)
    Bother problems in prostate cancer patients after curative treatment
    Urol Oncol, 31 (7), 1067-78
    DOI 10.1016/j.urolonc.2011.12.020, PubMed 22341412
19. Wagenlehner F, van Oostrum E, Tenke P, Tandogdu Z, Cek M, Grabe M, Wullt B, Pickard R, Naber KG, Pilatz A, Weidner W, Bjerklund-Johansen TE (2012)
    Reply from Authors re: Riccardo Bartoletti, Tommaso Cai. Prostate Biopsies Should Be Performed According to a Standard of Care. Eur Urol 2013;63:528-9
    Eur Urol, 63 (3), 529-30
    DOI 10.1016/j.eururo.2012.07.037, PubMed 22868669
20. Wagenlehner FM, van Oostrum E, Tenke P, Tandogdu Z, Çek M, Grabe M, Wullt B, Pickard R, Naber KG, Pilatz A, Weidner W, Bjerklund-Johansen TE, GPIU investigators (2012)
    Infective complications after prostate biopsy: outcome of the Global Prevalence Study of Infections in Urology (GPIU) 2010 and 2011, a prospective multinational multicentre prostate biopsy study
    Eur Urol, 63 (3), 521-7
    DOI 10.1016/j.eururo.2012.06.003, PubMed 22704727

Publications 2011

1. Axcrona K, Vlatkovic L, Hovland J, Brennhovd B, Kongsgaard U, Giercksky KE (2011)
   Robot-assisted laparoscopic prostatectomy in a 68-year-old patient with previous heart transplantation and pelvic irradiation
   J Robot Surg, 6 (1), 81-3
   DOI 10.1007/s11701-011-0270-y, PubMed 22408687
2. Berge V (2011)
   Editorial comment to transrectal high-intensity focused ultrasound for treatment of localized prostate cancer
   Int J Urol, 18 (5), 363-4
   DOI 10.1111/j.1442-2042.2011.02752.x, PubMed 21453400
3. Berge V, Baco E, Dahl AA, Karlsen SJ (2011)
   Health-related quality of life after salvage high-intensity focused ultrasound (HIFU) treatment for locally radiorecurrent prostate cancer
   Int J Urol, 18 (9), 646-51
   DOI 10.1111/j.1442-2042.2011.02815.x, PubMed 21771102
4. Berge V, Berg RE, Hoff JR, Wessel N, Svindland A, Karlsen SJ, Eri LM (2011)
   Five-year progression-free survival in 577 patients operated on with laparoscopic radical prostatectomy for localized prostate cancer
   Scand J Urol Nephrol, 46 (1), 8-13
   DOI 10.3109/00365599.2011.604790, PubMed 21843041
5. Dimmen M, Vlatkovic L, Hole KH, Nesland JM, Brennhovd B, Axcrona K (2011)
   Transperineal prostate biopsy detects significant cancer in patients with elevated prostate-specific antigen (PSA) levels and previous negative transrectal biopsies
   BJU Int, 110 (2 Pt 2), E69-75
   DOI 10.1111/j.1464-410X.2011.10759.x, PubMed 22093091
6. Grabe M, Botto H, Cek M, Tenke P, Wagenlehner FM, Naber KG, Bjerklund Johansen TE (2011)
   Preoperative assessment of the patient and risk factors for infectious complications and tentative classification of surgical field contamination of urological procedures
   World J Urol, 30 (1), 39-50
   DOI 10.1007/s00345-011-0722-z, PubMed 21779836
7. Jespersen CG, Nørgaard M, Bjerklund Johansen TE, Søgaard M, Borre M (2011)
   The influence of cardiovascular morbidity on the prognosis in prostate cancer. Experience from a 12-year nationwide Danish population-based cohort study
   BMC Cancer, 11, 519
   DOI 10.1186/1471-2407-11-519, PubMed 22172009
8. Lazarevic B, Boezelijn G, Diep LM, Kvernrod K, Ogren O, Ramberg H, Moen A, Wessel N, Berg RE, Egge-Jacobsen W, Hammarstrom C, Svindland A, Kucuk O, Saatcioglu F, Taskèn KA, Karlsen SJ (2011)
   Efficacy and safety of short-term genistein intervention in patients with localized prostate cancer prior to radical prostatectomy: a randomized, placebo-controlled, double-blind Phase 2 clinical trial
   Nutr Cancer, 63 (6), 889-98
   DOI 10.1080/01635581.2011.582221, PubMed 21714686
9. Ma Y, Liang D, Liu J, Axcrona K, Kvalheim G, Stokke T, Nesland JM, Suo Z (2011)
   Prostate cancer cell lines under hypoxia exhibit greater stem-like properties
   PLoS One, 6 (12), e29170 (Retracted)
   DOI 10.1371/journal.pone.0029170, PubMed 22216200
10. Malmström PU, Grabe M, Haug ES, Hellström P, Hermann GG, Mogensen K, Raitanen M, Wahlqvist R (2011)
    Role of hexaminolevulinate-guided fluorescence cystoscopy in bladder cancer: critical analysis of the latest data and European guidance
    Scand J Urol Nephrol, 46 (2), 108-16
    DOI 10.3109/00365599.2011.633279, PubMed 22087730
11. Matsumoto T, Wagenlehner FM, Johansen TE (2011)
    Antimicrobial therapy of urinary tract infections
    Int J Antimicrob Agents, 38 Suppl, 1-2
    DOI 10.1016/j.ijantimicag.2011.09.001, PubMed 22018987
12. Mills IG (2011)
    Nuclear translocation and functions of growth factor receptors
    Semin Cell Dev Biol, 23 (2), 165-71
    DOI 10.1016/j.semcdb.2011.09.004, PubMed 21930229
13. Montvilas P, Solvig J, Johansen TE (2011)
    Single-centre review of radiologically guided percutaneous nephrostomy using "mixed" technique: success and complication rates
    Eur J Radiol, 80 (2), 553-8
    DOI 10.1016/j.ejrad.2011.01.109, PubMed 21353753
14. Olofsson SE, Tandstad T, Jerkeman M, Dahl O, Ståhl O, Klepp O, Bremnes RM, Cohn-Cedermark G, Langberg CW, Laurell A, Solberg A, Stierner U, Wahlqvist R, Wijkström H, Anderson H, Cavallin-Ståhl E (2011)
    Population-based study of treatment guided by tumor marker decline in patients with metastatic nonseminomatous germ cell tumor: a report from the Swedish-Norwegian Testicular Cancer Group
    J Clin Oncol, 29 (15), 2032-9
    DOI 10.1200/JCO.2010.29.1278, PubMed 21482994
15. Ramberg H, Alshbib A, Berge V, Svindland A, Taskén KA (2011)
    Regulation of PBX3 expression by androgen and Let-7d in prostate cancer
    Mol Cancer, 10, 50
    DOI 10.1186/1476-4598-10-50, PubMed 21548940
16. Rosenblatt R, Sherif A, Rintala E, Wahlqvist R, Ullén A, Nilsson S, Malmström PU, Nordic Urothelial Cancer Group (2011)
    Pathologic downstaging is a surrogate marker for efficacy and increased survival following neoadjuvant chemotherapy and radical cystectomy for muscle-invasive urothelial bladder cancer
    Eur Urol, 61 (6), 1229-38
    DOI 10.1016/j.eururo.2011.12.010, PubMed 22189383
17. Servoll E, Saeter T, Vlatkovic L, Lund T, Nesland J, Waaler G, Axcrona K, Beisland HO (2011)
    Impact of a tertiary Gleason pattern 4 or 5 on clinical failure and mortality after radical prostatectomy for clinically localised prostate cancer
    BJU Int, 109 (10), 1489-94
    DOI 10.1111/j.1464-410X.2011.10583.x, PubMed 21933333
18. Steinsvik EA, Axcrona K, Dahl AA, Eri LM, Stensvold A, Fosså SD (2011)
    Can sexual bother after radical prostatectomy be predicted preoperatively? Findings from a prospective national study of the relation between sexual function, activity and bother
    BJU Int, 109 (9), 1366-74
    DOI 10.1111/j.1464-410X.2011.10598.x, PubMed 21999333
19. Tenke P, Köves B, Nagy K, Hultgren SJ, Mendling W, Wullt B, Grabe M, Wagenlehner FM, Cek M, Pickard R, Botto H, Naber KG, Bjerklund Johansen TE (2011)
    Update on biofilm infections in the urinary tract
    World J Urol, 30 (1), 51-7
    DOI 10.1007/s00345-011-0689-9, PubMed 21590469
20. Wagenlehner FM, Cek M, Naber KG, Kiyota H, Bjerklund-Johansen TE (2011)
    Epidemiology, treatment and prevention of healthcare-associated urinary tract infections
    World J Urol, 30 (1), 59-67
    DOI 10.1007/s00345-011-0757-1, PubMed 21898083
21. Wagenlehner FM, Grabe M, Naber KG, Bjerklund Johansen TE, Naber CK, Weidner W (2011)
    [Antibiotic prophylaxis in urology]
    Urologe A, 50 (11), 1469-78; quiz 1479-80
    DOI 10.1007/s00120-011-2661-0, PubMed 21997660
22. Wedde TB, Lobmaier IV, Brennhovd B, Lohne F, Hall KS (2011)
    Primary Ewing's Sarcoma of the Kidney in a 73-Year-Old Man
    Sarcoma, 2011, 978319
    DOI 10.1155/2011/978319, PubMed 21776194

Publications 2010

1. Berge V, Baco E, Karlsen SJ (2010)
   A prospective study of salvage high-intensity focused ultrasound for locally radiorecurrent prostate cancer: early results
   Scand J Urol Nephrol, 44 (4), 223-7
   DOI 10.3109/00365591003727551, PubMed 20350272
2. Kvåle R, Møller B, Angelsen A, Dahl O, Fosså SD, Halvorsen OJ, Hoem L, Solberg A, Wahlqvist R, Bray F (2010)
   Regional trends in prostate cancer incidence, treatment with curative intent and mortality in Norway 1980-2007
   Cancer Epidemiol, 34 (4), 359-67
   DOI 10.1016/j.canep.2010.04.017, PubMed 20627840
3. Mitra AV, Bancroft EK, Barbachano Y, Page EC, Foster CS, Jameson C, Mitchell G, Lindeman GJ, Stapleton A, Suthers G, Evans DG, Cruger D, Blanco I, Mercer C, Kirk J, Maehle L, Hodgson S, Walker L, Izatt L, Douglas F, Tucker K, Dorkins H, Clowes V, Male A, Donaldson A et al. (2010)
   Targeted prostate cancer screening in men with mutations in BRCA1 and BRCA2 detects aggressive prostate cancer: preliminary analysis of the results of the IMPACT study
   BJU Int, 107 (1), 28-39
   DOI 10.1111/j.1464-410X.2010.09648.x, PubMed 20840664
4. Mouraviev V, Johansen TE, Polascik TJ (2010)
   Contemporary results of focal therapy for prostate cancer using cryoablation
   J Endourol, 24 (5), 827-34
   DOI 10.1089/end.2009.0546, PubMed 20443724
5. Nøkleby K, Berge V, Stiris M, Tufteland KF, Humerfelt S (2010)
   [A 40ish man with weight loss and scrotum edema]
   Tidsskr Nor Laegeforen, 130 (20), 2026-8
   DOI 10.4045/tidsskr.09.0486, PubMed 20967042
6. Orlin JR, Klevmark B, Bjørnsen L, Hermansen P, Sanchez M (2010)
   Two screening tests for urinary voiding dysfunction used in 209 consecutive patients undergoing lumbar spine operations
   Scand J Urol Nephrol, 44 (2), 106-12
   DOI 10.3109/00365590903544223, PubMed 20095869
7. Røtterud R, Malmström PU, Wahlqvist R, Taskén KA (2010)
   The star chart to Ta bladder cancer: an unsophisticated analysis of two-dimensional gel electrophoresis proteome maps
   Scand J Urol Nephrol, 44 (2), 76-83
   DOI 10.3109/00365590903510729, PubMed 20059407
8. Steinsvik EA, Fosså SD, Axcrona K, Fransson P, Widmark A, Dahl AA (2010)
   Do perceptions of adverse events differ between patients and physicians? Findings from a randomized, controlled trial of radical treatment for prostate cancer
   J Urol, 184 (2), 525-31
   DOI 10.1016/j.juro.2010.04.009, PubMed 20620412
9. Stensvold A, Dahl AA, Fosså SD, Axcrona K, Lilleby W, Brennhovd B, Smeland S (2010)
   Clinicians' use of guidelines as illustrated by curative treatment of prostate cancer at a comprehensive cancer center
   Acta Oncol, 50 (3), 408-14
   DOI 10.3109/0284186X.2010.492236, PubMed 20586661

Publications 2009

1. Cytron S, Greene D, Witzsch U, Nylund P, Bjerklund Johansen TE (2009)
   Cryoablation of the prostate: technical recommendations
   Prostate Cancer Prostatic Dis, 12 (4), 339-46
   DOI 10.1038/pcan.2009.26, PubMed 19901934
2. Dizeyi N, Hedlund P, Bjartell A, Tinzl M, Austild-Taskén K, Abrahamsson PA (2009)
   Serotonin activates MAP kinase and PI3K/Akt signaling pathways in prostate cancer cell lines
   Urol Oncol, 29 (4), 436-45
   DOI 10.1016/j.urolonc.2009.09.013, PubMed 19926313
3. Fosså SD, Egey A, Haukaas SA, Angelsen A, Klepp O, Berge V, Axcrona K, Lilleby W (2009)
   [Incorrect about hormone treatment in prostatic cancer]
   Tidsskr Nor Laegeforen, 129 (5), 429
   DOI 10.4045/tidsskr.08.0649, PubMed 19247406
4. Hernes E, Kyrdalen A, Kvåle R, Hem E, Klepp O, Axcrona K, Fosså SD (2009)
   Initial management of prostate cancer: first year experience with the Norwegian National Prostate Cancer Registry
   BJU Int, 105 (6), 805-11; discussion 811
   DOI 10.1111/j.1464-410X.2009.08834.x, PubMed 19735258
5. Oldenburg J, Wahlqvist R, Fosså SD (2009)
   Late relapse of germ cell tumors
   World J Urol, 27 (4), 493-500
   DOI 10.1007/s00345-009-0411-3, PubMed 19373473

Publications 2008

1. Bø K, Talseth T, Holme I (2008)
   Comment on Schiøtz et al.: Ten-year follow-up after conservative treatment of stress urinary incontinence
   Int Urogynecol J Pelvic Floor Dysfunct, 20 (2), 265
   DOI 10.1007/s00192-008-0747-z, PubMed 18941703
2. Lazarevic B, Karlsen SJ, Saatcioglu F (2008)
   Genistein differentially modulates androgen-responsive gene expression and activates JNK in LNCaP cells
   Oncol Rep, 19 (5), 1231-5
   PubMed 18425381
3. Ramberg H, Eide T, Krobert KA, Levy FO, Dizeyi N, Bjartell AS, Abrahamsson PA, Taskén KA (2008)
   Hormonal regulation of beta2-adrenergic receptor level in prostate cancer
   Prostate, 68 (10), 1133-42
   DOI 10.1002/pros.20778, PubMed 18454446
4. Svendsen KO, Schultz A (2008)
   [Sexual dysfunction in men]
   Tidsskr Nor Laegeforen, 128 (4), 448-52
   PubMed 18274579
5. Tenke P, Bjerklund Johansen TE, Matsumoto T, Tambyah PA, Naber KG, European Urologist Association, Urologist Association of Asia (2008)
   [European and Asian guidelines on management and prevention of catheter-associated urinary tract infections]
   Urologiia (6), 84-91
   PubMed 19248605

Publications 2007

1. Axcrona K, Brennhovd B, Alfsen GC, Giercksky KE, Warloe T (2007)
   Photodynamic therapy with methyl aminolevulinate for atypial carcinoma in situ of the penis
   Scand J Urol Nephrol, 41 (6), 507-10
   DOI 10.1080/00365590701428590, PubMed 17853049
2. Bakke A, Jensen KM, Jonsson O, Jónsson E, Månsson W, Paananen I, Schultz A, Thind P, Tuhkanen K (2007)
   The rationale behind recommendations for follow-up after urinary diversion: an evidence-based approach
   Scand J Urol Nephrol, 41 (4), 261-9
   DOI 10.1080/00365590600991284, PubMed 17763215
3. Cunderlíková B, Wahlqvist R, Berner A, Vasovic V, Warloe T, Nesland JM, Peng Q (2007)
   Detection of urinary bladder cancer with flow cytometry and hexaminolevulinate in urine samples
   Cytopathology, 18 (2), 87-95
   DOI 10.1111/j.1365-2303.2007.00436.x, PubMed 17397493
4. Hashim H, Elhilali M, Bjerklund Johansen TE, Abrams P, ARIB3004 Pressure Flow Study Group (2007)
   The immediate and 6-mo reproducibility of pressure-flow studies in men with benign prostatic enlargement
   Eur Urol, 52 (4), 1186-93
   DOI 10.1016/j.eururo.2007.01.075, PubMed 17293025
5. Karlsen SJ, Renkel J, Tahir AR, Angelsen A, Diep LM (2007)
   Extracorporeal shockwave lithotripsy versus ureteroscopy for 5- to 10-mm stones in the proximal ureter: Prospective effectiveness patient-preference trial
   J Endourol, 21 (1), 28-33
   DOI 10.1089/end.2006.0153, PubMed 17263604
6. Kvåle R, Auvinen A, Adami HO, Klint A, Hernes E, Møller B, Pukkala E, Storm HH, Tryggvadottir L, Tretli S, Wahlqvist R, Weiderpass E, Bray F (2007)
   Interpreting trends in prostate cancer incidence and mortality in the five Nordic countries
   J Natl Cancer Inst, 99 (24), 1881-7
   DOI 10.1093/jnci/djm249, PubMed 18073376
7. Lilleby W, Axcrona K, Alfsen GC, Urnes T, Hole KH (2007)
   Diagnosis and treatment of primary signet-ring cell carcinoma of the prostate
   Acta Oncol, 46 (8), 1195-7
   DOI 10.1080/02841860701367886, PubMed 17851841
8. Røtterud R, Fosså SD, Nesland JM (2007)
   Protein networking in bladder cancer: immunoreactivity for FGFR3, EGFR, ERBB2, KAI1, PTEN, and RAS in normal and malignant urothelium
   Histol Histopathol, 22 (4), 349-63
   DOI 10.14670/HH-22.349, PubMed 17290345
9. Tenke P, Kovacs B, Bjerklund Johansen TE, Matsumoto T, Tambyah PA, Naber KG (2007)
   European and Asian guidelines on management and prevention of catheter-associated urinary tract infections
   Int J Antimicrob Agents, 31 Suppl 1, S68-78
   DOI 10.1016/j.ijantimicag.2007.07.033, PubMed 18006279

Publications 2006

1. Bichler KH, Savatovsky I, Members of the Urinary Tract Infection (UTI) Working Group of the Guidelines Office of the European Association of Urology (EAU):, Naber KG, Bischop MC, Bjerklund-Johansen TE, Botto H, Cek M, Grabe M, Lobel B, Redorta JP, Tenke P (2006)
   EAU guidelines for the management of urogenital schistosomiasis
   Eur Urol, 49 (6), 998-1003
   DOI 10.1016/j.eururo.2006.02.022, PubMed 16519990
2. Brennhovd B, Johnsrud K, Berner A, Bogsrud T, Waehre H, Giercksky KE, Axcrona K (2006)
   Sentinel node procedure in low-stage/low-grade penile carcinomas
   Scand J Urol Nephrol, 40 (3), 204-7
   DOI 10.1080/00365590600589971, PubMed 16809260
3. Jensen D, Aasen S, Talseth T (2006)
   Uroflowmetry with simultaneous electromyography versus voiding video cystourethrography
   Scand J Urol Nephrol, 40 (3), 232-7
   DOI 10.1080/00365590600641590, PubMed 16809266
4. Kvissel AK, Ramberg H, Eide T, Svindland A, Skålhegg BS, Taskén KA (2006)
   Androgen dependent regulation of protein kinase A subunits in prostate cancer cells
   Cell Signal, 19 (2), 401-9
   DOI 10.1016/j.cellsig.2006.07.011, PubMed 16949795
5. Kvåle R, Skarre E, Tønne A, Kyrdalen AE, Norstein J, Angelsen A, Wahlqvist R, Fosså SD (2006)
   [Curative treatment of prostatic cancer in Norway in 1998 and 2001]
   Tidsskr Nor Laegeforen, 126 (7), 912-6
   PubMed 16554883
6. Nilsen FS, Haug E, Heidemann M, Karlsen SJ (2006)
   Does rapid intraoperative parathyroid hormone analysis predict cure in patients undergoing surgery for primary hyperparathyroidism? A prospective study
   Scand J Surg, 95 (1), 28-32
   DOI 10.1177/145749690609500106, PubMed 16579252
7. Tønseth KA, Egge T, Kolbenstvedt A, Hedlund H (2006)
   Evaluation of patients after treatment of arterial priapism with selective micro-embolization
   Scand J Urol Nephrol, 40 (1), 49-52
   DOI 10.1080/00365590500338040, PubMed 16452056

Publications 2005

1. Cek M, Lenk S, Naber KG, Bishop MC, Johansen TE, Botto H, Grabe M, Lobel B, Redorta JP, Tenke P, Members of the Urinary Tract Infection (UTI) Working Group of the European Association of Urology (EAU) Guidelines Office (2005)
   EAU guidelines for the management of genitourinary tuberculosis
   Eur Urol, 48 (3), 353-62
   DOI 10.1016/j.eururo.2005.03.008, PubMed 15982799
2. Dizeyi N, Bjartell A, Hedlund P, Taskén KA, Gadaleanu V, Abrahamsson PA (2005)
   Expression of serotonin receptors 2B and 4 in human prostate cancer tissue and effects of their antagonists on prostate cancer cell lines
   Eur Urol, 47 (6), 895-900
   DOI 10.1016/j.eururo.2005.02.006, PubMed 15925089
3. Fosså SD, Wahlqvist R (2005)
   [Radical treatment of prostatic cancer in Norway]
   Tidsskr Nor Laegeforen, 125 (20), 2834; author reply 2834-5
   PubMed 16244698
4. Talseth T, Hedlund H (2005)
   [Frequent urination and fibromyalgia]
   Tidsskr Nor Laegeforen, 125 (5), 623-4; author reply 624
   PubMed 15776046
5. Taskén KA, Angelsen A, Svindland A, Eide T, Berge V, Wahlquist R, Karlsen S (2005)
   [Markers for diagnosis, prediction and prognosis of prostate cancer]
   Tidsskr Nor Laegeforen, 125 (23), 3279-82
   PubMed 16327854
6. Tønseth KA, Schultz A, Talseth T, Hedlund H (2005)
   [Treatment of erectile dysfunction with penile implants]
   Tidsskr Nor Laegeforen, 125 (13), 1825-7
   PubMed 16012552

Publications 2004

1. Beisland C, Medby PC, Beisland HO (2004)
   Presumed radically treated renal cell carcinoma--recurrence of the disease and prognostic factors for subsequent survival
   Scand J Urol Nephrol, 38 (4), 299-305
   DOI 10.1080/00365590410028818, PubMed 15669589
2. Klevmark B (2004)
   Detrusor contractility during emptying
   Scand J Urol Nephrol Suppl (215), 6-10
   DOI 10.1080/03008880410015110, PubMed 15545191
3. Nordling J, Anjum FH, Bade JJ, Bouchelouche K, Bouchelouche P, Cervigni M, Elneil S, Fall M, Hald T, Hanus T, Hedlund H, Hohlbrugger G, Horn T, Larsen S, Leppilahti M, Mortensen S, Nagendra M, Oliveira PD, Osborne J, Riedl C, Sairanen J, Tinzl M, Wyndaele JJ (2004)
   Primary evaluation of patients suspected of having interstitial cystitis (IC)
   Eur Urol, 45 (5), 662-9
   DOI 10.1016/j.eururo.2003.11.021, PubMed 15082211
4. Padma-Nathan H, Christ G, Adaikan G, Becher E, Brock G, Carrier S, Carson C, Corbin J, Francis S, DeBusk R, Eardley I, Hedlund H, Hutter A, Jackson G, Kloner R, Lin CS, McVary K, McCullough A, Nehra A, Porst H, Schulman C, Seftel A, Sharlip I, Stief C, Teloken C (2004)
   Pharmacotherapy for erectile dysfunction
   J Sex Med, 1 (2), 128-40
   DOI 10.1111/j.1743-6109.2004.04021.x, PubMed 16422967
5. Seim A, Talseth T, Haukeland H, Høye K, Berg N, Bergeland T (2004)
   Validation of a simple patient questionnaire to assist self-detection of overactive bladder. A study in general practice
   Scand J Prim Health Care, 22 (4), 217-21
   DOI 10.1080/02813430410006639, PubMed 15765636

Publications 2003

1. Eide T, Taskén KA, Carlson C, Williams G, Jahnsen T, Taskén K, Collas P (2003)
   Protein kinase A-anchoring protein AKAP95 interacts with MCM2, a regulator of DNA replication
   J Biol Chem, 278 (29), 26750-6
   DOI 10.1074/jbc.M300765200, PubMed 12740381
2. Jichlinski P, Guillou L, Karlsen SJ, Malmström PU, Jocham D, Brennhovd B, Johansson E, Gärtner T, Lange N, van den Bergh H, Leisinger HJ (2003)
   Hexyl aminolevulinate fluorescence cystoscopy: new diagnostic tool for photodiagnosis of superficial bladder cancer--a multicenter study
   J Urol, 170 (1), 226-9
   DOI 10.1097/01.ju.0000060782.52358.04, PubMed 12796694
3. Johansen TE (2003)
   [A public disease without guidelines]
   Tidsskr Nor Laegeforen, 123 (17), 2410
   PubMed 14508529
4. Kolbenstvedt A, Jenssen G, Hedlund H (2003)
   Priapism of the glans and corpus spongiosum. Report of two cases with angiography
   Acta Radiol, 44 (4), 456-9
   DOI 10.1080/j.1600-0455.2003.00092.x, PubMed 12846700
5. Norderhaug I, Dahl O, Høisaeter PA, Heikkilä R, Klepp O, Olsen DR, Kristiansen IS, Waehre H, Bjerklund Johansen TE (2003)
   Brachytherapy for prostate cancer: a systematic review of clinical and cost effectiveness
   Eur Urol, 44 (1), 40-6
   DOI 10.1016/s0302-2838(03)00187-8, PubMed 12814673
6. Schultz A, Hedlund H, Talseth T (2003)
   [Expandable penile implants in patients with erectile dysfunction]
   Tidsskr Nor Laegeforen, 123 (17), 2449-50
   PubMed 14562782
7. Thiem B, Berge V (2003)
   [Cloudberry: an important source of ellagic acid, an anti-oxidant]
   Tidsskr Nor Laegeforen, 123 (13-14), 1856-7
   PubMed 12830265

Publications 2002

1. Beisland C, Medby PC, Beisland HO (2002)
   Renal cell carcinoma: gender difference in incidental detection and cancer-specific survival
   Scand J Urol Nephrol, 36 (6), 414-8
   DOI 10.1080/003655902762467558, PubMed 12623504
2. Dahle MK, Grønning LM, Cederberg A, Blomhoff HK, Miura N, Enerbäck S, Taskén KA, Taskén K (2002)
   Mechanisms of FOXC2- and FOXD1-mediated regulation of the RI alpha subunit of cAMP-dependent protein kinase include release of transcriptional repression and activation by protein kinase B alpha and cAMP
   J Biol Chem, 277 (25), 22902-8
   DOI 10.1074/jbc.M200131200, PubMed 11943768
3. Dahle MK, Taskén K, Taskén KA (2002)
   USF2 inhibits C/EBP-mediated transcriptional regulation of the RIIbeta subunit of cAMP-dependent protein kinase
   BMC Mol Biol, 3, 10
   DOI 10.1186/1471-2199-3-10, PubMed 12086590
4. Eide T, Carlson C, Taskén KA, Hirano T, Taskén K, Collas P (2002)
   Distinct but overlapping domains of AKAP95 are implicated in chromosome condensation and condensin targeting
   EMBO Rep, 3 (5), 426-32
   DOI 10.1093/embo-reports/kvf089, PubMed 11964380
5. Eri LM, Thomassen H, Brennhovd B, Håheim LL (2002)
   Accuracy and repeatability of prostate volume measurements by transrectal ultrasound
   Prostate Cancer Prostatic Dis, 5 (4), 273-8
   DOI 10.1038/sj.pcan.4500568, PubMed 12627211
6. Eri LM, Wessel N, Tysland O, Berge V (2002)
   Comparative study of pressure-flow parameters
   Neurourol Urodyn, 21 (3), 186-93
   DOI 10.1002/nau.10018, PubMed 11948710
7. Frick IM, Axcrona K, Härdig Y, Tapper H, Gustafsson L, Kellner R, Leanderson T, Björck L (2002)
   Uptake and intracellular transportation of a bacterial surface protein in lymphoid cells
   Mol Microbiol, 44 (4), 917-34
   DOI 10.1046/j.1365-2958.2002.02931.x, PubMed 12010489
8. Hedlund H (2002)
   Clinical trial designs: is it possible to have a unified approach and common end points?
   Int J Impot Res, 14 Suppl 1, S35-7
   DOI 10.1038/sj.ijir.3900794, PubMed 11850733
9. Hedlund H, Schultz A, Talseth T, Tonseth K, van der Hagen A (2002)
   Sacral neuromodulation in Norway: clinical experience of the first three years
   Scand J Urol Nephrol Suppl (210), 87-95
   DOI 10.1080/003655902320766024, PubMed 12475023
10. Iversen P, Tammela TL, Vaage S, Lukkarinen O, Lodding P, Bull-Njaa T, Viitanen J, Hoisaeter P, Lundmo P, Rasmussen F, Johansson JE, Persson BE, Carroll K, Scandinavian Prostatic Cancer Group (SPCG) (2002)
    A randomised comparison of bicalutamide ('Casodex') 150 mg versus placebo as immediate therapy either alone or as adjuvant to standard care for early non-metastatic prostate cancer. First report from the Scandinavian Prostatic Cancer Group Study No. 6
    Eur Urol, 42 (3), 204-11
    DOI 10.1016/s0302-2838(02)00311-1, PubMed 12234503
11. Johansen TE (2002)
    [Ritual circumcision]
    Tidsskr Nor Laegeforen, 122 (1), 15
    PubMed 11851285
12. Johansen TE (2002)
    [Renal cancer in a 20-year perspective]
    Tidsskr Nor Laegeforen, 122 (25), 2430
    PubMed 12448108
13. Klevmark B (2002)
    Volume threshold for micturition. Influence of filling rate on sensory and motor bladder function
    Scand J Urol Nephrol Suppl (210), 6-10
    DOI 10.1080/003655902320765890, PubMed 12475010

Publications 2001

1. Argiolas A, Hedlund H (2001)
   The pharmacology and clinical pharmacokinetics of apomorphine SL
   BJU Int, 88 Suppl 3, 18-21
   DOI 10.1046/j.1464-4096.2001.00124.x, PubMed 11578274
2. Bø K, Lilleås F, Talseth T, Hedland H (2001)
   Dynamic MRI of the pelvic floor muscles in an upright sitting position
   Neurourol Urodyn, 20 (2), 167-74
   DOI 10.1002/1520-6777(2001)20:2<167::aid-nau19>3.0.co;2-4, PubMed 11170191
3. Dahle MK, Knutsen HK, Taskén KA, Pilz R, Taskén K (2001)
   Cyclic AMP regulates expression of the RI alpha subunit of cAMP-dependent protein kinase through an alternatively spliced 5' UTR
   Eur J Biochem, 268 (22), 5920-9
   DOI 10.1046/j.0014-2956.2001.02542.x, PubMed 11722580
4. Dahle MK, Reinton N, Orstavik S, Taskén KA, Taskén K (2001)
   Novel alternatively spliced mRNA (1c) of the protein kinase A RIα subunit is implicated in haploid germ cell specific expression
   Mol Reprod Dev, 59 (1), 11-6
   DOI 10.1002/mrd.1001, PubMed 11335941
5. Eri LM, Sivertsen S, Nagelhus J (2001)
   The impact of participation in a study of medical treatment of lower urinary tract symptoms on the incidence of prostate surgery
   World J Urol, 19 (4), 256-8
   DOI 10.1007/s003450000180, PubMed 11550784
6. Eri LM, Svindland A, Tveter KJ (2001)
   The effect of bicalutamide on prostate histology
   Prostate, 46 (4), 275-80
   DOI 10.1002/1097-0045(20010301)46:4<275::aid-pros1033>3.0.co;2-2, PubMed 11241549
7. Eri LM, Tveter KJ (2001)
   Effects of bicalutamide and leuprolide on prostate-specific antigen (PSA), acid phosphatase (ACP) and prostatic acid phosphatase (PAP) in men with benign prostatic hyperplasia (BPH)
   Prostate Cancer Prostatic Dis, 4 (3), 173-177
   DOI 10.1038/sj.pcan.4500504, PubMed 12497037
8. Eri LM, Wessel N, Berge V (2001)
   Test-retest variation of pressure flow parameters in men with bladder outlet obstruction
   J Urol, 165 (4), 1188-92
   DOI 10.1016/S0022-5347(05)66466-X, PubMed 11257668
9. Fosså SD, Eri LM, Skovlund E, Tveter K, Vatten L, Norwegian Urological Cancer Group (2001)
   No randomised trial of prostate-cancer screening in Norway
   Lancet Oncol, 2 (12), 741-5; discussion 746-9
   DOI 10.1016/S1470-2045(01)00588-5, PubMed 11902516
10. Hedlund H, Bø K, Lilleås F, Talseth T, Tillung T (2001)
    The clinical value of dynamic magnetic resonance imaging in normal and incontinent women--a preliminary study on micturition
    Scand J Urol Nephrol Suppl (207), 87-91; discussion 106-25
    DOI 10.1080/003655901750174999, PubMed 11409620
11. Hedlund H, Hjelmås K, Jonsson O, Klarskov P, Talja M (2001)
    Hydrophilic versus non-coated catheters for intermittent catheterization
    Scand J Urol Nephrol, 35 (1), 49-53
    DOI 10.1080/00365590151030822, PubMed 11291688
12. Jensen KM, Månsson W, Bakke A, Jonsson E, Jonsson O, Lindell O, Schultz A, Steven K, Tuhkanen K (2001)
    Reconstructive urology in the nordic countries--a hospital questionnaire survey
    Scand J Urol Nephrol, 35 (3), 186-9
    DOI 10.1080/003655901750291935, PubMed 11487069
13. Karlsen SJ, Bull-Njaa T, Krokstad A (2001)
    Measurement of sound emission by endoscopic lithotripters: an in vitro study and theoretical estimation of risk of hearing loss in a fetus
    J Endourol, 15 (8), 821-6
    DOI 10.1089/089277901753205825, PubMed 11724122
14. Lindgren H, Axcrona K, Leanderson T (2001)
    Regulation of transcriptional activity of the murine CD40 ligand promoter in response to signals through TCR and the costimulatory molecules CD28 and CD2
    J Immunol, 166 (7), 4578-85
    DOI 10.4049/jimmunol.166.7.4578, PubMed 11254715
15. Naber KG, Bergman B, Bishop MC, Bjerklund-Johansen TE, Botto H, Lobel B, Jinenez Cruz F, Selvaggi FP, Urinary Tract Infection (UTI) Working Group of the Health Care Office (HCO) of the European Association of Urology (EAU) (2001)
    EAU guidelines for the management of urinary and male genital tract infections. Urinary Tract Infection (UTI) Working Group of the Health Care Office (HCO) of the European Association of Urology (EAU)
    Eur Urol, 40 (5), 576-88
    DOI 10.1159/000049840, PubMed 11752870
16. Nilsen FS, Karlsen SJ, Gjertsen O (2001)
    Gas-containing renal stones treated with percutaneous nephrolithotomy: case report
    J Endourol, 15 (9), 915-7
    DOI 10.1089/089277901753284134, PubMed 11769846
17. Scheepens WA, Weil EH, van Koeveringe GA, Rohrmann D, Hedlund HE, Schurch B, Ostardo E, Pastorello M, Ratto C, Nordling J, van Kerrebroeck PE (2001)
    Buttock placement of the implantable pulse generator: a new implantation technique for sacral neuromodulation--a multicenter study
    Eur Urol, 40 (4), 434-8
    DOI 10.1159/000049812, PubMed 11713399
18. Wessel N, Liestøl K, Maehlen J, Brorson SH (2001)
    The apolipoprotein E epsilon4 allele is no risk factor for prostate cancer in the Norwegian population
    Br J Cancer, 85 (9), 1418
    DOI 10.1054/bjoc.2001.2098, PubMed 11720484

Publications 2000

1. Angelsen A, Talseth T, Mjønes JG, Hedlund H (2000)
   Hypertension and pseudoaneurism on the renal artery following retrograde endopyelotomy (Acucise)
   Scand J Urol Nephrol, 34 (1), 79-80
   DOI 10.1080/003655900750016977, PubMed 10757279
2. Beisland C, Medby PC, Sander S, Beisland HO (2000)
   Nephrectomy - indications, complications and postoperative mortality in 646 consecutive patients
   Eur Urol, 37 (1), 58-64
   DOI 10.1159/000020101, PubMed 10671787
3. Bø K, Talseth T, Vinsnes A (2000)
   Randomized controlled trial on the effect of pelvic floor muscle training on quality of life and sexual problems in genuine stress incontinent women
   Acta Obstet Gynecol Scand, 79 (7), 598-603
   DOI 10.1034/j.1600-0412.2000.079007598.x, PubMed 10929962
4. Eri LM, Svindland A (2000)
   Can prostate epithelial content predict response to hormonal treatment of patients with benign prostatic hyperplasia?
   Urology, 56 (2), 261-5
   DOI 10.1016/s0090-4295(00)00629-4, PubMed 10925090
5. Grønning LM, Wang JE, Ree AH, Haugen TB, Taskén K, Taskén KA (2000)
   Regulation of tissue inhibitor of metalloproteinases-1 in rat Sertoli cells: induction by germ cell residual bodies, interleukin-1alpha, and second messengers
   Biol Reprod, 62 (4), 1040-6
   DOI 10.1095/biolreprod62.4.1040, PubMed 10727275
6. Hedlund H (2000)
   [Sildenafil (Viagra)--a new drug in the treatment of erectile dysfunction]
   Tidsskr Nor Laegeforen, 120 (22), 2674-5
   PubMed 11077515
7. Nesbakken A, Nygaard K, Bull-Njaa T, Carlsen E, Eri LM (2000)
   Bladder and sexual dysfunction after mesorectal excision for rectal cancer
   Br J Surg, 87 (2), 206-10
   DOI 10.1046/j.1365-2168.2000.01357.x, PubMed 10671929
8. Olson BJ, Skavdahl M, Ramberg H, Osterman JC, Markwell J (2000)
   Formate dehydrogenase in Arabidopsis thaliana: characterization and possible targeting to the chloroplast
   Plant Sci, 159 (2), 205-212
   DOI 10.1016/s0168-9452(00)00337-x, PubMed 11074273

Publications 1999

1. Abrams P, Schäfer W, Tammela TL, Barrett DM, Hedlund H, Rollema HJ, Matos-Ferreira A, Nordling J, Bruskewitz R, Andersen JT, Hald T, Miller P, Kirby R, Mustonen S, Cannon A, Jacobsen CA, Gormley GJ, Malice MP, Bach MA (1999)
   Improvement of pressure flow parameters with finasteride is greater in men with large prostates. Finasteride Urodynamics Study Group
   J Urol, 161 (5), 1513-7
   PubMed 10210385
2. Bo K, Holme I, Talseth T (1999)
   Conservative management of genuine stress incontinence in women - Study's flaws may be misleading - Reply
   BMJ-British Medical Journal, 319 (7203), 191
3. Bø K, Talseth T, Holme I (1999)
   Single blind, randomised controlled trial of pelvic floor exercises, electrical stimulation, vaginal cones, and no treatment in management of genuine stress incontinence in women
   BMJ, 318 (7182), 487-93
   DOI 10.1136/bmj.318.7182.487, PubMed 10024253
4. Daehlin L, Hedlund H (1999)
   Interstitial laser coagulation in patients with lower urinary tract symptoms from benign prostatic obstruction: treatment under sedoanalgesia with pressure-flow evaluation
   BJU Int, 84 (6), 628-36
   DOI 10.1046/j.1464-410x.1999.00212.x, PubMed 10510106
5. Diseth TH, Emblem R, Schultz A (1999)
   Mental health, psychosocial functioning, and quality of life in patients with bladder exstrophy and epispadias - an overview
   World J Urol, 17 (4), 239-48
   DOI 10.1007/s003450050139, PubMed 10460407
6. Fosså SD, Eri LM (1999)
   [Timely screening routines for prostatic cancer by Norwegian physicians]
   Tidsskr Nor Laegeforen, 119 (24), 3572-6
   PubMed 10563174
7. Giuliano F, Hultling C, El Masry WS, Luchner E, Stien R, Maytom MC, Orr M, Smith MD, Osterloh IH (1999)
   Sildenafil citrate (VIAGRA (R)): a novel oral treatment for erectile dysfunction caused by traumatic spinal cord injury
   Int. J. Clin. Pract. (102), 24-26
8. Gronning LM, Knutsen HK, Eskild W, Hansson V, Taskén K, Taskén KA (1999)
   Method of transfection affects the cAMP-mediated induction of the RIIbeta subunit of protein kinase A in Sertoli cells: inhibition of response by increase in intracellullar calcium
   Eur J Endocrinol, 141 (1), 75-82
   DOI 10.1530/eje.0.1410075, PubMed 10407227
9. Grønning LM, Dahle MK, Taskén KA, Enerbäck S, Hedin L, Taskén K, Knutsen HK (1999)
   Isoform-specific regulation of the CCAAT/enhancer-binding protein family of transcription factors by 3',5'-cyclic adenosine monophosphate in Sertoli cells
   Endocrinology, 140 (2), 835-43
   DOI 10.1210/endo.140.2.6526, PubMed 9927313
10. Hedlund H, Hedlund P (1999)
    Treatment of benign prostatic enlargement with alpha-blockers: an updated review
    Scand J Urol Nephrol Suppl, 203, 9-13
    DOI 10.1080/00365599950509988, PubMed 10636563
11. Klevmark B (1999)
    Natural pressure-volume curves and conventional cystometry
    Scand J Urol Nephrol Suppl, 201, 1-4
    PubMed 10573769
12. Liberg D, Lazarevic B, Pero RW, Leanderson T (1999)
    N-substituted benzamides inhibit NFkappaB activation and induce apoptosis by separate mechanisms
    Br J Cancer, 81 (6), 981-8
    DOI 10.1038/sj.bjc.6690796, PubMed 10576654
13. Osther PJ, Grenabo L, Haraldsson G, Holmberg G, Lindell O, Mogensen P, Schultz A, Ulvik NM (1999)
    Metabolic evaluation and medical management of upper urinary tract stone disease. Guidelines from the Scandinavian Cooperative Group for Urinary Stones
    Scand J Urol Nephrol, 33 (6), 372-81
    PubMed 10636576
14. Ree AH, Hansson V, Walaas SI, Eskild W, Taskén KA (1999)
    Calcium/phospholipid-dependent protein kinases in rat Sertoli cells: regulation of androgen receptor messenger ribonucleic acid
    Biol Reprod, 60 (5), 1257-62
    DOI 10.1095/biolreprod60.5.1257, PubMed 10208993
15. Schäfer W, Tammela TL, Barrett DM, Abrams P, Hedlund H, Rollema HJ, Nordling J, Andersen JT, Hald T, Matos-Ferriera A, Bruskewitz R, Miller P, Mustonen S, Cannon A, Malice MP, Jacobsen CA, Bach MA (1999)
    Continued improvement in pressure-flow parameters in men receiving finasteride for 2 years. Finasteride Urodynamics Study Group
    Urology, 54 (2), 278-83
    DOI 10.1016/s0090-4295(99)00130-2, PubMed 10443725
16. Talseth T (1999)
    [From physician to technician]
    Tidsskr Nor Laegeforen, 119 (19), 2892-3
    PubMed 10494219
17. Tammela TL, Schäfer W, Barrett DM, Abrams P, Hedlund H, Rollema HJ, Matos-Ferreira A, Nordling J, Bruskewitz R, Miller P, Kirby R, Andersen JT, Jacobsen C, Gormley GJ, Malice MP, Bach MA (1999)
    Repeated pressure-flow studies in the evaluation of bladder outlet obstruction due to benign prostatic enlargement. Finasteride Urodynamics Study Group
    Neurourol Urodyn, 18 (1), 17-24
    DOI 10.1002/(sici)1520-6777(1999)18:1<17::aid-nau4>3.0.co;2-m, PubMed 10090123

Publications 1998

1. Diseth TH, Bjordal R, Schultz A, Stange M, Emblem R (1998)
   Somatic function, mental health and psychosocial functioning in 22 adolescents with bladder exstrophy and epispadias
   J Urol, 159 (5), 1684-9; discussion 1689-90
   DOI 10.1097/00005392-199805000-00092, PubMed 9554394
2. Hedlund H (1998)
   Mechanism of action of the intracavernosal agents
   8TH WORLD MEETING ON IMPOTENCE RESEARCH, 29-30
3. Hellsten S, Rintala E, Wahlqvist R, Malmström PU (1998)
   Nordic prospective trials of radical cystectomy and neoadjuvant chemotherapy. The Nordic Cooperative Bladder Cancer Study Group
   Eur Urol, 33 Suppl 4, 35-8
   DOI 10.1159/000052263, PubMed 9615209
4. Jensen KM, Hedlund H (1998)
   Management of benign prostatic hyperplasia in Scandinavia. A hospital questionnaire on pretreatment evaluation and treatment. The Scandinavian Urologic Association Subcommittee on Benign Prostatic Hyperplasia
   Scand J Urol Nephrol, 32 (1), 26-32
   DOI 10.1080/003655998750014648, PubMed 9561570
5. Kløw NE, Paulsen D, Vatne K, Rokstad B, Lien B, Fauchald P (1998)
   Percutaneous transluminal renal artery angioplasty using the coaxial technique. Ten years of experience from 591 procedures in 419 patients
   Acta Radiol, 39 (6), 594-603
   DOI 10.3109/02841859809175483, PubMed 9817028

Publications 1997

1. Bø K, Talseth T (1997)
   Change in urethral pressure during voluntary pelvic floor muscle contraction and vaginal electrical stimulation
   Int Urogynecol J Pelvic Floor Dysfunct, 8 (1), 3-6; discussion 6-7
   DOI 10.1007/BF01920286, PubMed 9260089
2. Daehlin L, Mohn J, Høisaeter PA, Hedlund H, Kapstad L, Moen G, Fossberg E (1997)
   [Interstitial laser coagulation in the treatment of benign prostatic hyperplasia. Preliminary results]
   Tidsskr Nor Laegeforen, 117 (26), 3790-3
   PubMed 9417682
3. Eri LM, Tveter KJ (1997)
   Treatment of benign prostatic hyperplasia. A pharmacoeconomic perspective
   Drugs Aging, 10 (2), 107-18
   DOI 10.2165/00002512-199710020-00004, PubMed 9061268
4. Furuset AS, Bjerklund Johansen TE, Majak B (1997)
   [Renal angiomyolipoma as a cause of acute retroperitoneal hemorrhage]
   Tidsskr Nor Laegeforen, 117 (29), 4215-7
   PubMed 9441463
5. Hedlund H (1997)
   Posterior sagittal resection for rectal aganglionosis: preliminary results of a new approach
   J Pediatr Surg, 32 (12), 1717-20
   DOI 10.1016/s0022-3468(97)90514-5, PubMed 9434007
6. Hernes EH, Fosså SD, Vaage S, Ogreid P, Heilo A, Paus E (1997)
   Epirubicin combined with estramustine phosphate in hormone-resistant prostate cancer: a phase II study
   Br J Cancer, 76 (1), 93-9
   DOI 10.1038/bjc.1997.342, PubMed 9218739
7. Jørgensen T, Kanagasingam Y, Kaalhus O, Tveter KJ, Bryne M, Skjørten F, Berner A, Danielsen HE (1997)
   Prognostic factors in patients with metastatic (stage D2) prostate cancer: experience from the Scandinavian Prostatic Cancer Group Study-2
   J Urol, 158 (1), 164-70
   DOI 10.1097/00005392-199707000-00052, PubMed 9186346
8. Knutsen HK, Taskén K, Eskild W, Richards JS, Kurten RC, Torjesen PA, Jahnsen T, Hansson V, Guérin S, Taskén KA (1997)
   Characterization of the 5'-flanking region of the gene for the cAMP-inducible protein kinase A subunit, RIIbeta, in Sertoli cells
   Mol Cell Endocrinol, 129 (1), 101-14
   DOI 10.1016/s0303-7207(97)04045-8, PubMed 9175634
9. Månsson W, Bakke A, Bergman B, Brekkan E, Jonsson O, Kihl B, Nurmi M, Pedersen J, Schultz A, Sørensen B, Urnes T, Wolf H (1997)
   Perforation of continent urinary reservoirs. Scandinavian experience
   Scand J Urol Nephrol, 31 (6), 529-32
   DOI 10.3109/00365599709030656, PubMed 9458509
10. Ogreid P, Wahlqvist R (1997)
    [Laser treatment of benign prostatic hyperplasia]
    Nord Med, 112 (3), 89-92
    PubMed 9190566
11. Talseth T, Hedlund H (1997)
    [Benign prostatic hyperplasia. Shared care between urologists and general practitioners]
    Tidsskr Nor Laegeforen, 117 (3), 389-93
    PubMed 9064864
12. Taskén K, Skålhegg BS, Taskén KA, Solberg R, Knutsen HK, Levy FO, Sandberg M, Orstavik S, Larsen T, Johansen AK, Vang T, Schrader HP, Reinton NT, Torgersen KM, Hansson V, Jahnsen T (1997)
    Structure, function, and regulation of human cAMP-dependent protein kinases
    Adv Second Messenger Phosphoprotein Res, 31, 191-204
    DOI 10.1016/s1040-7952(97)80019-5, PubMed 9344252
13. Vukelić J, Kapamadzija A, Bingold B, Lazarević B, Lazarević V, Petrović D (1997)
    [The volume and present methods of legal abortion in children and adolescents at the Gynecology Clinic in Novi Sad 1985-1995]
    Med Pregl, 50 (7-8), 297-300
    PubMed 9441215

Publications 1996

1. Bø K, Talseth T (1996)
   Long-term effect of pelvic floor muscle exercise 5 years after cessation of organized training
   Obstet Gynecol, 87 (2), 261-5
   DOI 10.1016/0029-7844(95)60375-1, PubMed 8559536
2. Davidsson T, Hedlund H, Månsson W (1996)
   Detubularized right colonic reservoir with intussuscepted ileal nipple valve or stapled ileal ("Lundiana") outlet. Clinical and urodynamic results in a prospective randomized study
   World J Urol, 14 (2), 78-84
   DOI 10.1007/BF00182562, PubMed 8731122
3. Djukić S, Nedeljković M, Pervulov M, Ljubić A, Radunović N, Lazarević B (1996)
   Intra-amniotic Chlamydia trachomatis infection
   Gynecol Obstet Invest, 42 (2), 109-12
   DOI 10.1159/000291911, PubMed 8878715
4. Eri LM, Haug E, Tveter KJ (1996)
   Effects on the endocrine system of long-term treatment with the luteinizing hormone-releasing hormone agonist leuprolide in patients with benign prostatic hyperplasia
   Scand J Clin Lab Invest, 56 (4), 319-25
   DOI 10.3109/00365519609090583, PubMed 8837238
5. Eri LM, Wahlqvist R, Tveter KJ (1996)
   [Diagnosis and treatment of benign prostatic hyperplasia in general practice. Norwegian Medical Society]
   Tidsskr Nor Laegeforen, 116 (27), 3240-4
   PubMed 9011979
6. Hedlund H, Hedlund P (1996)
   Pharmacotherapy in erectile dysfunction agents for self-injection programs and alternative application models
   Scand. J. Urol. Nephrol., 30 179, 129-138
7. Iversen P, Tveter K, Varenhorst E (1996)
   Randomised study of Casodex 50 MG monotherapy vs orchidectomy in the treatment of metastatic prostate cancer. The Scandinavian Casodex Cooperative Group
   Scand J Urol Nephrol, 30 (2), 93-8
   DOI 10.3109/00365599609180896, PubMed 8738052
8. Jørgensen T, Yogesan K, Tveter KJ, Skjørten F, Danielsen HE (1996)
   Nuclear texture analysis: a new prognostic tool in metastatic prostate cancer
   Cytometry, 24 (3), 277-83
   DOI 10.1002/(SICI)1097-0320(19960701)24:3<277::AID-CYTO11>3.0.CO;2-N, PubMed 8800561
9. Karlsen SJ (1996)
   [Surgical treatment of urolithiasis in Norway]
   Tidsskr Nor Laegeforen, 116 (24), 2875-8
   PubMed 8975401
10. Karlsen SJ (1996)
    [Extracorporeal shock wave lithotripsy in urolithiasis. An update]
    Tidsskr Nor Laegeforen, 116 (24), 2889-92
    PubMed 8975405
11. Karlsen SJ, Lund M (1996)
    Visual laser coagulation of the prostate using intraurethral gel anesthesia and light intravenous analgesia and sedation
    J Endourol, 10 (4), 389-91
    DOI 10.1089/end.1996.10.389, PubMed 8872741
12. Knutsen HK, Reinton N, Taskén KA, Hansson V, Eskild W (1996)
    Regulation of protein kinase A subunits by cyclic adenosine 3',5'-monophosphate in a mouse Sertoli cell line (MSC-1): induction of RII beta messenger ribonucleic acid is independent of continuous protein synthesis
    Biol Reprod, 55 (1), 5-10
    DOI 10.1095/biolreprod55.1.5, PubMed 8793051
13. Kolbenstvedt A, Egge T, Schultz A (1996)
    Arterial high flow priapism role of radiology in diagnosis and treatment
    Scand. J. Urol. Nephrol., 30 179, 143-146
14. Larsen A, Bjerklund Johansen TE, Solheim BM, Urnes T (1996)
    Diagnosis and treatment of enterovesical fistula
    Eur Urol, 29 (3), 318-21
    DOI 10.1159/000473768, PubMed 8740039
15. Lundholm C, Norlén BJ, Ekman P, Jahnson S, Lagerkvist M, Lindeborg T, Olsson JL, Tveter K, Wijkstrom H, Westberg R, Malmström PU (1996)
    A randomized prospective study comparing long-term intravesical instillations of mitomycin C and bacillus Calmette-Guerin in patients with superficial bladder carcinoma
    J Urol, 156 (2 Pt 1), 372-6
    DOI 10.1016/s0022-5347(01)65853-1, PubMed 8683682
16. Malmström PU, Rintala E, Wahlqvist R, Hellström P, Hellsten S, Hannisdal E (1996)
    Five-year followup of a prospective trial of radical cystectomy and neoadjuvant chemotherapy: Nordic Cystectomy Trial I. The Nordic Cooperative Bladder Cancer Study Group
    J Urol, 155 (6), 1903-6
    DOI 10.1016/S0022-5347(01)66042-7, PubMed 8618283
17. Schultz A, Talseth T (1996)
    Continent urinary diversion in patients with dysfunction of the lower urinary tract. Experience with the detubularized right colonic segment as urinary reservoir
    Scand J Urol Nephrol Suppl, 179, 93-6
    PubMed 8908672
18. Schultz A, Talseth T (1996)
    Continent urinary diversion in patients with dysfunction of the lower urinary tract. Experience with the detubularized right colonic segment as urinary reservoir.
    Scand. J. Urol. Nephrol., 30 179, 93-96
19. Svindland A, Eri LM, Tveter KJ (1996)
    Morphometry of benign prostatic hyperplasia during androgen suppressive therapy. Relationships among epithelial content, PSA density, and clinical outcome
    Scand J Urol Nephrol Suppl, 179, 113-7
    PubMed 8908676
20. Thüroff JW, Mattiasson A, Andersen JT, Hedlund H, Hinman F, Hohenfellner M, Månsson W, Mundy AB, Rowland RG, Steven K (1996)
    Standardization of terminology and assessment of functional characteristics of intestinal urinary reservoirs
    Neurourol Urodyn, 15 (5), 499-511
    DOI 10.1002/(SICI)1520-6777(1996)15:5<499::AID-NAU7>3.0.CO;2-A, PubMed 8857618
21. Thüroff JW, Mattiasson A, Andersen JT, Hedlund H, Hinman F, Hohenfellner M, Månsson W, Mundy AR, Rowland RG, Steven K (1996)
    The standardization of terminology and assessment of functional characteristics of intestinal urinary reservoirs
    Scand J Urol Nephrol, 30 (5), 349-56
    DOI 10.3109/00365599609181309, PubMed 8936622
22. Thüroff JW, Mattiasson A, Andersen JT, Hedlund H, Hinman F, Hohenfellner M, Månsson W, Mundy AR, Rowland RG, Steven K (1996)
    The standardization of terminology and assessment of functional characteristics of intestinal urinary reservoirs. International Continence Society Committee on Standardization of Terminology. Subcommittee on Intestinal Urinary Reservoirs
    Br J Urol, 78 (4), 516-23
    DOI 10.1046/j.1464-410x.1996.01394.x, PubMed 8944506
23. Wold T, Karlsen SJ, Bull-Njaa T, Lund M (1996)
    [Visual laser coagulation for benign prostatic hyperplasia. Preliminary experiences]
    Tidsskr Nor Laegeforen, 116 (10), 1223-5
    PubMed 8658394
24. Yogesan K, Jørgensen T, Albregtsen F, Tveter KJ, Danielsen HE (1996)
    Entropy-based texture analysis of chromatin structure in advanced prostate cancer
    Cytometry, 24 (3), 268-76
    DOI 10.1002/(SICI)1097-0320(19960701)24:3<268::AID-CYTO10>3.0.CO;2-O, PubMed 8800560

Publications 1995

1. Berge V, Eri LM, Tveter KJ (1995)
   Complications of invasive, urodynamic examinations and prostate biopsies in patients with benign prostatic hyperplasia
   Scand J Urol Nephrol Suppl, 172, 95-8
   PubMed 8578262
2. BERGE V, ERI LM, TVETER KJ (1995)
   COMPLICATIONS OF INVASIVE, URODYNAMIC EXAMINATIONS AND PROSTATE BIOPSIES IN PATIENTS WITH BENIGN PROSTATIC HYPERPLASIA
   Scand. J. Urol. Nephrol. (172), 95-98
3. Bødker A, Balslev E, Juul BR, Stimpel H, Meyhoff HH, Hedlund H, Hedlund P, Iversen HG, Andersson KE (1995)
   Estrogen receptors in the human male bladder, prostatic urethra, and prostate. An immunohistochemical and biochemical study
   Scand J Urol Nephrol, 29 (2), 161-5
   DOI 10.3109/00365599509180557, PubMed 7569793
4. Djukić S, Nedeljković M, Pervulov M, Bojić V, Ljubić A, Radunović N, Lazarević B (1995)
   [Chlamydia trachomatis infection in newborn infants]
   Srp Arh Celok Lek, 123 (9-10), 244-6
   PubMed 17974440
5. Eri LM, Haug E, Tveter KJ (1995)
   Effects on the endocrine system of long-term treatment with the non-steroidal anti-androgen Casodex in patients with benign prostatic hyperplasia
   Br J Urol, 75 (3), 335-40
   DOI 10.1111/j.1464-410x.1995.tb07345.x, PubMed 7537602
6. Eri LM, Tveter KJ (1995)
   alpha-blockade in the treatment of symptomatic benign prostatic hyperplasia
   J Urol, 154 (3), 923-34
   DOI 10.1016/S0022-5347(01)66936-2, PubMed 7543612
7. Eri LM, Urdal P (1995)
   Effects of the nonsteroidal antiandrogen Casodex on lipoproteins, fibrinogen and plasminogen activator inhibitor in patients with benign prostatic hyperplasia
   Eur Urol, 27 (4), 274-9
   DOI 10.1159/000475180, PubMed 7544732
8. Eri LM, Urdal P, Bechensteen AG (1995)
   Effects of the luteinizing hormone-releasing hormone agonist leuprolide on lipoproteins, fibrinogen and plasminogen activator inhibitor in patients with benign prostatic hyperplasia
   J Urol, 154 (1), 100-4
   DOI 10.1016/S0022-5347(01)67239-2, PubMed 7539852
9. Hedlund P, Alm P, Ekström P, Fahrenkrug J, Hannibal J, Hedlund H, Larsson B, Andersson KE (1995)
   Pituitary adenylate cyclase-activating polypeptide, helospectin, and vasoactive intestinal polypeptide in human corpus cavernosum
   Br J Pharmacol, 116 (4), 2258-66
   DOI 10.1111/j.1476-5381.1995.tb15062.x, PubMed 8564257
10. Jørgensen T, Berner A, Kaalhus O, Tveter KJ, Danielsen HE, Bryne M (1995)
    Up-regulation of the oligosaccharide sialyl LewisX: a new prognostic parameter in metastatic prostate cancer
    Cancer Res, 55 (9), 1817-9
    PubMed 7728744
11. Jørgensen T, Müller C, Kaalhus O, Danielsen HE, Tveter KJ (1995)
    Extent of disease based on initial bone scan: important prognostic predictor for patients with metastatic prostatic cancer. Experience from the Scandinavian Prostatic Cancer Group Study No. 2 (SPCG-2)
    Eur Urol, 28 (1), 40-6
    DOI 10.1159/000475018, PubMed 8521893
12. Jørgensen T, Yogesan K, Skjørten F, Berner A, Tveter KJ, Danielsen HE (1995)
    Histopathological grading and DNA ploidy as prognostic markers in metastatic prostatic cancer
    Br J Cancer, 71 (5), 1055-60
    DOI 10.1038/bjc.1995.203, PubMed 7734299
13. Karlsen SJ, Grenabo L, Holmberg G, Colstrup H, Jørgensen TM, Lindell O, Ala-Opas M, Ulvik NM, Schultz A (1995)
    A new system for descriptive classification of stones in the upper urinary tract
    J Urol, 153 (2), 378-9
    DOI 10.1097/00005392-199502000-00024, PubMed 7815588
14. Radosević-Radojković N, Bosković D, Lazarević B, Elezović I, Tomashević R, Rolović Z (1995)
    [Acute myeloblastic leukemia during pregnancy]
    Srp Arh Celok Lek, 123 (3-4), 96-9
    PubMed 16296234

Publications 1994

1. Eri LM, Tveter KJ (1994)
   Safety, side effects and patient acceptance of the luteinizing hormone releasing hormone agonist leuprolide in treatment of benign prostatic hyperplasia
   J Urol, 152 (2 Pt 1), 448-52
   DOI 10.1016/s0022-5347(17)32760-x, PubMed 7516978
2. Eri LM, Tveter KJ (1994)
   Safety, side effects and patient acceptance of the antiandrogen Casodex in the treatment of benign prostatic hyperplasia
   Eur Urol, 26 (3), 219-26
   DOI 10.1159/000475384, PubMed 7528662
3. Hedlund P, Alm P, Hedlund H, Larsson B, Andersson KE (1994)
   Localization and effects of pituitary adenylate cyclase-activating polypeptide (PACAP) in human penile erectile tissue
   Acta Physiol Scand, 150 (1), 103-4
   DOI 10.1111/j.1748-1716.1994.tb09665.x, PubMed 7907833
4. Hedlund P, Holmquist F, Hedlund H, Andersson KE (1994)
   Effects of nicorandil on human isolated corpus cavernosum and cavernous artery
   J Urol, 151 (4), 1107-13
   DOI 10.1016/s0022-5347(17)35193-5, PubMed 8126802
5. Klevmark B, Andersen M, Schultz A, Talseth T (1994)
   Congenital and acquired curvature of the penis treated surgically by plication of the tunica albuginea
   Br J Urol, 74 (4), 501-6
   DOI 10.1111/j.1464-410x.1994.tb00431.x, PubMed 7820431
6. Lindberg BF, Nilsson LG, Hedlund H, Stahl M, Andersson KE (1994)
   Angiotensin I is converted to angiotensin II by a serine protease in human detrusor smooth muscle
   Am J Physiol, 266 (6 Pt 2), R1861-7
   DOI 10.1152/ajpregu.1994.266.6.R1861, PubMed 8024040
7. Talseth T (1994)
   [Are leadership principles of the private sector valid for hospital leadership?]
   Tidsskr Nor Laegeforen, 114 (10), 1237-8
   PubMed 8209329
8. Aanestad O, Flink R (1994)
   Interference pattern in perineal muscles. A quantitative electromyographic study in patients with faecal incontinence
   Eur J Surg, 160 (2), 111-8
   PubMed 8193207

Publications 1993

1. Eikvar L, Taskén KA, Eskild W, Hansson V (1993)
   Protein kinase C activation and positive and negative agonist regulation of 3',5'-cyclic adenosine monophosphate levels in cultured rat Sertoli cells
   Acta Endocrinol (Copenh), 128 (6), 568-72
   DOI 10.1530/acta.0.1280568, PubMed 7687809
2. Eri LM, Tveter KJ (1993)
   A prospective, placebo-controlled study of the antiandrogen Casodex as treatment for patients with benign prostatic hyperplasia
   J Urol, 150 (1), 90-4
   DOI 10.1016/s0022-5347(17)35406-x, PubMed 7685428
3. Eri LM, Tveter KJ (1993)
   A prospective, placebo-controlled study of the luteinizing hormone-releasing hormone agonist leuprolide as treatment for patients with benign prostatic hyperplasia
   J Urol, 150 (2 Pt 1), 359-64
   DOI 10.1016/s0022-5347(17)35483-6, PubMed 7686981
4. Harvei S, Sander S, Tretli S, Langmark F (1993)
   Survival after transurethral and transvesical surgery in localized cancer of the prostate, Norway 1957-1981
   Cancer, 71 (12), 3966-71
   DOI 10.1002/1097-0142(19930615)71:12<3966::aid-cncr2820711227>3.0.co;2-h, PubMed 8508361
5. Holmquist F, Fridstrand M, Hedlund H, Andersson KE (1993)
   Actions of 3-morpholinosydnonimin (SIN-1) on rabbit isolated penile erectile tissue
   J Urol, 150 (4), 1310-5
   DOI 10.1016/s0022-5347(17)35767-1, PubMed 8396690
6. Jørgensen T, Tveter KJ, Jørgensen LH (1993)
   Total androgen suppression: experience from the Scandinavian Prostatic Cancer Group Study No. 2
   Eur Urol, 24 (4), 466-70
   DOI 10.1159/000474351, PubMed 8287887
7. Karlsen SJ, Smevik B, Aasen AO (1993)
   Absence of activation of proteolytic enzymes by extracorporeal shock waves
   J Endourol, 7 (3), 193-6
   DOI 10.1089/end.1993.7.193, PubMed 8358413
8. Rosić B, Sulović V, Lazarević B, Jevremović M, Gligorović S, Spasić S, Stojanov M, Milacić D, Poljaković LJ, Vucetić M (1993)
   The estimation of fructosamine and HbAlc in pregnant women with diabetes mellitus
   Clin Exp Obstet Gynecol, 20 (3), 189-91
   PubMed 8403429
9. Taskén K, Andersson KB, Skålhegg BS, Taskén KA, Hansson V, Jahnsen T, Blomhoff HK (1993)
   Reciprocal regulation of mRNA and protein for subunits of cAMP-dependent protein kinase (RI alpha and C alpha) by cAMP in a neoplastic B cell line (Reh)
   J Biol Chem, 268 (31), 23483-9
   PubMed 8226875
10. Waehre H, Ous S, Klevmark B, Kvarstein B, Urnes T, Ogreid P, Johansen TE, Fosså SD (1993)
    A bladder cancer multi-institutional experience with total cystectomy for muscle-invasive bladder cancer
    Cancer, 72 (10), 3044-51
    DOI 10.1002/1097-0142(19931115)72:10<3044::aid-cncr2820721029>3.0.co;2-d, PubMed 8221572
11. Westlie L, Fauchald P, Talseth T, Jakobsen A, Flatmark A (1993)
    Quality of life in Norwegian kidney donors
    Nephrol Dial Transplant, 8 (10), 1146-50
    PubMed 7818616

Publications 1992

1. Andersson KE, Hedlund H, Månsson W (1992)
   Pharmacologic treatment of bladder hyperactivity after augmentation and substitution enterocystoplasty
   Scand J Urol Nephrol Suppl, 142, 42-6
   PubMed 1353902
2. Andersson KE, Hedlund H, Stahl M (1992)
   Contractions induced by angiotensin I, angiotensin II and bradykinin in isolated smooth muscle from the human detrusor
   Acta Physiol Scand, 145 (3), 253-9
   DOI 10.1111/j.1748-1716.1992.tb09362.x, PubMed 1519483
3. Eri LM, Tveter KJ (1992)
   Measuring the quality of life of patients with benign prostatic hyperplasia. Assessment of the usefulness of a new quality of life questionnaire specially adapted to benign prostatic hyperplasia patients
   Eur Urol, 21 (4), 257-62
   DOI 10.1159/000474853, PubMed 1281101
4. Eri LM, Tveter KJ (1992)
   Patient recruitment to and cost of a prospective trial of medical treatment for benign prostatic hyperplasia
   Eur Urol, 22 (1), 9-13
   DOI 10.1159/000474714, PubMed 1385147
5. Fosså SD, Dearnaley DP, Law M, Gad J, Newling DW, Tveter K (1992)
   Prognostic factors in hormone-resistant progressing cancer of the prostate
   Ann Oncol, 3 (5), 361-6
   DOI 10.1093/oxfordjournals.annonc.a058207, PubMed 1616889
6. Hartmann A, Holdaas H, Fauchald P, Nordal KP, Berg KJ, Talseth T, Leivestad T, Brekke IB, Flatmark A (1992)
   Fifteen years' experience with renal transplantation in systemic amyloidosis
   Transpl Int, 5 (1), 15-8
   DOI 10.1007/BF00337183, PubMed 1580980
7. Havránek P, Hedlund H, Rubenson A, Güth D, Husberg M, Frykberg T, Larsson LT (1992)
   Sacrococcygeal teratoma in Sweden between 1978 and 1989: long-term functional results
   J Pediatr Surg, 27 (7), 916-8
   DOI 10.1016/0022-3468(92)90398-q, PubMed 1640343
8. Holmquist F, Hedlund H, Andersson KE (1992)
   Characterization of inhibitory neurotransmission in the isolated corpus cavernosum from rabbit and man
   J Physiol, 449, 295-311
   DOI 10.1113/jphysiol.1992.sp019087, PubMed 1326047
9. Knutsen HK, Taskén KA, Eskild W, Hansson V (1992)
   Inhibitors of RNA and protein synthesis stabilize messenger RNA for the RII beta subunit of protein kinase A in different cellular compartments
   Biochem Biophys Res Commun, 183 (2), 632-9
   DOI 10.1016/0006-291x(92)90529-t, PubMed 1550570
10. Knutsen HK, Taskén KA, Eskild W, Jahnsen T, Hansson V (1992)
    Half-lives of different sized mRNAs for the PKA subunit RI alpha are regulated differently in response to inhibition of transcription and translation
    Biochem Biophys Res Commun, 184 (1), 454-60
    DOI 10.1016/0006-291x(92)91215-c, PubMed 1314594
11. Rosić Dj, Lazarević B, Radunović N, Ljubić A, Ilić S (1992)
    [Etiologic factors in fetal intrauterine growth retardation]
    Srp Arh Celok Lek, 120 (11-12), 329-31
    PubMed 1340643

Publications 1991

1. Andersson KE, Holmquist F, Fovaeus M, Hedlund H, Sundler R (1991)
   Muscarinic receptor stimulation of phosphoinositide hydrolysis in the human isolated urinary bladder
   J Urol, 146 (4), 1156-9
   DOI 10.1016/s0022-5347(17)38030-8, PubMed 1654463
2. Beisland HO, Sander S (1991)
   Localized prostate carcinoma treated with TUR and neodymium-YAG laser irradiation
   Scand J Urol Nephrol Suppl, 138, 117-9
   PubMed 1784994
3. Beisland HO, Sander S, Andersson L (1991)
   Transurethral resection and laser irradiation in low stage prostatic carcinoma
   Prog Clin Biol Res, 370, 269-73
   PubMed 1924459
4. Goldwasser B, Månsson W, Davidsson T, Hedlund H, Brooks M, Ramon J (1991)
   Cystourethrometric findings in patients with detubularized right colonic segment for bladder replacement
   J Urol, 145 (3), 538-41
   DOI 10.1016/s0022-5347(17)38390-8, PubMed 1997705
5. Holmquist F, Hedlund H, Andersson KE (1991)
   Pre- and postjunctional effects of some prostanoids in human isolated vas deferens
   Am J Physiol, 260 (4 Pt 2), R792-7
   DOI 10.1152/ajpregu.1991.260.4.R792, PubMed 1707245
6. Holmquist F, Hedlund H, Andersson KE (1991)
   L-NG-nitro arginine inhibits non-adrenergic, non-cholinergic relaxation of human isolated corpus cavernosum
   Acta Physiol Scand, 141 (3), 441-2
   DOI 10.1111/j.1748-1716.1991.tb09103.x, PubMed 1858516
7. Holmquist F, Lundin S, Larsson B, Hedlund H, Andersson KE (1991)
   Studies on binding sites, contents, and effects of AVP in isolated bladder and urethra from rabbits and humans
   Am J Physiol, 261 (4 Pt 2), R865-74
   DOI 10.1152/ajpregu.1991.261.4.R865, PubMed 1928432
8. Karlsen SJ, Berg KJ (1991)
   Acute changes in renal function following extracorporeal shock wave lithotripsy in patients with a solitary functioning kidney
   J Urol, 145 (2), 253-6
   DOI 10.1016/s0022-5347(17)38307-6, PubMed 1988713
9. Karlsen SJ, Berg KJ (1991)
   Acute changes in kidney function following extracorporeal shock wave lithotripsy for renal stones
   Br J Urol, 67 (3), 241-5
   DOI 10.1111/j.1464-410x.1991.tb15126.x, PubMed 2021807
10. Karlsen SJ, Smevik B, Klingenberg Lund K, Berg KJ (1991)
    Do extracorporeal shock waves affect urinary excretion of glycosaminoglycans?
    Br J Urol, 67 (1), 24-8
    DOI 10.1111/j.1464-410x.1991.tb15062.x, PubMed 1993272
11. Klepp O, Olsson AM, Ous S, Nilsson S, Høisaether PA, Tveter K (1991)
    Early clinical stages of nonseminomatous testis cancer. Evaluation of the primary treatment and follow-up procedures of the SWENOTECA project
    Scand J Urol Nephrol, 25 (3), 179-90
    DOI 10.3109/00365599109107944, PubMed 1658924
12. Knutsen HK, Taskén KA, Eskild W, Jahnsen T, Hansson V (1991)
    Adenosine 3',5'-monophosphate-dependent stabilization of messenger ribonucleic acids (mRNAs) for protein kinase-A (PKA) subunits in rat Sertoli cells: rapid degradation of mRNAs for PKA subunits is dependent on ongoing RNA and protein synthesis
    Endocrinology, 129 (5), 2496-502
    DOI 10.1210/endo-129-5-2496, PubMed 1657577
13. Krstić M, Sulović V, Marković S, Lazarević B (1991)
    [Biopsy of the chorionic villi with the aid of ultrasound in the diagnosis of chromosome disorders in the 1st trimester]
    Glas Srp Akad Nauka Med (40), 63-6
    PubMed 1916429
14. Kvittingen EA, Talseth T, Halvorsen S, Jakobs C, Hovig T, Flatmark A (1991)
    Renal failure in adult patients with hereditary tyrosinaemia type I
    J Inherit Metab Dis, 14 (1), 53-62
    DOI 10.1007/BF01804389, PubMed 1861460
15. Pilić Z, Sulović V, Mujić G, Radunović N, Lazarević B (1991)
    [Standard fetal growth curves--current aspects of their utilization]
    Glas Srp Akad Nauka Med (40), 49-57
    PubMed 1916427
16. Rosić B, Sulović V, Juznić N, Lazarević B, Vidanović M, Milacić D (1991)
    [Levels of immunoglobulins in various media from healthy pregnant women and women with diabetes mellitus and EPH gestosis]
    Glas Srp Akad Nauka Med (41), 71-9
    PubMed 1916449
17. Rosic B, Sulovic V, Lazarevic B (1991)
    [The determination of specific proteins in the biological fluids from pregnant women suffering from diabetes mellitus]
    Akush Ginekol (Mosk) (2), 32-4
    PubMed 1862849
18. Talseth T, Westlie L, Daae L (1991)
    Doxazosin and atenolol as monotherapy in mild and moderate hypertension: a randomized, parallel study with a three-year follow-up
    Am Heart J, 121 (1 Pt 2), 280-5
    DOI 10.1016/0002-8703(91)90858-f, PubMed 1824651

Publications 1990

1. Albrechtsen D, Bentdal O, Berg KJ, Brekke I, Fauchald P, Jakobsen A, Pfeffer P, Sødal G, Talseth T, Flatmark A (1990)
   Infections in cyclosporine-treated kidney graft recipients: beneficial effect of cotrimoxazole prophylaxis
   Transplant Proc, 22 (1), 245
   PubMed 2309322
2. Albrechtsen D, Berg KJ, Brekke I, Fauchald P, Jakobsen A, Sødal G, Talseth T, Leivestad T, Flatmark A (1990)
   Renal replacement therapy in the cyclosporine era: results of a national transplantation program
   Transplant Proc, 22 (1), 155-6
   PubMed 2309295
3. Albrechtsen D, Sødal G, Jakobsen A, Brekke I, Bentdal O, Berg KJ, Fauchald P, Pfeffer P, Talseth T, Leivestad T (1990)
   Kidney transplantation from a spouse: an alternative to years of dialysis waiting for a graft that may never turn up?
   Transplant Proc, 22 (4), 1435
   PubMed 2389351
4. Albrechtsen D, Sødal G, Jakobsen A, Brekke I, Flatmark A, Fauchald P, Talseth T, Thorsby E (1990)
   [Kidney transplantation in Norway]
   Tidsskr Nor Laegeforen, 110 (3), 327-31
   PubMed 2309172
5. Andersson KE, Hedlund H (1990)
   Basic and clinical aspects of cholinergic agents in bladder dysfunction
   Prog Brain Res, 84, 201-7
   DOI 10.1016/s0079-6123(08)60904-8, PubMed 2267297
6. Beisland HO, Sander S (1990)
   Neodymium-YAG laser irradiation of stage T2 muscle-invasive bladder cancer. Long-term results
   Br J Urol, 65 (1), 24-6
   DOI 10.1111/j.1464-410x.1990.tb14654.x, PubMed 2310928
7. Eriksson LO, Larsson B, Hedlund H, Andersson KE (1990)
   Prostaglandin E2 binding sites in human renal tissue: characterization and localization by radioligand binding and autoradiography
   Acta Physiol Scand, 139 (3), 393-404
   DOI 10.1111/j.1748-1716.1990.tb08940.x, PubMed 2173350
8. Fauchald P, Joachim Berg K, Brodwall EK, Talseth T, Flatmark A, Leivestad T, Halvorsen S (1990)
   [Treatment of chronic kidney failure with dialysis and transplantation. Development, need and organization in Norway]
   Tidsskr Nor Laegeforen, 110 (3), 332-4
   PubMed 2309173
9. Fossberg E, Sørensen S, Ruutu M, Bakke A, Stien R, Henriksson L, Kinn AC (1990)
   Maximal electrical stimulation in the treatment of unstable detrusor and urge incontinence
   Eur Urol, 18 (2), 120-3
   DOI 10.1159/000463887, PubMed 2226580
10. Hagen RH, Bjerklund Johansen TE (1990)
    [Xanthogranulomatous pyelonephritis. A benign, solid kidney tumor]
    Tidsskr Nor Laegeforen, 110 (21), 2763-4
    PubMed 2219050
11. Holdaas H, Hartmann A, Talseth T, Fauchald P, Sødal G, Brekke IB, Berg KJ (1990)
    Change in intrarenal sodium reabsorption following donor nephrectomy
    Transplant Proc, 22 (1), 246
    PubMed 2309323
12. Holmquist F, Andersson KE, Fovaeus M, Hedlund H (1990)
    K(+)-channel openers for relaxation of isolated penile erectile tissue from rabbit
    J Urol, 144 (1), 146-51
    DOI 10.1016/s0022-5347(17)39398-9, PubMed 2359166
13. Holmquist F, Andersson KE, Hedlund H (1990)
    Actions of endothelin on isolated corpus cavernosum from rabbit and man
    Acta Physiol Scand, 139 (1), 113-22
    DOI 10.1111/j.1748-1716.1990.tb08903.x, PubMed 2192537
14. Holmquist F, Andersson KE, Hedlund H (1990)
    Effects of pinacidil on isolated human corpus cavernosum penis
    Acta Physiol Scand, 138 (4), 463-9
    DOI 10.1111/j.1748-1716.1990.tb08873.x, PubMed 2353577
15. Holmquist F, Hedlund H, Andersson KE (1990)
    Effects of the alpha 1-adrenoceptor antagonist R-(-)-YM12617 on isolated human penile erectile tissue and vas deferens
    Eur J Pharmacol, 186 (1), 87-93
    DOI 10.1016/0014-2999(90)94063-4, PubMed 1980892
16. Jakobsen A, Albrechtsen D, Leivestad T, Sødal G, Talseth T, Flatmark A (1990)
    Steroid-resistant rejection: the effect of ATG on renal allograft survival
    Transplant Proc, 22 (1), 225
    PubMed 2309320
17. Karlsen SJ, Smevik B, Stenstrøm J, Berg KJ (1990)
    Acute physiological changes in canine kidneys following exposure to extracorporeal shock waves
    J Urol, 143 (6), 1280-3
    DOI 10.1016/s0022-5347(17)40255-2, PubMed 2342201
18. Klevmark B, Talseth T, Stien R, Schultz A (1990)
    [Electric stimulation of the pelvis]
    Tidsskr Nor Laegeforen, 110 (15), 1988
    PubMed 2363173
19. Kolbenstvedt A, Egge T, Klevmark B, Talseth T (1990)
    Isolated cavernous bodies
    J Urol, 143 (2), 356-7
    DOI 10.1016/s0022-5347(17)39961-5, PubMed 2299731
20. Riddervold F, Forslund T, Endresen K, Simonsen S, Talseth T, Fyhrquist F (1990)
    Hormonal changes during tilt and atrial pacing in heart transplant patients
    Transplant Proc, 22 (1), 191-4
    PubMed 2137947
21. Rosić B, Sulović V, Juznić N, Lazarević B, Milacić D, Vidanović M (1990)
    The complements and immunoglobulins in different media of healthy pregnant women and in pregnant women with increased blood pressure
    Clin Exp Obstet Gynecol, 17 (1), 31-5
    PubMed 2364549
22. Talseth T, Westlie L, Daae L (1990)
    A long-term study of atenolol and doxazosin in mild and moderate hypertension
    J Hum Hypertens, 4 Suppl 3, 39-44
    PubMed 2148194
23. Talseth T, Westlie L, Daae LN (1990)
    Long-term effects of doxazosin and atenolol on serum lipids and blood pressure in hypertensive smokers
    J Hypertens Suppl, 8 (5), S47-51
    PubMed 1981077

Publications 1989

1. Berg KJ, Gjellestad A, Nordby G, Rootwelt K, Djøseland O, Fauchald P, Mehl A, Narverud J, Talseth T (1989)
   Renal effects of trimethoprim in ciclosporin- and azathioprine-treated kidney-allografted patients
   Nephron, 53 (3), 218-22
   DOI 10.1159/000185747, PubMed 2677807
2. Bjerklund Johansen TE (1989)
   [Urethral stricture as the cause of retrograde ejaculation and infertility]
   Tidsskr Nor Laegeforen, 109 (12), 1300
   PubMed 2734759
3. Flesland O, Solheim BG, Gaustad P, Mellbye O, Albrechtsen DA, Talseth T, Leivestad T (1989)
   Antibody production by donor lymphocytes in transplant patients
   Transplantation, 48 (5), 883-5
   DOI 10.1097/00007890-198911000-00036, PubMed 2815263
4. Fovaeus M, Andersson KE, Hedlund H (1989)
   The action of pinacidil in the isolated human bladder
   J Urol, 141 (3), 637-40
   DOI 10.1016/s0022-5347(17)40922-0, PubMed 2918608
5. Hallgren P, Sjöström L, Hedlund H, Lundell L, Olbe L (1989)
   Influence of age, fat cell weight, and obesity on O2 consumption of human adipose tissue
   Am J Physiol, 256 (4 Pt 1), E467-74
   DOI 10.1152/ajpendo.1989.256.4.E467, PubMed 2495730
6. Holdaas H, Brekke IB, Hartmann A, Talseth T, Sødal G, Jervell J, Flatmark A (1989)
   Long-term metabolic control in recipients of duct-occluded segmental pancreatic grafts
   Transplant Proc, 21 (1 Pt 3), 2854-5
   PubMed 2650384
7. Lazarević B, Poljaković L, Ljubić A, Radunović N (1989)
   [Lecithin in the amniotic fluid in the determination of fetal lung maturity]
   Jugosl Ginekol Perinatol, 29 (5-6), 165-7
   PubMed 2640262
8. Månsson W, Hedlund H, Andersson KE (1989)
   Effect of atropine and terbutaline on motor activity of the continent caecal reservoir for urine
   Br J Urol, 63 (4), 375-8
   DOI 10.1111/j.1464-410x.1989.tb05221.x, PubMed 2540869
9. Radunović N, Lazarević B (1989)
   [Cordocentesis--a new diagnostic approach in modern perinatology]
   Jugosl Ginekol Perinatol, 29 (5-6), 161-4
   PubMed 2640261
10. Rosić B, Sulović V, Juznić N, Lazarević B, Vidanović M (1989)
    [Complement and immunoglobulin levels in pregnant women with EPH gestosis]
    Srp Arh Celok Lek, 117 (7-8), 459-64
    PubMed 2595470

Publications 1988

1. ALBRECHTSEN D, FAUCHALD P, LEIVESTAD T, TALSETH T, FLATMARK A (1988)
   RENAL REPLACEMENT THERAPY IN ELDERLY PATIENTS
   Transplant. Proc., 20 (1 1), 367-369
2. Andersson KE, Andersson PO, Fovaeus M, Hedlund H, Malmgren A, Sjögren C (1988)
   Effects of pinacidil on bladder muscle
   Drugs, 36 Suppl 7, 41-9
   DOI 10.2165/00003495-198800367-00007, PubMed 3076135
3. Andersson KE, Fovaeus M, Hedlund H (1988)
   Urogenital muscarinic receptors and drug effects
   Ann Clin Res, 20 (5), 356-66
   PubMed 3218906
4. Andersson KE, Fovaeus M, Hedlund H, Holmquist F, Lundin S (1988)
   Immunoreactive arginine vasopressin (AVP) and effects of AVP in the human vas deferens
   J Urol, 140 (5), 1054-7
   DOI 10.1016/s0022-5347(17)41925-2, PubMed 3172359
5. Berg KJ, Nordby G, Rootwelt K, Djøseland O, Fauchald P, Mehl A, Narverud J, Talseth T (1988)
   Effects on renal function of combined treatment with trimethoprim and cyclosporine A in kidney transplant patients
   Transplant Proc, 20 (3), 413-5
   PubMed 3289171
6. Eri LM, Harbitz TB, Løtveit T (1988)
   Pseudocyst of the spleen after closed abdominal injury
   Injury, 19 (4), 297
   DOI 10.1016/0020-1383(88)90057-5, PubMed 3229854
7. Eri LM, Klevmark B (1988)
   [Urethral diverticulum in women]
   Tidsskr Nor Laegeforen, 108 (12), 925-7
   PubMed 3132747
8. Eri LM, Klevmark B (1988)
   [Primary megaureter in adults]
   Tidsskr Nor Laegeforen, 108 (12), 930-2
   PubMed 3381207
9. Fauchald P, Albrechtsen D, Leivestad T, Berg KJ, Talseth T, Flatmark A (1988)
   Renal replacement therapy in elderly patients
   Transpl Int, 1 (3), 131-4
   DOI 10.1007/BF00348834, PubMed 3075472
10. Fauchald P, Albrechtsen D, Leivestad T, Pfeffer P, Talseth T, Flatmark A (1988)
    Renal replacement therapy in patients over 60 years of age
    Transplant Proc, 20 (3), 432-3
    PubMed 3289177
11. Fossberg E, Rud T (1988)
    Fiber-optic versus microtip transducers in simultaneous urethrocystometry. A comparative study
    Eur Urol, 14 (1), 27-9
    DOI 10.1159/000472891, PubMed 3342802
12. Hem E, Attramadal A, Tveter KJ (1988)
    Synchronous bilateral primary germ cell tumors in patient receiving estrogen therapy
    Urology, 31 (1), 70-1
    DOI 10.1016/0090-4295(88)90578-x, PubMed 3336932
13. Hem E, Tveter KJ, Karlsen S, Sander S, Talseth T, Klevmark B, Sundby K (1988)
    [Shock wave therapy of urolithiasis. Norwegian experiences]
    Tidsskr Nor Laegeforen, 108 (5), 382-6
    PubMed 3353931
14. Hem E, Wahlqvist R, Sivertsen S, Tveter K (1988)
    [Uretero-renoscopy. Our initial experience]
    Tidsskr Nor Laegeforen, 108 (24), 1898-901
    PubMed 3206400
15. Holdaas H, Hartmann A, Talseth T, Berg KJ, Fauchald P, Stenstrøm J, Djøseland O, Nordal KP, Brodwall E (1988)
    Short-term changes in renal function of the remaining kidney after donor nephrectomy
    Transplant Proc, 20 (3), 434-5
    PubMed 3381255
16. Holdaas H, Talseth T, Berg KJ, Fauchald P, Nordal KP, Hartmann A (1988)
    Diagnostic value of peripheral plasma renin response to a single dose of captopril in suspected renal transplant artery stenosis
    Transplant Proc, 20 (3), 423-4
    PubMed 3289174
17. Kirkhus B, Clausen OP, Fjordvang H, Helander K, Iversen OH, Reitan JB, Vaage S (1988)
    Characterization of bladder tumours by multiparameter flow cytometry with special reference to grade II tumours
    APMIS, 96 (9), 783-92
    DOI 10.1111/j.1699-0463.1988.tb00945.x, PubMed 3166807
18. Klevmark B, Talseth T, Eri LM, Borchgrevink HH, Kolbenstvedt A (1988)
    [Congenital curvature of the erect penis without simultaneous changes in the urethra or corpus spongiosum and with normal erection]
    Tidsskr Nor Laegeforen, 108 (8-9), 683-5
    PubMed 3353973
19. Klevmark B, Talseth T, Eri LM, Kolbenstvedt A, Egge T (1988)
    Abnormal venous drainage from the penis examined by dynamic cavernosography and surgically treated
    Scand J Urol Nephrol Suppl, 110, 261-5
    PubMed 3187421
20. Klevmark B, Talseth T, Eri LM, Kolbenstvedt AN (1988)
    [Erectile impotence and disorders of venous circulation]
    Tidsskr Nor Laegeforen, 108 (8-9), 679-80
    PubMed 3353971
21. Radunović N, Lazarević B, Plećas D, Aleksić M, Popović M (1988)
    [Intrauterine intravascular transfusion--the effect of treatment on severe types of Rh isoimmunization]
    Srp Arh Celok Lek, 116 (4), 317-22
    PubMed 3142057
22. Radunović N, Petković S, Krajinović M, Marković S, Lazarević B (1988)
    [Advantages and disadvantages of transabdominal taking of chorionic villi in prenatal diagnosis]
    Srp Arh Celok Lek, 116 (7-8), 617-25
    PubMed 21213422
23. Rosić B, Sulović V, Juznić N, Lazarević B (1988)
    [Variation in complement and immunoglobulins in maternal and umbilical cord blood and in the amniotic fluid and urine in pregnant women with diabetes mellitus]
    Jugosl Ginekol Perinatol, 28 (3-4), 73-6
    PubMed 3172833
24. Rosić B, Sulović V, Juznić N, Lazarević B, Vidanović M (1988)
    The significant of complement and immunoglobulin determination in healthy pregnant women and patients with EPH gestoses
    Clin Exp Obstet Gynecol, 15 (4), 157-60
    PubMed 3233758
25. Strizova N, Sulović V, Djugeev A, Lazarević B (1988)
    [Prognostic significance of thrombocyte metabolism in pregnancy]
    Jugosl Ginekol Perinatol, 28 (5-6), 129-30
    PubMed 2851076
26. Talseth T, Holdaas H, Albrechtsen D, Berg KJ, Fauchald P, Naalsund A, Nordal KP, Skar AG, Sødal G, Flatmark A (1988)
    Increasing incidence of Pneumocystis carinii pneumonia in renal transplant patients
    Transplant Proc, 20 (3), 400-1
    PubMed 3289169
27. Talseth T, Westlie L, Daae L, Vatle S (1988)
    Comparison of the effects of doxazosin and atenolol on blood pressure and blood lipids: a one-year, double-blind study in 228 hypertensive patients
    Am Heart J, 116 (6 Pt 2), 1790-6
    DOI 10.1016/0002-8703(88)90231-1, PubMed 2904752

Publications 1987

1. Andersson KE, Fovaeus M, Hedlund H, Lundin S (1987)
   Characterization of immunoreactive arginine vasopressin (AVP) in and effects of AVP on isolated human penile erectile tissues
   J Urol, 137 (6), 1278-82
   DOI 10.1016/s0022-5347(17)44482-x, PubMed 2953909
2. Andersson KE, Hedlund H, Larsson B, Mattiasson A, Sjögren C (1987)
   Ketanserin interaction with urethral alpha-adrenoceptors
   J Urol, 137 (3), 534-8
   DOI 10.1016/s0022-5347(17)44101-2, PubMed 3029437
3. Batra S, Biörklund A, Hedlund H, Andersson KE (1987)
   Identification and characterization of muscarinic cholinergic receptors in the human urinary bladder and parotid gland
   J Auton Nerv Syst, 20 (2), 129-35
   DOI 10.1016/0165-1838(87)90110-x, PubMed 3668160
4. Eri LM, Gjengedal E (1987)
   [Surgical treatment of the impingement syndrome]
   Tidsskr Nor Laegeforen, 107 (6), 543-4
   PubMed 3576543
5. Eri LM, Liavåg I (1987)
   [Subtotal cholecystectomy. An alternative to a difficult cholecystectomy]
   Tidsskr Nor Laegeforen, 107 (5), 467-8
   PubMed 3576533
6. Fauchald P, Leivestad T, Bratlie A, Albrechtsen D, Talseth T, Flatmark A (1987)
   Plasma exchange and immunosuppressive therapy before renal transplantation in allosensitized patients
   Transplant Proc, 19 (5), 3748-9
   PubMed 3313908
7. Fovaeus M, Andersson KE, Hedlund H (1987)
   Calcium channel blockade and contractile responses in the isolated human vas deferens
   J Urol, 138 (3), 654-8
   DOI 10.1016/s0022-5347(17)43292-7, PubMed 2442424
8. Fovaeus M, Andersson KE, Hedlund H (1987)
   Effects of some calcium channel blockers on isolated human penile erectile tissues
   J Urol, 138 (5), 1267-72
   DOI 10.1016/s0022-5347(17)43582-8, PubMed 3669187
9. Hedlund H, Lindstedt E (1987)
   Urovaginal fistulas: 20 years of experience with 45 cases
   J Urol, 137 (5), 926-8
   DOI 10.1016/s0022-5347(17)44296-0, PubMed 3573185
10. Pervulov M, Lazarević B, Avramović D, Radojković Z (1987)
    [Etiologic factors in premature labor in pregnant women with insulin-dependent diabetes]
    Srp Arh Celok Lek, 115 (5-6), 539-46
    PubMed 3269660
11. Rosić B, Lazarević B, Milacić D (1987)
    [Diagnostic value of magnetic and nuclear magnetic resonance in gynecology and obstetrics]
    Srp Arh Celok Lek, 115 (7), 755-63
    PubMed 3270190
12. Ruud TE, Aasen AO, Stadaas JO, Wahlqvist R, Tveter K, Osnes M, Skjennald A (1987)
    [Extracorporeal shock waves. A new alternative in the treatment of bile duct stones]
    Tidsskr Nor Laegeforen, 107 (13), 1134-6
    PubMed 3603472
13. Ruud TE, Aasen AO, Stadaas JO, Wahlqvist R, Tveter K, Osnes M, Skjennald A (1987)
    [Extracorporeal shock waves--a new alternative in the treatment of gallstones]
    Nord Med, 102 (12), 343-6
    PubMed 3697056
14. Sillén U, Hagberg S, Hedlund H, Rubenson A, Sörsensen SE (1987)
    Early complications and long-term results of colorectal resection ad modum Rehbein for Hirschsprung's disease
    Z Kinderchir, 42 (6), 362-5
    DOI 10.1055/s-2008-1075623, PubMed 3439359
15. Sødal G, Albrechtsen D, Berg KJ, Bondevik H, Brekke IB, Fauchald P, Jakobsen A, Talseth T, Thorsby E, Flatmark A (1987)
    Renal transplantation from living donors mismatched for two HLA haplotypes
    Transplant Proc, 19 (1 Pt 2), 1509-10
    PubMed 3079022
16. Talseth T, Westre B, Bondevik H, Albrechtsen D (1987)
    Prognostic information in biopsies of transplanted kidneys with unsatisfactory response to antirejection therapy
    Transplant Proc, 19 (1 Pt 2), 1623-4
    PubMed 2484096

Publications 1986

1. ALBRECHTSEN D, BERG KJ, BONDEVIK H, BREKKE IB, FAUCHALD P, JAKOBSEN A, MOEN T, SODAL G, TALSETH T, THORSBY E, FLATMARK A (1986)
   IMPROVED RESULTS USING CYCLOSPORINE IN CADAVERIC RENAL-TRANSPLANTATION
   Transplant. Proc., 18 (1), 92-94
2. ALBRECHTSEN D, BERG KJ, BONDEVIK H, BREKKE IB, FAUCHALD P, JAKOBSEN A, SODAL G, TALSETH T, FLATMARK A (1986)
   PROGNOSTIC FACTORS IN AZATHIOPRINE-TREATED AND CYCLOSPORINE-TREATED RECIPIENTS OF CADAVERIC RENAL-TRANSPLANTS
   Transplant. Proc., 18 (5), 1073-1076
3. Beisland HO, Sander S (1986)
   First clinical experiences on neodymium-YAG laser irradiation of localized prostatic cancer
   Scand J Urol Nephrol, 20 (2), 113-7
   DOI 10.3109/00365598609040558, PubMed 3755842
4. Bjerklund Johansen TE, Gran L (1986)
   [Parietal abdominal pain. Abdominal cutaneous nerve entrapment syndrome]
   Tidsskr Nor Laegeforen, 106 (26), 2151-4
   PubMed 2946095
5. Eri LM, Sander S (1986)
   [Primary hyperparathyroidism. Surgical case material from Aker Hospital 1974-85]
   Tidsskr Nor Laegeforen, 106 (12), 1028-30
   PubMed 3726830
6. Eri LM, Sander S, Rostad B, Bay D (1986)
   [Preoperative localization of parathyroid tumors. CT and ultrasonics before surgery of primary hyperparathyroidism]
   Tidsskr Nor Laegeforen, 106 (12), 1042-5
   PubMed 3523823
7. Gjengedal E, Rolfsen L, Eri LM (1986)
   [Acute total dislocation of the acromioclavicular joint. Surgical treatment]
   Tidsskr Nor Laegeforen, 106 (30), 2515-7, 2530
   PubMed 3798429
8. Hedlund H, Fändriks L, Delbro D, Fasth S (1986)
   Effect of alpha, beta-methylene ATP on distal colonic and rectal motility--a possible involvement of P2-purinoceptors in pelvic nerve mediated non-adrenergic, non-cholinergic contraction
   Acta Physiol Scand, 127 (4), 425-32
   DOI 10.1111/j.1748-1716.1986.tb07923.x, PubMed 2875603
9. Jacobsen D, Frederichsen PS, Knutsen KM, Sørum Y, Talseth T, Odegaard OR (1986)
   Self-poisoning and moon phases in Oslo
   Hum Toxicol, 5 (1), 51-2
   DOI 10.1177/096032718600500110, PubMed 3949368
10. Nilssen DE, Talseth T, Brodwall EK (1986)
    The many faces of Goodpasture's syndrome
    Acta Med Scand, 220 (5), 489-91
    DOI 10.1111/j.0954-6820.1986.tb02800.x, PubMed 3492866
11. Strømme JH, Haffner F, Johannessen NB, Talseth T, Frederichsen P, Theodorsen L (1986)
    Diagnostic efficiency of biological markers in blood serum on prostate cancer: a comparison of four different markers and 12 different methods
    Scand J Clin Lab Invest, 46 (5), 443-50
    DOI 10.3109/00365518609083696, PubMed 2428093
12. TALSETH T, FAUCHALD P, FLATMARK A (1986)
    THE LONG-TERM PROGNOSIS OF LIVING KIDNEY DONORS
    Transplant. Proc., 18 (1), 106-107
13. Talseth T, Fauchald P, Skrede S, Djøseland O, Berg KJ, Stenstrøm J, Heilo A, Brodwall EK, Flatmark A (1986)
    Long-term blood pressure and renal function in kidney donors
    Kidney Int, 29 (5), 1072-6
    DOI 10.1038/ki.1986.109, PubMed 3523003

Publications 1985

1. Berg KJ, Talseth T (1985)
   Acute renal effects of sulindac and indomethacin in chronic renal failure
   Clin Pharmacol Ther, 37 (4), 447-52
   DOI 10.1038/clpt.1985.69, PubMed 3884224
2. Delbro D, Hedlund H, Kennedy C, Burnstock G (1985)
   Potent vasoconstrictor actions of alpha, beta-methylene ATP, a stable analogue of ATP, on the rat vasculature, in vivo
   Acta Physiol Scand, 123 (4), 501-3
   DOI 10.1111/j.1748-1716.1985.tb07616.x, PubMed 3993405
3. Ekholdt PF, Gulsvik A, Digranes S, Hovig T, Mellbye OJ, Talseth T (1985)
   Recurrent diffuse pulmonary hemorrhage with minor kidney lesions
   Eur J Respir Dis, 66 (5), 353-9
   PubMed 3874785
4. Eri LM, Hoel R (1985)
   [Adenocarcinoma of the colon and rectum. A population study]
   Tidsskr Nor Laegeforen, 105 (9-10), 665-8
   PubMed 3992555
5. Eri LM, Hvaal K, Gjølberg TO (1985)
   [Percutaneous transluminal angioplasty in the lower limbs]
   Tidsskr Nor Laegeforen, 105 (7), 503-6
   PubMed 3158096
6. GERHARDT P, MEVAG B, RUI H, TVETER KJ, PURVIS K (1985)
   TWO-DIMENSIONAL ELECTROPHORESIS OF PROTEINS FROM DIFFERENT LOBES OF THE RAT PROSTATE AND SEMINAL-VESICLE
   Prostate, 7 (3), 321-326
   DOI 10.1002/pros.2990070309
7. Hedlund H, Andersson KE (1985)
   Effects of some peptides on isolated human penile erectile tissue and cavernous artery
   Acta Physiol Scand, 124 (3), 413-9
   DOI 10.1111/j.1748-1716.1985.tb07677.x, PubMed 2413712
8. Hedlund H, Andersson KE (1985)
   Comparison of the responses to drugs acting on adrenoreceptors and muscarinic receptors in human isolated corpus cavernosum and cavernous artery
   J Auton Pharmacol, 5 (1), 81-8
   DOI 10.1111/j.1474-8673.1985.tb00568.x, PubMed 3157689
9. Hedlund H, Andersson KE (1985)
   Contraction and relaxation induced by some prostanoids in isolated human penile erectile tissue and cavernous artery
   J Urol, 134 (6), 1245-50
   DOI 10.1016/s0022-5347(17)47704-4, PubMed 3903226
10. Hedlund H, Andersson KE, Larsson B (1985)
    Alpha-adrenoceptors and muscarinic receptors in the isolated human prostate
    J Urol, 134 (6), 1291-8
    DOI 10.1016/s0022-5347(17)47714-7, PubMed 2414474
11. Hedlund H, Andersson KE, Larsson B (1985)
    Effect of drugs interacting with adrenoreceptors and muscarinic receptors in the epididymal and prostatic parts of the human isolated vas deferens
    J Auton Pharmacol, 5 (3), 261-70
    DOI 10.1111/j.1474-8673.1985.tb00127.x, PubMed 2997231
12. Hedlund H, Ek A (1985)
    Ejaculation and sexual function after endoscopic bladder neck incision
    Br J Urol, 57 (2), 164-7
    DOI 10.1111/j.1464-410x.1985.tb06413.x, PubMed 4039208
13. Hedlund H, Fasth S, Hultén L, Nordgren S (1985)
    Studies on the integrated extrinsic nervous control of rectal motility in the cat
    Acta Physiol Scand, 124 (1), 43-51
    DOI 10.1111/j.1748-1716.1985.tb07630.x, PubMed 2861713
14. Hedlund H, Fändriks L, Delbro D, Fasth S (1985)
    On the transmission of sacral parasympathetic nervous influence on distal colonic and rectal motility in the cat
    Acta Physiol Scand, 125 (2), 225-34
    DOI 10.1111/j.1748-1716.1985.tb07711.x, PubMed 2866661
15. Helander K, Kirkhus B, Iversen OH, Johansson SL, Nilsson S, Vaage S, Fjordvang H (1985)
    Studies on urinary bladder carcinoma by morphometry, flow cytometry, and light microscopic malignancy grading with special reference to grade II tumours
    Virchows Arch A Pathol Anat Histopathol, 408 (2-3), 117-26
    DOI 10.1007/BF00707976, PubMed 3936256
16. Nordal KP, Talseth T, Dahl E, Attramadal A, Albrechtsen D, Halse J, Brodwall EK, Flatmark A (1985)
    Aluminium overload, a predisposing condition for epileptic seizures in renal-transplant patients treated with cyclosporin?
    Lancet, 2 (8447), 153-4
    DOI 10.1016/s0140-6736(85)90254-5, PubMed 2862341
17. NORDAL KP, TALSETH T, DAHL E, ATTRAMADAL A, ALBRECHTSEN D, HALSE J, BRODWALL EK, FLATMARK A (1985)
    ALUMINUM OVERLOAD, A PREDISPOSING CONDITION FOR EPILEPTIC SEIZURES IN RENAL-TRANSPLANT PATIENTS TREATED WITH CYCLOSPORIN
    Lancet, 2 (8447), 153-154
18. Radunović N, Lazarević B, Pilić Z, Plećas D (1985)
    [Antenatal echocardiography in the monitoring of functional disorders of the fetal heart]
    Srp Arh Celok Lek, 113 (3), 235-42
    PubMed 4071287

Publications 1984

1. Bjerklund Johansen TE (1984)
   [Disaster preparedness and exercises. Responsibility, conduct and evaluation]
   Tidsskr Nor Laegeforen, 104 (33), 2303-9
   PubMed 6523461
2. Eri LM, Drabløs PA (1984)
   [Inguinal hernia in children. Case material from a central hospital]
   Tidsskr Nor Laegeforen, 104 (2), 81-3
   PubMed 6701841
3. Fosså SD, Telhaug R, Wahlqvist R (1984)
   [Spontaneous remission of metastases from renal cancer]
   Tidsskr Nor Laegeforen, 104 (8), 583-5
   PubMed 6719422
4. Hedlund H, Andersson KE, Mattiasson A (1984)
   Pre- and postjunctional adreno- and muscarinic receptor functions in the isolated human corpus spongiosum urethrae
   J Auton Pharmacol, 4 (4), 241-9
   DOI 10.1111/j.1474-8673.1984.tb00101.x, PubMed 6152266
5. Hedlund H, Fasth S, Hultén L (1984)
   Efferent sympathetic nervous control of rectal motility in the cat
   Acta Physiol Scand, 121 (4), 317-24
   DOI 10.1111/j.1748-1716.1984.tb07462.x, PubMed 6148839
6. Hedlund H, Lindström K, Månsson W (1984)
   Dynamics of a continent caecal reservoir for urinary diversion
   Br J Urol, 56 (4), 366-72
   DOI 10.1111/j.1464-410x.1984.tb05822.x, PubMed 6534422
7. Jacobsen D, Frederichsen PS, Knutsen KM, Sørum Y, Talseth T, Odegaard OR (1984)
   Clinical course in acute self-poisonings: a prospective study of 1125 consecutively hospitalised adults
   Hum Toxicol, 3 (2), 107-16
   DOI 10.1177/096032718400300204, PubMed 6724591
8. Jacobsen D, Frederichsen PS, Knutsen KM, Sørum Y, Talseth T, Odegaard OR (1984)
   A prospective study of 1212 cases of acute poisoning: general epidemiology
   Hum Toxicol, 3 (2), 93-106
   DOI 10.1177/096032718400300203, PubMed 6724595
9. Lazarevic B, Katatikarn V, Marks RA (1984)
   Primary squamous-cell carcinoma of the breast. Diagnosis by fine needle aspiration cytology
   Acta Cytol, 28 (3), 321-4
   PubMed 6587708
10. Radunović N, Marković A, Lazarević B (1984)
    [Fetal echocardiography in the 2d half of pregnancy]
    Srp Arh Celok Lek, 112 (6), 703-8
    PubMed 6523257
11. Rosić B, Sulović B, Lazarević B, Pervulov M, Cvetković M, Vidanović M (1984)
    [Significance of the determination of alpha 1-antitrypsin in pregnancy]
    Srp Arh Celok Lek, 112 (10), 1039-45
    PubMed 6336158
12. Rosić B, Sulović V, Lazarević B, Pervulov M, Cvetković M, Vidanović M (1984)
    [Determination of alpha acid glycoprotein in normal and pathologic pregnancy]
    Jugosl Ginekol Opstet, 24 (5-6), 98-9
    PubMed 6535893
13. Rui H, Gerhardt P, Mevåg B, Thomassen Y, Purvis K (1984)
    Seminal plasma characteristics during frequent ejaculation
    Int J Androl, 7 (2), 119-28
    DOI 10.1111/j.1365-2605.1984.tb00767.x, PubMed 6724722
14. Sander S, Beisland HO (1984)
    Laser in the treatment of localized prostatic carcinoma
    J Urol, 132 (2), 280-1
    DOI 10.1016/s0022-5347(17)49592-9, PubMed 6737577

Publications 1983

1. Avramović D, Sulović V, Lazarević B, Cvetković M, Gligorović S, Pervulov M, Nikolić-Dukanović L (1983)
   [Etiological factors in sterility and infertility as risk factors in future pregnancies]
   Jugosl Ginekol Opstet, 23 (3-4), 68-71
   PubMed 6664103
2. Daniel S, Lazarevic B, Attia A (1983)
   Lymphangioma of the mesentery of the jejunum: report of a case and a brief review of the literature
   Am J Gastroenterol, 78 (11), 726-9
   PubMed 6637962
3. Engberg A, Spångberg A, Urnes T (1983)
   Transurethral resection of bladder tumors under local anesthesia
   Urology, 22 (4), 385-7
   DOI 10.1016/0090-4295(83)90415-6, PubMed 6636393
4. Fasth S, Hedlund H, Hultén L, Nordgren S, Oresland T (1983)
   The effects of 5-hydroxytryptamine on large intestinal motility and blood flow in the cat
   Acta Physiol Scand, 118 (4), 329-36
   DOI 10.1111/j.1748-1716.1983.tb07279.x, PubMed 6637536
5. Fasth S, Hedlund H, Svaninger G, Oresland T, Hultén L (1983)
   Functional results after subtotal colectomy and caecorectal anastomosis
   Acta Chir Scand, 149 (6), 623-7
   PubMed 6650075
6. Hedlund H, Andersson KE, Ek A (1983)
   Effects of prazosin in patients with benign prostatic obstruction
   J Urol, 130 (2), 275-8
   DOI 10.1016/s0022-5347(17)51106-4, PubMed 6192252
7. Hedlund H, Fändriks L, Delbro D, Fasth S (1983)
   Blockade of non-cholinergic non-adrenergic colonic contraction in response to pelvic nerve stimulation by large doses of alpha, beta-methylene ATP
   Acta Physiol Scand, 119 (4), 451-4
   DOI 10.1111/j.1748-1716.1983.tb07361.x, PubMed 6320588
8. Lazarević B, Milacić D, Stanković A, Cvetković M, Avramović D (1983)
   [Continuous ultrasonic biometry in the determination of fetal growth retardation in pregnant women with the hypertensive syndrome]
   Med Pregl, 36 (5-6), 201-3
   PubMed 6633450
9. Lazarevic B, Rodgers JB (1983)
   Aspiration cytology of carcinoid tumor of the breast. A case report
   Acta Cytol, 27 (3), 329-33
   PubMed 6575550
10. Lazarević B, Sulović V, Pervulov M, Maran S, Avramović D (1983)
    [Hypocorticism, pregnancy, labor and the newborn infant]
    Jugosl Ginekol Opstet, 23 (5-6), 124-5
    PubMed 6679000
11. Milacić D, Lazarević B, Krstić M, Stanković A, Radunović N (1983)
    [Comparative analysis of various standard curves in the evaluation of the body weight of the fetus using ultrasound]
    Med Pregl, 36 (1-2), 21-4
    PubMed 6633438
12. Radunović N, Lazarević B, Pilić Z, Krstić M, Milacić D, Plecas D (1983)
    [Ultrasonic study of pregnancy complicated by a uterine myoma]
    Med Pregl, 36 (3-4), 149-51
    PubMed 6888346
13. Talseth T, Schrumpf E, Ulrichsen H (1983)
    Acute effects of intravenous cimetidine upon gastric secretion in patients with impaired renal function
    Nephron, 33 (4), 244-7
    DOI 10.1159/000182961, PubMed 6405296
14. Ulrichsen H, Fauchald P, Talseth T (1983)
    [Experiences of a subclavian catheter in hemodialysis]
    Tidsskr Nor Laegeforen, 103 (27), 1876-8
    PubMed 6648924
15. Vatn MH, Schrumpf E, Talseth T (1983)
    Effect of cimetidine on intrinsic factor secretion stimulated by different doses of pentagastrin in patients with impaired renal function
    Scand J Gastroenterol, 18 (8), 1109-14
    DOI 10.3109/00365528309181849, PubMed 6424229
16. Vinje O, Fryjordet A, Bruu AL, Møller P, Mellbye OJ, Kåss E (1983)
    Laboratory findings in chronic prostatitis--with special reference to immunological and microbiological aspects
    Scand J Urol Nephrol, 17 (3), 291-7
    DOI 10.3109/00365598309182134, PubMed 6648377

Publications 1982

1. Clementi WA, McNay JL, Talseth T, Haegele KD, Ludden TM, Musgrave GE (1982)
   Endogenous generation of hydralazine from labile hydralazine hydrazones
   J Pharmacol Exp Ther, 222 (1), 159-65
   PubMed 7086698
2. Fasth S, Hedlund H, Svaninger G, Hultén L (1982)
   Autosuture of low colorectal anastomosis
   Acta Chir Scand, 148 (6), 535-9
   PubMed 6760642
3. Onsrud M, Sander S (1982)
   Influence of in vivo diethylstilbosterol phosphate on some human blood lymphocyte sub-populations
   Acta Pathol Microbiol Immunol Scand C, 90 (5), 271-6
   DOI 10.1111/j.1699-0463.1982.tb01449.x, PubMed 6217720
4. Talseth T, McNay JL, Haegele KD (1982)
   Hypotensive effect of the hydralazine--acetone hydrazone in conscious rabbits: evidence for its back-conversion to hydralazine in vivo
   J Cardiovasc Pharmacol, 4 (3), 370-4
   DOI 10.1097/00005344-198205000-00005, PubMed 6177931

Publications 1981

1. Andersson KE, Ek A, Hedlund H, Mattiasson A (1981)
   Effects of prazosin on isolated human urethra and in patients with lower motor neurons lesions
   Invest Urol, 19 (1), 39-42
   PubMed 7251323
2. BEISLAND HO, FOSSBERG E, SANDER S (1981)
   SURGICAL-TREATMENT OF RENAL PAPILLARY NECROSIS
   Scand. J. Urol. Nephrol. (60), 103-106
3. Dahl T, Eide I, Fryjordet A (1981)
   Hypernephroma and hypertension. Two case reports
   Acta Med Scand, 209 (1-2), 121-4
   PubMed 7010927
4. Haegele KD, Talseth T, Skrdlant HB, Shepherd AM, Huff SL (1981)
   Determination of hydralazine pyruvic acid hydrazone and its correlation with "apparent" hydralazine
   Arzneimittelforschung, 31 (2), 357-62
   PubMed 7194654
5. Sulović V, Lazarević B, Abramović D, Cvetković M, Krstić N (1981)
   [Gestational and pregestational diabetes: course and outcome of pregnancy]
   Srp Arh Celok Lek, 109 (12), 1583-98
   PubMed 6755758
6. Talseth T, Boye NP, Bredesen JE, Kornstad S (1981)
   A comparison of the plasma profiles of two slow-release theophylline preparations (Nuelin depot and Theo-dur) in healthy volunteers
   Ann Allergy, 46 (5), 279-80
   PubMed 7235323
7. Talseth T, Boye NP, Kongerud J, Bredesen JE (1981)
   Aging, cigarette smoking and oral theophylline requirement
   Eur J Clin Pharmacol, 21 (1), 33-7
   DOI 10.1007/BF00609585, PubMed 7333344
8. Talseth T, Kongerud J, Boye NP, Bredesen JE (1981)
   [Microcrystallinic theophylline, plasma concentration and adverse effects in patients with obstructive lung disease]
   Tidsskr Nor Laegeforen, 101 (29), 1648-50
   PubMed 7339948
9. TALSETH T, KORNSTAD S, BOYE NP (1981)
   MINOR SIDE-EFFECTS FROM ORAL THEOPHYLLINE - RELATIONSHIP WITH PLASMA THEOPHYLLINE CONCENTRATIONS
   Curr. Ther. Res.-Clin. Exp., 30 (1), 63-70
10. Talseth T, Kornstad S, Boye NP, Bredesen JE (1981)
    Individualization of oral theophylline dosage in elderly patients
    Acta Med Scand, 210 (6), 489-92
    DOI 10.1111/j.0954-6820.1981.tb09856.x, PubMed 7331897
11. Talseth T, McNay JL, Ballinger K, Clementi WA, Shepherd AM (1981)
    Vasoconstriction limits to the use of the central ear artery pressure in conscious rabbits
    Lab Anim, 15 (1), 1-3
    DOI 10.1258/002367781780958667, PubMed 7265889

Publications 1980

1. Haegele KD, Skrdlant HB, Talseth T, McNay JL, Shepherd AM, Clementi WA (1980)
   Quantitative analysis of hydralazine pyruvic acid hydrazone, the major plasma metabolite of hydralazine
   J Chromatogr, 187 (1), 171-9
   DOI 10.1016/s0021-9673(00)87883-8, PubMed 7358814
2. Lien HH, Kolbenstvedt A, Miller A, Bakke SJ (1980)
   Antegrade testicular vein phlebography and funicular lymphography in testicular tumors
   Acta Radiol Diagn (Stockh), 21 (5), 603-13
   DOI 10.1177/028418518002100506, PubMed 7457191
3. Møller P, Vinje O, Fryjordet A (1980)
   HLA antigens and sacro-iliitis in chronic prostatitis
   Scand J Rheumatol, 9 (3), 138-40
   DOI 10.3109/03009748009098144, PubMed 7455619
4. Normann E, Fryjordet A, Halvorsen S (1980)
   Stones in renal transplants
   Scand J Urol Nephrol, 14 (1), 73-6
   DOI 10.3109/00365598009181194, PubMed 6990478
5. Skjennald A, Klevmark B, Stenwig JT (1980)
   Transcatheter embolization of the renal artery with bucrylate in renal carcinoma
   Acta Radiol Diagn (Stockh), 21 (2A), 215-9
   DOI 10.1177/028418518002102a12, PubMed 7424555
6. Talseth T (1980)
   [Colitis cystica profunda]
   Tidsskr Nor Laegeforen, 100 (8-9), 493-5
   PubMed 7385206
7. Talseth T, Haegele KD, McNay JL (1980)
   Studies in the rabbit on 3-methyltriazolophthalazine, an acetylated metabolite of hydralazine. Evidence for an alternative route of formation
   Drug Metab Dispos, 8 (2), 73-6
   PubMed 6103791
8. Talseth T, McNay JL, Clementi WA (1980)
   Route and rate of hydrallazine administration as determinants to its hypotensive effect in rabbits
   Clin Exp Pharmacol Physiol, 7 (4), 403-6
   DOI 10.1111/j.1440-1681.1980.tb00089.x, PubMed 7418274
9. Vinje B, Skjennald A, Fryjordet A (1980)
   Lymphography in the evaluation of urinary bladder carcinoma
   Clin Radiol, 31 (5), 551-3
   DOI 10.1016/s0009-9260(80)80046-8, PubMed 7471630
10. VINJE O, DALE K, MOLLER P, KASS E (1980)
    RADIOGRAPHIC FINDINGS IN THE SPINE AND THE SACROILIAC JOINTS IN PSORIASIS, PROSTATITIS AND ACUTE ANTERIOR UVEITIS
    Scand. J. Rheumatol. (32), 138-140
11. VINJE O, MOLLER P, MELLBYE OJ, FRYJORDET A, KASS E (1980)
    IMMUNOLOGICAL FINDINGS IN PSORIASIS, CHRONIC NON-BACTERIAL PROSTATITIS AND ACUTE ANTERIOR UVEITIS
    Scand. J. Rheumatol. (32), 81-85

Publications 1979

1. Avramović D, Sulović V, Lazarević B, Cvetković M, Milacić D (1979)
   [Use of simethicone in the prevention of postoperative abdominal discomfort and gastrointestinal distension after cesarean section]
   Jugosl Ginekol Opstet, 19 (5-6), 307-11
   PubMed 399787
2. Kolbenstvedt A, Andrew E, Christophersen B, Golman K, Kvarstein B, Lien HH (1979)
   Metrizamide in high-dose urography
   Acta Radiol Diagn (Stockh), 20 (1), 39-45
   DOI 10.1177/028418517902001a05, PubMed 433646
3. Shepherd AM, Ludden TM, Haegele KD, Talseth T, McNay JL (1979)
   Pharmacokinetics of hydralazine, apparent hydralazine and hydralazine pyruvic acid hydrazone in humans
   Res Commun Chem Pathol Pharmacol, 26 (1), 129-44
   PubMed 515498
4. Talseth T, Boye NP, Bredesen JE (1979)
   Clinical and pharmacological observations on a new microcrystalline theophylline preparation
   Scand J Respir Dis, 60 (6), 358-66
   PubMed 538420
5. Talseth T, Haegele KD, McNay JL, Skrdlant HB, Clementi WA, Shepherd AM (1979)
   Pharmacokinetics and cardiovascular effects in rabbits of a major hydralazine metabolite, the hydralazine pyruvic-acid hydrazone
   J Pharmacol Exp Ther, 211 (3), 509-13
   PubMed 512915
6. Tveter KJ, Attramadal A, Hannestad R, Otnes B (1979)
   A morphological study on the effect of cyproterone acetate on human prostatic carcinoma
   Scand J Urol Nephrol, 13 (3), 237-43
   DOI 10.3109/00365597909179531, PubMed 531525

Publications 1978

1. Lazarevic B, Garret R (1978)
   Inverted papilloma and papillary transitional cell carcinoma of urinary bladder: report of four cases of inverted papilloma, one showing papillary malignant transformation and review of the literature
   Cancer, 42 (4), 1904-11
   DOI 10.1002/1097-0142(197810)42:4<1904::aid-cncr2820420431>3.0.co;2-3, PubMed 361216
2. Otnes B, Refsum SB, Husby G, Mathisen W (1978)
   Probable endometrial carcinoma of the prostate, crossed renal ectopia and dermatomyositis in a 32-year-old man
   J Urol, 120 (4), 504-7
   DOI 10.1016/s0022-5347(17)57247-x, PubMed 702678
3. PURVIS K, CALANDRA R, SANDER S, HANSSON V (1978)
   ANDROGEN BINDING-PROTEINS AND ANDROGEN LEVELS IN THE HUMAN TESTIS AND EPIDIDYMIS
   Int. J. Androl., 1 (6), 531-548
   DOI 10.1111/j.1365-2605.1978.tb00624.x
4. Skretting A, Aas M, Normann E, Sødal G, Lindegaard MW (1978)
   Clinical results with 131I-toluidine blue and triple radionuclide subtraction for preoperative localization of enlarged parathyroid glands
   Eur J Nucl Med, 3 (1), 5-9
   DOI 10.1007/BF00253470, PubMed 753623
5. Talseth T (1978)
   Inflammatory tumours in the rectum clinically simulating cancer
   Acta Chir Scand, 144 (5), 321-3
   PubMed 735668
6. Talseth T, Eika C (1978)
   [Protracted glibenclamide induced hypoglycemia]
   Tidsskr Nor Laegeforen, 98 (19-21), 949-50
   PubMed 98861
7. Tveter KJ, Otnes B, Hannestad R (1978)
   Treatment of prostatic carcinoma with cyproterone acetate
   Scand J Urol Nephrol, 12 (2), 115-8
   DOI 10.3109/00365597809179976, PubMed 694435

Publications 1977

1. Lien HH, Kolbenstvedt A (1977)
   Phlebography, urography and lymphography in the diagnosis of metastases from testicular tumors
   Acta Radiol Diagn (Stockh), 18 (2), 177-85
   DOI 10.1177/028418517701800205, PubMed 577113
2. Talseth T (1977)
   Kinetics of hydralazine elimination
   Clin Pharmacol Ther, 21 (6), 715-20
   DOI 10.1002/cpt1977216715, PubMed 862310
3. Talseth T (1977)
   Clinical pharmacokinetics of hydrallazine
   Clin Pharmacokinet, 2 (5), 317-29
   DOI 10.2165/00003088-197702050-00001, PubMed 913002
4. Talseth T, Boye NP, Bredesen JE, Lunde PK (1977)
   [Intravenous influsion of theophyllamine]
   Tidsskr Nor Laegeforen, 97 (29), 1511-13
   PubMed 918923
5. Talseth T, Fauchald P, Pape JF (1977)
   Hydralazine slow-release: observations on serum profile and clinical efficacy in man
   Curr Ther Res Clin Exp, 21 (2), 157-68
   PubMed 403050
6. Talseth T, Landmark KH (1977)
   Polymorphic acetylation of sulphadimidine in normal and uraemic man
   Eur J Clin Pharmacol, 11 (1), 33-6
   DOI 10.1007/BF00561785, PubMed 832655

Publications 1976

1. Buehler PK, Dailey TH, Lazarevic B (1976)
   Spontaneous rupture of colic-artery aneurysms: report of two cases
   Dis Colon Rectum, 19 (8), 671-4
   DOI 10.1007/BF02591007, PubMed 1086764
2. Fossa SD, Kaalhus O (1976)
   Nuclear size and chromatin concentration in transitional cell carcinoma of the human urinary bladder
   Beitr Pathol, 157 (2), 109-25
   DOI 10.1016/s0005-8165(76)80098-4, PubMed 1275858
3. Fosså SD, Miller A (1976)
   Treatment of advanced carcinoma of the prostate with estramustine phosphate
   J Urol, 115 (4), 406-8
   DOI 10.1016/s0022-5347(17)59220-4, PubMed 1263316
4. Sulović V, Avramović D, Lazarević B, Momcilović P, Petković S (1976)
   [Tocolysis in prevention of spontaneous abortion]
   Jugosl Ginekol Opstet, 16 (5-6), 411-9
   PubMed 1027938
5. Talseth T (1976)
   Studies on hydralazine. II. Elimination rate and steady-state concentration in patients with impaired renal function
   Eur J Clin Pharmacol, 10 (5), 311-7
   DOI 10.1007/BF00565619, PubMed 976304
6. Talseth T (1976)
   Studies on hydralazine. III. Bioavailability of hydralazine in man
   Eur J Clin Pharmacol, 10 (6), 395-401
   DOI 10.1007/BF00563075, PubMed 1001354
7. TALSETH T (1976)
   STUDIES ON HYDRALAZINE .1. SERUM CONCENTRATIONS OF HYDRALAZINE IN MAN AFTER A SINGLE DOSE AND AT STEADY-STATE
   Eur. J. Clin. Pharmacol., 10 (3-4), 183-187
   DOI 10.1007/BF00558327
8. Tveter KJ, Mathisen W (1976)
   Uretero-vaginal fistula
   Ann Chir Gynaecol, 65 (6), 408-11
   PubMed 1020907
9. Tveter KJ, Taksdal S, Mathisen W (1976)
   Duplication of the male urethra treated by septotomy. A case report
   Scand J Urol Nephrol, 10 (1), 84-7
   DOI 10.3109/00365597609179661, PubMed 1273537

Publications 1975

1. Kolbenstvedt A, Lien HH, Miller A, Haveland H (1975)
   Antegrade spermatic vein phlebography in testicular tumors. A preliminary report
   Radiology, 114 (2), 461-3
   DOI 10.1148/114.2.461, PubMed 1111017
2. Otnes B, Rootwelt K, Mathisen W (1975)
   A comparison between urography and radioisotope renography in the follow-up of surgery for hydronephrosis
   Scand J Urol Nephrol, 9 (1), 50-6
   DOI 10.3109/00365597509139914, PubMed 1215846
3. Talseth T, Storstein O (1975)
   [Letter: Roentgenologic examination of heart volume]
   Tidsskr Nor Laegeforen, 95 (33), 1943
   PubMed 1188914
4. Tveter KJ, Taksdal S, Mathisen W (1975)
   Traumatic renal arteriovenous fistula treated by ligation and preservation of the kidney
   Scand J Urol Nephrol, 9 (3), 289-92
   DOI 10.3109/00365597509134229, PubMed 1209188
5. Waaler G (1975)
   Idiopathic retroperitoneal fibrosis
   Scand J Urol Nephrol, 9 (2), 110-3
   DOI 10.3109/00365597509180916, PubMed 1145140

Publications 1974

1. Kvarstein B, Mathisen W (1974)
   Surgical treatment of horseshoe kidney. A follow-up study
   Scand J Urol Nephrol, 8 (1), 10-2
   DOI 10.3109/00365597409132810, PubMed 4822979
2. Mjolnerod OK, Haugen HN, Fretheim B, Otnes B, Mathisen W (1974)
   Surgical treatment of Cushing's syndrome in 72 patients
   Scand J Urol Nephrol, 8 (1), 13-8
   DOI 10.3109/00365597409132811, PubMed 4822980
3. Priebe CJ, Marsden DS, Lazarevic B (1974)
   The use of 99m technetium pertechnetate to detect transplanted gastric mucosa in the dog
   J Pediatr Surg, 9 (5), 605-13
   DOI 10.1016/0022-3468(74)90095-5, PubMed 4425274

Publications 1973

1. Kvarstein B, Lindemann R, Mathisen W (1973)
   Renal carcinoma with increased erythropoietin production and secondary polycythemia
   Scand J Urol Nephrol, 7 (2), 178-80
   DOI 10.3109/00365597309133698, PubMed 4759782
2. Tveter KJ (1973)
   Unusual manifestations of renal carcinoma. A review of the literature
   Acta Chir Scand, 139 (4), 401-9
   PubMed 4718185

Publications 1972

1. Topal S, Neuwirth RS, Lazarevic B (1972)
   Variations of ectopic pregnancy as seen at laparoscopy
   J Reprod Med, 8 (1), 26-8
   PubMed 4260585
2. Tveter KJ, Mathisen W, Enge I (1972)
   Primary tumours of the ureter
   Scand J Urol Nephrol, 6 (3), 299-303
   DOI 10.3109/00365597209132106, PubMed 4639099

Publications 1970

1. Sanderud A, Talseth T (1970)
   [Breast neoplasms]
   Nord Med, 84 (32), 1021
   PubMed 5453732

Publications 1965

1. Pavićević R, Lazarević B (1965)
   [Anti-smallpox vaccination in children with allergic disposition]
   Srp Arh Celok Lek, 93 (10), 943-9
   PubMed 5872504

Publications 1957

1. TOMIC J, LAZAREVIC B (1957)
   [Treatment of tuberculous meningitis without intrathecal administration of drugs]
   Tuberkuloza, 9 (1), 3-18
   PubMed 13468115